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Abstract 
 
T(4;11) acute lymphoblastic leukaemia (ALL) presenting the fusion gene MLL/AF4 is a 
hallmark of infant ALL. The 5 year event free survival is less than 40%. It was shown 
that MLL/AF4 is important for cell cycle progression, proliferation, clonogenicity, 
engraftment in mice and repression of apoptosis. However, in order to improve 
treatment MLL/AF4 needs to be examined in contexts closer to the leukaemic situation 
in vivo.   
To investigate the fusion gene, MLL/AF4 positive SEM, generated from an ALL patient, 
were depleted for MLL/AF4 by RNAi. The consequential changes in gene expression 
patterns were analyzed using cDNA- and Oligo- arrays. These gene expression patterns 
were assigned to biological functions and pathways using the Ingenuity platform. A set 
of significantly differently expressed genes such as N-CADHERIN and FGFR1, both 
described for the adherence and regulation of haematopoietic stem cells (HSC), was 
identified and validated by qRT-PCR.  
The HSC niche context was further investigated by establishment of a leukaemic - bone 
marrow feeder cell-to-cell interaction assay. Increased cell death, cell cycle arrest and 
prolonged growth curves caused by MLL/AF4 depletion in SEM could also be shown 
on feeders. Additionally, culturing of MLL/AF4 positive patient material on feeders 
allowed for long-term culture.  
An imaging method using fluorescent MLL/AF4 positive cells in mouse xenograft 
models was employed to monitor the distribution and biology of MLL/AF4 positive 
cells, showing colonisation of bone marrow rich spinal, femoral and cranial bones. 
Finally, in order to analyze the function of identified target genes of MLL/AF4 by over-
expression, a novel lentiviral expression system allowing transduction of stem cells and 
tightly regulating induction of expression, was initiated.   
In conclusion, these data indicate a central role of MLL/AF4 in leukaemogenisis while 
the systems established in this work are of relevance for drug development assays. 
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Chapter 1: Introduction 
 
1.1  Haematopoiesis 
 
Haematopoiesis is the formation (greek: poiesis) of blood (greek: haima) cells. This 
process provides all blood cells which originate from haematopoietic stem cells (HSC). 
Haematopoietic stem cells are able to self-renew and are multipotent meaning they can 
differentiate into all types of blood cells. In human adults they are located in the bone 
marrow. In principle, haematopoietic stem cells can divide indefinitely and maintain the 
stem cell pool, whilst producing progenitor cells. This function of dividing to form at 
least one identical daughter cell with full differentiation potential is called self-renewal. 
In contrast progenitors are already restricted, meaning they cannot differentiate into all 
types of blood cells anymore. Progenitor cells and subsequently differentiated cells 
show increasing restriction to specific cell types and increasing proliferation potential, 
while HSCs divide only rarely. More and more differentiated blood cells are amplified 
by proliferation and continuously provide the cellular components of blood (Figure 1). 
Fetal haematopoiesis occurs mainly in the liver. However, other organs can harbor 
haematopoiesis if necessary, including the thymus and spleen. These are known as 
extramedullary sites of haematopoiesis.  
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Figure 1  Basic model of Haematopoiesis 
A haematopoietic stem cell can differentiate into progenitor cells which can further differentiate into fully 
mature lymphoid and myeloid blood cells. There are two major types of blood cells: myeloid cells which 
derive from the common myeloid progenitor and comprise cells such as Erythrocytes and Granulocytes 
and lymphoid cells which derive from the common lymphoid progenitor and comprise cells such as B and 
T lymphocytes    from scioly.org/w/index.php?title=Anatomy 
 
 
There are two main subgroups of blood cells:  
 the myeloid which comprise the macrophages, monocytes,  granulocytes 
(basophil, neutrophil and eosinophil), mast cells, erythrocytes and thrombocytes 
(fragments of megakaryocytes)  
 the lymphocytes which comprise natural killer cells, T-lymphocytes and B-
lymphocytes.  
The myeloid cells are derived from a common myeloid progenitor while the lymphoid 
derive from a common lymphoid progenitor. 
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A more up to date model from Adolfsson et al 2005 (Adolfsson, Mansson et al. 2005) 
slightly changes the position of the progenitor cells (see Figure 2). 
 
Figure 2  Composite model of Haematopoiesis 
A longterm Haematopoietic stem cell (LT-HSC) differentiates into a short term HSC (ST-HSC) which 
can further differentiate into a common myeloid progenitor (CMP) and a lymphoid primed multipotent 
progenitor (LMPP). CMPs give rise to megakaryocyte/erythroid progenitors (MkEP) and 
granulocyte/macrophage progenitors (GMP). LMPP give rise to GMPs as well as to CLPs which 
differentiate into B and T cells. So far this was shown in mice.     from Adolfsson et al  2005 
 
This model further specifies longterm HSCs (LT-HSC), with full self renewal capacity 
and short term HSCs (ST-HSC), with reduced self-renewal capacity compared to LT-
HSCs, but still full myelo-lymphoid differentiation potential (Figure 2). Most 
importantly, the existence of a so called lymphoid-primed multipotent progenitor 
(LMPP) with high proliferation potential and combined myelo-lymphoid differentiation 
potential, but an ablated ability to generate erythroid and megakaryocyte lineages, 
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changed the current model (Adolfsson, Borge et al. 2001; Adolfsson, Mansson et al. 
2005). However, the existence of a LMPP was shown in mice so far. 
Lymphoid organs such as spleen, thymus and lymph nodes are important in the 
maturation, activation and proliferation of certain lymphoid cells. The old model 
consisted of a lymphoid restricted progenitor which should migrate to lymphoid organs 
for the maturation into fully differentiated cells, however the newer finding of the 
LMPP in mice, which can also give rise to GMPs (granulocyte macrophage progenitors) 
questions if such a LMPP would migrate to lymphoid organs. 
The various sub branches of haematopoiesis can be activated and thus regulated by 
certain growth factors such as colony stimulating growth factors and interleukins. 
Haematopoietic stem cells, progenitors and fully differentiated blood cells show a 
characteristic set of surface expression markers by which they can be identified. 
 
1.2 Leukaemia  
 
Leukaemia is a term constituted of the two greek words leukos for “white” and hamia 
for “blood”. Leukaemia is a haematological malignancy, a type of cancer which affects 
blood cells. Leukaemias are divided onto two main groups: the chronic and the acute 
leukaemias. In chronic leukaemia, mature but abnormal white blood cells accumulate 
over a long period, the progression usually takes months to years and is often monitored 
for evidence of substantial disease progression before being treated. Chronic leukaemia 
is mainly found in older patients. 
In contrast, acute leukaemia is characterized by a fast progression. Immature cells 
accumulate and interfere with the production of normal blood cells in the bone marrow, 
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resulting in bone marrow failure syndrome – the combination of low levels of 
erythrocytes, leukocytes and platelets.  Early initiation of treatment is required due to 
the fast progression of the disease. The extreme enrichment of malignant cells leads to a 
spill over in the blood and organ infiltration. These two features result in the common 
presenting symptoms: 
fatigue; breathlessness; susceptibility to infections; excessive bruising; petechiae; (little 
spots or lines in the skin due to low platelets); bone pain; joint pain and enlargement of 
lymph nodes, liver and spleen.  
Acute leukaemia is subclassified into acute myeloid leukaemia (AML) and acute 
lymphoblastic leukaemia (ALL). 
 
1.2.1 AML 
 
Acute myeloid leukaemia (AML) affects white blood cells from the myeloid lineage. 
Similar to ALL it is characterized by a rapid growth of abnormal myeloid cells which 
accumulate in the bone marrow and interfere with the generation of normal blood cells. 
This results in fatigue, shortness of breath, bruising, bleeding and a higher risk for 
infections. The symptoms are caused by the replacement of normal cells, the drop in red 
blood cells and platelets. One subgroup are AMLs with recurrent genetic abnormalities 
like translocations, e.g. t(8;21) where a RUNX1 / RUNX1T1 fusion protein is present. 
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1.2.2 ALL 
 
Acute lymphoblastic leukaemia (ALL) affects white blood cells of the lymphoid lineage. 
The symptoms are the same as for acute leukaemia in general.  
ALL is diagnosed by analysis of the complete blood count, blood smears and the white 
cell count. Blood smears show blasts in the majority of ALL cases (see Figure 3). 
 
Figure 3 Pappenheim stains from patients with ALL 
(Left) Peripheral blood of a child (magnification x100), 3 violet stained bigger cells are lymphoblasts, 
grey cells are erythrocytes (Right) Bone marrow smear (large magnification).  Bone marrow containing 
numerous  lymphoblasts.    free to publish 
 
Bone marrow biopsies are used to prove ALL. Further diagnostics include cytogenetics 
and immunophenotyping to subclassify if blasts derive from B or T-cells, determining 
T- or B-cell ALL. But also imaging methods such as ultrasound and CT are used to 
investigate if organs such as lungs, liver, spleen, lymph nodes, kidneys and brain were 
infiltrated.   
B lineage ALL can be further subdivided by surface marker expression into progenitor 
cells (see Figure 4).  
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In precursor B cell ALL (CD10+, cytIgM+) a precursor, a partially differentiated, 
unipotent cell, often called blast as well is affected. Subtypes of precursor B-cell ALL 
comprise translocation generated forms (see chapter 1.3) such as t(12;21)-ETV, t(1;19)-
E2A/PBX1, t(9;22)-BCR/ABL and t(v;11q23)-MLL rearrangement. 
Pro-B ALL (CD10-) is one of the most immature ALL subtypes. Approximately 30% 
show the t(4;11) translocation (see chapter 1.3 ).  
Finally common ALL (cALL) (CD10+, cytIgM -) which is more mature than pro B-
ALL is found to be connected to t(9;22), t(12;21) and hyperploid B-cells. cALL 
comprises for 20% of childhood ALL. It shows  a high recurrence of chromosomal 
translocations such as t(1;19)(q23;p13). 
 
 
Figure 4  B-cell development 
A B-cell differentiates starting from a pro-B cell to a pre B cell, to a B cell and finally a plasmacell. These 
stages correspond to genetic processes.  Rag (recombination active gene) involved in recombination and 
rearrangement; H Heavy chain, L light chain of immunoglobuline; DJ, VJ, VDJ Diverse (D), Variable (V) 
and Joining (J) gene segment events.     from nfs.unipv.it/.../immunology/bcelldif 
 
1.2.2.1 ALL epidemiology and aetiology  
The majority of the ALL cases occur in children with a peak age of 2 to 5 years with a 
1:1.3 predominance in males. Although a few cases are connected to inherited diseases 
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such as Down syndrome, Bloom’s syndrome, Ataxia telangiectasia and Nijmegen 
breakage syndrome they only account for less than 5% (Pui, Robison et al. 2008). 
Studies have shown that ALL is also associated to ionizing radiation, exposure to 
chemotherapy and a high birth weight (Hjalgrim, Westergaard et al. 2003). Overall a 
relation to industrialization was found. Additionally, it is known that there is a prenatal 
origin for some childhood leukaemias (Wiemels, Cazzaniga et al. 1999).  
Flavonoids such as Querceptin found in fruits and vegetables could, according to a 
hypothesis, act as Topoisomerase II inhibitors and could increase the risk of childhood 
leukaemias as discussed by Juli A. Ross 2000 (Ross 2000) .  
Twin studies in TEL/AML1 (ETV6/RUNX1)-positive ALL revealed that although there 
is a much higher prevalence for ALL of about 100 times (Mori, Colman et al. 2002) the 
concordance of developing ALL in identical twins who bear this fusion is only 10%. 
This can be explained by  the concept that additional events to a first hit are required 
after birth to induce leukaemia (Greaves and Wiemels 2003).  
The delayed infection hypothesis from Greaves relies on a minimum two-hits model 
connecting prenatal events to second hits (see Figure 5). Because of the increased 
hygienic situation in industrialized countries a pre-leukaemic cell would have low 
exposure to antigens. If a delayed, meaning later in life, infection occurs it could trigger 
an aberrant response of the pre-leukaemic cell. This response is induced by cytokines 
produced from activated T-cells, which lead to a suppression of haematopoiesis and a 
selective outgrowth of preleukaemic cells. Secondary mutations can then generate 
“overt leukaemic cells” (Greaves 2006). 
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Figure 5  Delayed infection hypothesis 
Greaves’ hypotheses is based on a pre-leukaemic cell which is exposed to low antigen levels after birth 
due to higher hygiene in industrialized countries. It assumes that infections in early childhood could 
trigger the growth of such a pre-leukaemic cell.        from Pui et al.  2008 
 
1.2.2.2 ALL Development 
The development of ALL is thought to begin in committed blood progenitor cells that 
received events such as mutations, deletions and translocations. Committed 
haematopoietic progenitors in general can be of the myeloid (CMP, MkEP, GMP) the 
lymphoid branch (CLP) or mixed lympho-myeloid (LMPP). If genetic lesions such as 
mutations occur in a B or T-cell, they can produce a stage specific developmental arrest 
or an impaired capacity for unlimited self renewal (Armstrong and Look 2005). But 
such mutations can have already occurred in haematopoietic stem cells providing those 
with multi-lineage capacities (Wang and Dick 2005).  
A recent study investigated bone marrow mesenchymal stem (BM-MSC) cells of 
children with B-ALL for different cytogenetic abnormalities with fusion genes like 
TEL/AML1, BCR/ABL, AML/MTG8, MLL/AF9, MLL/AF10 and MLL/ENL (Menendez 
P, Catalina P 2009). Only MLL/AF4 patient mesenchymal stem cells were positive for 
the corresponding fusion gene and its expression. In this context the fusion could be 
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generated early in the stem cell hierarchy while the leukaemic blast is arrested in the 
later stage of a pro B cell (Menendez P, Catalina P 2009). 
Although chromosomal abnormalities are a hallmark of ALL, additional genetic events 
are necessary to induce leukaemia. In 40% of B-cell precursor ALLs events such as 
amplifications, point mutations and deletions are located in B-cell regulating genes 
(Mullighan, Goorha et al. 2007). The B cell developmental genes are frequent targets 
for mutation, these include TCF3, LEF1 and IKZF1 and most frequently PAX5, which 
is mutated in about 30% of precursor ALLs (Mullighan, Goorha et al. 2007). The 
sequential expression of these and other transcription factors drives the B-cell though its 
several developmental stages. 
The Knudson 2-hits model is based on observations in retinoblastoma but was 
generalized to all cancers. According to this model, cancer is the result of accumulated 
mutations to a cell's DNA. As retinoblastoma cases showed, children with early disease 
onset had inherited a first event and just needed a second event for the generation of 
retinoblastoma. Older patients should have acquired two mutations before they 
developed this cancer type (Knudson A 2001). Later this model was expanded, stating 
that carcinogenesis is dependent on tumour suppressor genes, which control cell growth, 
and on proto-oncogenes, which stimulate cell growth (Tomlinson, Roylance et al. 
2001).  
Beside the HSC as cell of origin for ALL, previous models also state that leukaemia is 
established by a rare leukaemic stem cell (LSC) within the leukaemic cell population. In 
contrast to the rare LSC (leukaemic stem cell) model, Le Viseur et al. have shown that 
sorted primary blast populations from B precursor ALL, representative of several stages 
of B precursor maturation, are able to initiate leukaemia in a NSG mouse model, even 
Chapter 1: Introduction 
11 
 
with restricted numbers transplanted (Le Viseur 2008). This has lead to the development 
of a new ALL stem cell model, where almost every cell has the potential to activate 
stem cell phenotype, as discussed by Vormoor (Vormoor 2009). 
1.2.2.3 Treatment 
Following diagnosis of the subgroup of leukaemia and the allocation into the low, high 
or very high risk group treatment is started with the remission induction phase. This first 
phase aims to kill 99% of the leukaemic cells while allowing normal haematopoiesis to 
proceed. The standard treatment is a 3 drug protocol consisting of a glucocorticoid 
(prednisone or dexamethasone) vincristine and asparaginase, whilst adults and children 
with a high risk receive a 4 drug treatment induction (Pui and Evans 2006) with addition 
of an anthracycline. The second phase is the consolidation phase in which the treatment 
in intensified to kill remaining more resistant leukaemic cells, such as remaining cells 
from the marrow or in the CNS. This treatment reduces the risk of relapse and 
frequently includes high doses of methotrexate plus mercaptopurine. The last phase is 
the continuation/maintenance treatment and is mainly thought to prevent relapse (see 
Figure 6) (Pui, Robison et al. 2008). 
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Figure 6  Treatment of leukaemia 
A general treatment protocol for leukaemia is shown. Induction of treatment aims to kill the majority of 
cells initially present leading to a strong decrease in leukaemic cell numbers. Consolidation aims to 
further reduce more resistant leukaemic cells and maintenance treatment aims to prevent relapse from 
outgrowth of surviving leukaemic cells. Red curve cured patient, green curves relapsing patients        from 
www.atlasgeneticsoncology.org/Deep/MinResDiseaseA...                                                
 
ALL patients receive chemotherapy for 2 (girls) to 3 years (boys), in which daily 
mercaptopurine and weekly methotrexate are the basic drugs. 
For patients with very high risk, relapsed or refractory disease, treatment may also 
include radiation to the CNS or allow stem cell transplantations. Prior to transplantation 
a myoablative therapy is given which should kill all haematopoietic stem cells. An HLA 
(tissue type) matched donour is required, and may be an identical twin, sibling or 
unrelated person. However, this treatment modality has significant and potentially life 
threatening side effects including prolonged bone marrow suppression and such as graft 
versus host disease.  
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1.2.2.3.1 Chemotherapeutic agents 
Chemotherapy is in principle a treatment with chemicals to eradicate microorganisms or 
cancer cells, nevertheless the term chemotherapy is widely used for anti-neoplastic 
drugs, which are cytotoxic or cytostatic and mainly harm cells with a high proliferation 
rate. The inhibition of highly proliferating cells can also harm hair follicles, the bone 
marrow and the digestive tract leading to alopecia (hair loss), myelosuppression and 
mucositis (inflammation in the intestines). Nausea is a common acute side effect of 
treatment. 
Listed below are the  most common therapeutic agents for the treatment of ALL. 
Prednisolone (Figure 7A) is an anti-inflammatory corticosteroid. It inhibits functions 
such as leukocyte migration and capillary proliferation. It is thought to induce apoptosis 
in lymphoid cells. Long term side effects include cushing syndrome, glaucoma, 
osteoporosis, diabetes mellitus. 
Dexamethasone (Figure 7 B) is an anti-inflammatory altenative corticosteroid. It is 
believed to provide better penetration into the CNS but has a higher incidence of side 
effects including psychological disturbance and avascular necrosis. 
Vincristine (Figure 7 C) is a vinca alkaloid from the Catharanthus roseus plant. It acts 
as a mitotic inhibitor by binding to tubulin and inhibition of microtubule assembly. 
Long term side effects include neuropathy. 
Asparaginase (no image) is an enzyme that catalyzes the hydrolysis of asparagine to 
aspartic acid. The principle of its function is that, in contrast to healthy cells, the non-
essential aminoacid asparagine cannot be synthesized by ALL cells.  
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Cyclophosphamide (Figure 7 D) is a nitrogen mustard compound which alkylates DNA 
at the N7 of the base guanine. Long term side effects include the increased risk for bone 
marrow and lymph node cancers. 
 
Figure 7  Chemotherapeutic agents  
Structural formulas of   (A) Prednisolone   (B) Dexamethasone   (C) Vincristine  and (D) 
Cyclophosphamide       free to publish 
 
Cytarabine (Ara C) (Figure 8 A) is a nucleoside analogue which damages DNA making 
S-phase cells especially susceptible. As long term effects secondary malignancy and 
infertility are reported   
(http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=6253). 
Etoposide (Figure 8 E) is an inhibitor of Topoisomerase II whose natural function is to 
unwind the DNA double helix by cutting and re ligating both strands and is essential in 
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replication. This inhibitor targets the re ligation. A known long term side effect is the 
induction of secondary AML. 
6-Thioguanine (Figure 8 B) is an antimetabolite which interferes with the purine and 
pyrimidine biosynthesis. It can possibly interfere with epigenetic gene regulation by 
perturbing cytosine methylation. Identified side effects include veno-acclusive disease 
of the liver (hepatotoxicity) and secondary malignancies.  
6-Mercaptopurine (Figure 8 C) is a 6-Thioguanine prodrug and a purine derivate which 
inhibits nucleotide synthesis and metabolism as well. It affects nucleotide 
interconversion and glycoprotein synthesis. Possible long term side effects are diseases 
such as lymphomas. 
Methotrexate (Figure 8 D) is an antimetabolite which inhibits the metabolism of folic 
acid. Side effects are hepatotoxicity and cytopenia, meaning decreased blood cell 
production. 
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Figure 8 Chemotherapeutic agents 2 
Structural formulas of   (A) Cytarabine  (B) 6-Thioguanine  (C) 6-Mercaptopurine   (D)  Methotrexate 
and   (E) Etoposide      free to publish 
 
1.2.2.4 Outcome 
 
Nowadays the  overall survival rates of ALL in children are higher than 80% (Silverman, 
Gelber et al. 2001). Important prognostic factors are the level of the leukocyte count and 
the age at diagnosis. Children of 1 to 9 years of age have a better prognosis than infants 
(Pui, Campana et al. 2001). The 5 year event free survival is 88% for 1 to 9 years, 73% 
for 10 to15 years, 69% for patients older than 15 and 44% for infants younger than 12 
months (see Figure 9). Infants younger than 6 month at diagnosis have the poorest 
prognosis (Hilden, Dinndorf et al. 2006). 
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Figure 9  Kaplan-Meier estimates of event-free survival  
Kaplan-Meier estimates of event-free survival according to age at diagnosis of acute lymphoblastic 
leukaemia. The table below the diagram shows the number of patients assessed corresponding to the years 
on the x-axis.         from Pui, Robinson et al. 2008 
 
A low risk of relapse is found in patients aged 1 to 9 and a leukocyte count below 
50x109/l (Pui, Campana et al. 2001) while patients with more than 400x109/l are 
hyperleukocytic and are at high risk for early complications (Lowe, Pui et al. 2005).  
Additionally genetic factors determine the prognosis of a patient. The 5 year event free 
survival is 91% for hyperploidy, 89% for TEL/AML1, 86% for E2A/ PBX1 fusion, 82% 
for other B-lineage leukaemias, 73% for T-cell ALL, 37% for BCR/ABL and 32% for 
MLL/AF4 (Pui, Robison et al. 2008) (see Figure 10).  
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Figure 10  Kaplan-Meier analysis of event-free survival 2 
Kaplan-Meier analysis of event-free survival according to biological subtype of leukaemia                      
The table below the diagram shows the number of patients assessed corresponding to the years on the x-
axis.      from Pui, Robinson et al. 2008   
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1.3 Recurrent chromosomal rearrangements 
 
Genetic lesions such as mutations, deletions, duplications, inversions, insertions and 
translocations are very common in leukaemias. In a translocation a chromosomal region 
is located to another chromosome. This chromosomal rearrangement with a non-
homologous chromosome is called reciprocal if, chromosomal segments are exchanged 
between these chromosomes (see Figure 11). They occur in 0.16% of all newborns, but 
in the majority of the cases they have no consequences due to the lack of secondary 
mutations. These would be required to induce leukaemia according to the two hit model. 
 
Figure 11  Balanced translocation 
In a balanced translocation portions of chromosome “A” and chromosome “B” are exchanged and fused 
leading to two newly fused chromosomes but no loss of genetic material.     from U.S. National Library of 
Medicine 
 
Chromosomal translocations can result in the generation of fusion genes. These are 
generated if the breakpoint of one chromosome segment lies within a gene and this is 
fused to the breakpoint of another gene, which can give rise to a unique gene translating 
into a fusion protein with novel properties. Common examples are the CML-associated 
t(9;22)(q34;q11) reciprocal translocation which generates BCR/ABL fusion gene and the 
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t(4;11) translocation which generates two reciprocal fusion genes MLL/AF4 and 
AF4/MLL. 
Reciprocal translocations are responsible for the generation of different leukaemias of 
which the majority are generated de novo. Elliot and Jasin suggested that repair 
mechanisms accidently produce translocations while trying to repair an extended DNA 
damage (Elliott 2002). In contrast therapy related leukaemias are known to be caused by 
chemotherapeutic agents. Especially several cases of AML are connected to 
Topoisomerase II inhibitors. Uninhibited Topoisomerase II controls double-strand 
breaks and helps maintain the structure of DNA throughout different cell phases. The 
blockage of this enzyme supports non-homologous recombinations, creating various 
MLL rearrangements and inducing relatively therapy resistant leukaemias. (Andersen, 
Christiansen et al. 2001). Etoposide, a commonly used Topoisomerase II inhibitor, was 
shown to induce MLL rearrangements in fetal liver cells (Moneypenny, Shao et al. 
2006).  
The mechanism of aberrant translocation relies on two or more double strand breaks 
followed by incorrect rejoining of the broken ends. Many of those new junctions show 
loss of substantial DNA material at the breakpoints, suggesting DNA degradation 
before joining. The non-homologous end joining (NHEJ) pathway employing DNA-
dependent protein kinase (XRCC4) and DNA ligase IV (Povirk 2006), is used to repair 
double strand breaks. Unlike the homologous recombination, no homologous sequence 
is required to ligate the ends of the breaks.  After a double strand break DNA dependent 
protein kinase (DNA-PK) and several other proteins are required to prepare the ends of 
the DNA for subsequent ligation (see Figure 12).  
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Figure 12  Non-homologous end joining 
After a double strand break DNA-PK and other proteins prepare the ends of double strand broken DNA 
for ligation. DSB double strand break; Ku70, Ku80 autoantigens forming a heterodimer; DNA-PK DNA 
dependend protein kinase, Rad50 RAD50 homolog, Mre11 meiotic recombination 11 homolog A , 
XRCC4 X-ray repair complementing defective repair in Chinese hamster cells 4    from 
www.gurdon.cam.ac.uk/.../research_interests.htm 
 
 
1.4 MLL 
 
Mixed lineage leukaemia gene MLL, also called ALL1, is a proto-oncogene which is 
translocated in various ALLs.  MLL belongs to the human trithorax gene family and is 
homologous to the Drosophila trithorax (trx). Amongst others the Drosophila trithorax 
stimulates gene expression during embryogenesis. The polycomb genes act 
antagonistically to trx, repressing target genes (Popovic and Zeleznik-Le 2005). 
Polycomb proteins can act in epigenetic silencing of genes such as HOX genes. In 
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contrast trithorax genes (trx) maintain gene expression by influencing the chromatin 
structure. 
 
Figure 13  The MLL protein and gene 
(A)   MLL protein;  shown in green are protein interactions that are present after translocations and shown 
in purple are protein interactions  lost in the MLL fusion proteins.     (B)   Mll gene  left chromosome 11 
and the position of MLL and right schematic of MLL gene  AT hooks  regions of DNA binding, SNL1,2 
nuclear localization signals, RD1,2 repression domains,  DNMT1 DNA methyl transferase 1, HDAC 
Histone deacetylase, PHD plant homology domain, FYRN and FYRC N and C terminal domain for 
heterodimerisation, TAD transcriptional activation domain and SET  histone methylase             from 
Daser et al. 2004 
 
The gene locus of MLL is positioned at the long arm band q23.3 of chromosome 11. 
The gene comprises 36 exons. The transcribed 11.9 kb long mRNA translates into a 
3969 amino acids long protein which contains many domains with regions homologous 
to various proteins (see Figure 13). Three AT-hooks are located close to the MLL N-
terminus. These promote binding to AT-rich DNA in the minor groove (N.J. Zeleznik-
Lee 1994). By binding to DNA, MLL can recruit proteins to the DNA by protein-
protein interactions. The AT hooks are followed by SNL1 and SNL2, which are nuclear 
localization signals. Further downstream RD1 and RD2 are located, two repression 
domains of different function, which can be found in all MLL fusions and which are 
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necessary for the fusion gene-mediated transformation (Slany, Lavau et al. 1998). Then 
Polycomb repressor proteins HPC2 and BMI-1 and the co repressor CTBP are recruited 
by the DNA methyltransferase homology domain located in RD1 (Xia, Anderson et al. 
2003). The histone deacetylases HDAC1 and HDAC2 are recruited by RD2 and cause 
repression (Xia, Anderson et al. 2003). Taspase 1 cleaves the MLL protein at CS1 and 
CS2 into 2 polypeptides, of N-terminally 2666 and C-terminally 1251 amino acids size. 
They form a heterodimer by connection of the FRYN and FRYC domains (Hsieh, Ernst 
et al. 2003) (see Figure 14). MLL, or more exactly cleaved MLL, is important for HOX 
gene expression, as knockdown of Taspase 1 was linked to loss of Hox gene expression 
(Hsieh, Cheng et al. 2003). Regions including the PHD domain (plant homology 
domain), downstream TAD (transcriptional activation domain) and the C-Terminal SET 
domain are not retained in MLL fusions such as MLL/AF4. TAD interferes with 
acetylation and HOX gene expression while SET possesses a histone methylase activity 
for  histone 3 at lysine 4 (Milne, Briggs et al. 2002). H3K4 methylation represents an 
active state of transcription, which is probably induced at HOX gene promoters by the 
SET domain of MLL. (Daser and Rabbitts 2004).  
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Figure 14  The processing of the MLL protein 
MLL is cleaved by Taspase 1 leading to the heterodimerisation of the N and C terminal fragment which 
can locate into the nucleus and regulate gene expression, here the HOX gene exons are shown   AT hooks  
regions of DNA binding, PHD plant homology domain, FYRN and FYRC N and C terminal domain for 
heterodimerisation and SET  histone methylase.       from Hsieh et al. 2003 
 
The MLL gene contains a breakpoint cluster region (BCR). This 8.3kb spanning region 
is known to produce several different breakpoints and related translocations. For the 
MLL gene more than 100 translocation partners are known. Within a single 
translocation partner, such as t(4;11), translocation produces slightly different fusion 
genes due to the variety of MLL Breakpoints. MLL rearrangement is the most common 
translocation in childhood ALL. A prominent fusion partner of MLL is AF4 (see Figure 
15). 
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Figure 15  The frequency of MLL associated chromosomal abnormalities 
The frequency of MLL associated c hromosomal abnormalities in (A) Spontaneous acute leukaemia            
(B) Therapy related acute leukaemia     MLLT myeloid/lymphoid or mixed-lineage leukemia (trithorax 
homolog, Drosophila); translocated to 4 (AF6), 3 (AF9), 10 (AF10), 1 (ENL); ELL elongation factor 
RNA polymerase II        from Daser et al 2004 
 
 
1.5 AF4  
 
The AF4  gene encodes a 125 to 145 kDa protein from a 10.5 kb mRNA, which is 
transcribed from 23 exons covering 300kb on chromosome 4 band q21 (Bursen, Moritz 
et al. 2004). The ubiquitous protein AF4 localizes to subnuclear compartments and is 
expressed in various haematopoietic and non-haematopoietic cells (Li, Frestedt et al. 
1998). 
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Figure 16  Schematic representation of the protein AF4 
NHD N terminal homology domain, ALF AF4/LAF4/FMR2 protein family, pSer serine and proline rich 
region, NLS Nucleus localization signal and CHD C terminal homology domain         from Bursen et al 
2004  
 
The NHD (N-terminal homology domain), the CHD (C-terminal homology domain), 
ALF, pSer and NLS are all conserved protein domains (see Figure 16). ALF is the 
consensus domain for the members of the ALF protein family which include 
AF4/LAF4/FMR2 (ALF) and encode for transcription cofactors which are frequently 
translocated in childhood leukaemia. The downstream pSer domain is a proline and 
serine rich region. Finally, upstream of CHD is the NLS, a nuclear localization region. 
Because AF4 has DNA binding and transcriptional activation properties it is thought to 
act as a nuclear transcription factor (Prasad, Yano et al. 1995; Ma C 1996; Nilson I 
1997). The interaction of AF4 with ubiquitin ligases SIAH1 and SIAH2 regulates its 
proteasomal degradation. These two ubiquitin ligases and the N-terminal portion of AF4 
are thought to be involved in the oncogenic mechanism of AF4/MLL (Bursen, Moritz et 
al. 2004). 
AF4 inactivation in mice causes defects in the development of B and T cells, such as 
lower expression of CD4 and CD8 and reduced numbers of mature and pre B cells in 
the bone marrow (Isnard, Core et al. 2000).  
Isnard et al assumed that the translocation of AF4 with MLL could orientate the 
oncogenic process towards the lymphoid lineage. Interestingly the MLL/AF4 fusion 
protein has the same sub cellular distribution as AF4 (Li, Frestedt et al. 1998). 
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1.6 MLL/AF4 ALL 
 
MLL/AF4 is a fusion gene which is generated by the translocation of chromosome 4 and 
11 - t(4;11)(q21;q23) (see Figure 17). 
MLL/AF4 ALL has the worst outcome in infants and adults while children do better 
(Mancini, Scappaticci et al. 2005). It is also the most common translocation in infant 
leukaemia, being present in 70-80% of cases. Infant MLL/AF4 cases are considered as 
high or very high risks patients. 
 
 
           
 
Figure 17  The MLL, MLL/AF4 and the AF4/MLL gene 
(Top) the MLL gene  (2nd from top) the AF4  gene  (3rd) MLL-AF4  fusion gene and (4th) the AF4-MLL 
fusion gene; NHD N terminal homology domain, ALF AF4/LAF4/FMR2 protein family, pSer serine and 
proline rich region, NLS Nucleus localization signal and CHD C terminal homology domain, AT hooks  
regions of DNA binding, PHD plant homology domain, FYRN and FYRC N and C terminal domain for 
heterodimerisation and SET  histone methylase 
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However, the t(4;11) translocation produces a second fusion gene AF4/MLL which 
fuses the C terminal part of MLL to the N terminal part of AF4 (see Figure 17). This 
fusion gene was associated with oncogenic potential and other properties which are 
mentioned later, paradoxically it is only present in 80% of the MLL/AF4 patients. 
An interesting indication for the cause of such MLL rearrangements and thereby 
resultant leukaemias, is the occurrence of MLL rearrangements in secondary leukaemias 
(see Figure 15 B) following Topoisomerase II inhibitor treatment (Pui and Relling 
2000). It was speculated that MLL rearrangements could be caused by Topoisomerase II 
inhibitors from environmental, medical or dietary exposure (Biondi, Cimino et al. 2000).  
Leukaemic translocations such as t(4;11) often activate genes that encode for master 
oncogenic transcription factors that are developmentally regulated, controlling cell 
differentiation and encoding proteins in important transcription cascades (Armstrong 
and Look 2005). They are aberrantly expressed in leukaemic cells and regulate 
downstream responder genes positively or negatively (Pui, Relling et al. 2004).     
The biological function of MLL/AF4 was studied by several ways in vivo and in vitro, 
by knock-in, over expression and by knock down. 
An MLL/AF4 knock-in mouse model showed that MLL/AF4 expression in young mice 
resulted in a lymphoid and myeloid deregulation, while bone marrow colonies showed 
unique mixed pro-b lymphoid colonies (Chen, Li et al. 2006). After 520 days (median) 
incubation time mice developed mixed lymphoid and myeloid hyperplasia, B-cell 
lymphomas and haematopoietic malignancies. The white blood count was increased and 
immature cells were found in the blood. Despite these symptoms the long time for the 
onset of the haematological malignancy suggested that a second hit was missing (Chen, 
Li et al. 2006). 
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In an alternative model the conditional expression of MLL/AF4 resulted in large, 
diffuse B-cell lymphomas and in a long latency. The tumours were transplantable but 
MLL/AF4 knock-in mice seemed, as in the previous model, to lack the 2nd hit. The 
authors concluded that only in lymphoid cells MLL/AF4 can act as an oncogene 
(Metzler, Forster et al. 2006). 
The group of Scott Armstrong has created a conditional mouse knock-in model for 
MLL/AF4 which generates precursor B cell ALL or AML. The immunophenotype and 
gene-expression profile of induced MLL/AF4 ALL cells confirmed the pre B ALL 
status. This model could resemble the phenotype of the human disease and its gene 
expression patterns, proving that MLL/AF4 is sufficient to induce leukaemia (Andrei V. 
Krivtsov, Zhaohui Feng 2008). 
The Heidenreich group has already shown that MLL/AF4 can be investigated by 
depletion of the corresponding fusion transcript with RNAi without affecting the 
transcript levels of native MLL and native AF4. With the decrease in MLL/AF4 mRNA, 
protein levels have been reduced by 67% in the relapsed childhood ALL cell line, SEM. 
Most importantly mouse engraftment of SEM depleted for MLL/AF4 prolonged median 
survival to 82 days compared to 52 days in controls.  These findings showed that 
MLL/AF4 is important in engraftment (Thomas, Gessner et al. 2005).  Although 
previous mouse models implied that MLL/AF4 lacks a second hit to be carcinogenic, 
our data agreed with the recent Armstrong model, which shows the importance of 
MLL/AF4 in inducing leukaemia. They also agreed with other mouse models showing a 
lymphoma phenotype, which could be promoted by the strong anti-apoptotic effect of 
MLL/AF4. 
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Timecourse experiments suggested that the half life for the MLL/AF4 protein is shorter 
than 48h. Depletion of MLL/AF4 transcript resulted in inhibited clonogenicity, 
proliferation and cell cycle progression. Furthermore this depletion induced apoptosis 
3fold compared to controls; this finding was supported by the activation of pro-
apoptotic Caspase 3 and reduced BCL-Xl which in contrast is anti-apoptotic (Thomas, 
Gessner et al. 2005).  MLL/AF4 induces expression of HOX genes, shown in HOXA7, 
HOXA9 and MEIS1 levels being reduced after MLL/AF4 knockdown. CD133 a marker 
for haematopoietic stem and early progenitor cells was reduced 2 fold in transcript 
levels following MLL/AF4 depletion, but also in surface expression (Thomas, Gessner 
et al. 2005). 
2 years later the group of R. Marschalek investigated the effect of MLL/AF4 and its 
reciprocal fusion gene product, AF4/MLL, in leukaemogenesis by over expressing them 
separately and in combination in vitro and in vivo. Using murine embryonic fibroblast 
cells they observed that co-transfected cells gained the highest number of cycling cells 
and lowest levels of apoptosis. Both fusion proteins showed oncogenic properties, but 
AF4/MLL transfected cells showed higher proliferation than MLL/AF4 and alone 
induced focus formation. Therefore, the authors suggested AF4/MLL to be of greater 
significance in inducing growth transformation. Their conclusion was that t(4;11) 
represents two hits; MLL/AF4 and AF4/MLL (Gaussmann, Wenger et al. 2007). 
Very recently the same group published results showing mice which were engrafted 
with Lin-Sca1+ positive cells which had been transduced with onco-retroviruses 
encoding AF4/MLL and / or MLL/AF4. Within the observation period of 13months, 
only the AF4/MLL and MLL/AF4 + AF4/MLL transduced cells induced a pro B-ALL. 
These data suggest that AF4/MLL has a different function than MLL/AF4 in 
leukaemogenesis. In particular, these data imply that AF4/MLL may be the driver at 
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least at the early phases of leukaemogenesis. However as previously mentioned 
AF4/MLL is present in only 80% of t(4;11) derived leukaemias. Explaining the role of 
these two fusion proteins, it was stated that they correspond to two hits, explaining the 
early onset of the disease in infants (Bursen, Schwabe et al. 2010). 
 
1.7 The RNAi pathway and siRNA 
 
RNA interference (RNAi) has probably evolved to protect the genome against aberrant 
RNA or dsRNA deriving from active transposons or viruses in the cell (Ketting, 
Haverkamp et al. 1999; Tabara, Sarkissian et al. 1999). The transposon and virus 
replication is antagonized by degradation of their corresponding mRNA. RNAi was 
originally discovered in C.elegans (Fire, Xu et al. 1998) and subsequently in the frog 
(Oelgeschlager, Larrain et al. 2000) and mouse (Svoboda, Stein et al. 2000; Wianny and 
Zernicka-Goetz 2000). Today it is accepted as to be relevant across a wide range of 
eukaryotic organisms. The mechanism has similarities to the posttranscriptional gene-
silencing (PTGS) which is found in plants and funghi (Smardon, Spoerke et al. 2000). 
RNAi is induced by double strand RNA (dsRNA), which is cleaved by the dsRNA-
specific ribonuclease Dicer into small dsRNA fragments of 21-23 nt in length called 
short interfering RNAs (siRNAs) (Zamore, Tuschl et al. 2000). These siRNAs are 
separated into single strands by a protein component of the RNA-induced silencing 
complex (RISC) (Matranga, Tomari et al. 2005) (see Figure 18). RISCcontains 
endonucleases and cleaves mRNA complementary to the included siRNA strand . Only 
one of the two siRNA strands becomes part of RISC, this strand is called the guide 
strand. The other strand is called passenger strand and is degraded during RISC 
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activation (Gregory, Chendrimada et al. 2005). The catalytic components of RISC are 
argonaute proteins; they are located in cytoplasmic P-Bodies which show high rates of 
mRNA degradation (Sen and Blau 2005). Of the argonaute 1-4 proteins included in the 
RISC complex only the hsAgo2 has Slicer activity and is therefore responsible for 
mRNA cleavage (Liu, Carmell et al. 2004). 
 
Figure 18  siRNA mediated RNAi 
A long double stranded RNA sequence  (A) is bound by the nuclease Dicer which cuts the long dsRNA 
strand into short dsRNA generating siRNA of 21-23 nt lenght (B).  siRNA and Argonoute proteins form 
the RISC complex (C).  By this RISC complex the passenger strand is cleaved (D).  The guide strand 
leads the RISC complex to target mRNA (E)  and target mRNA is cleaved (F)  resulting in no translation 
of the mRNA into protein       from http://www.genome.ou.edu/5853/rnai/RNAi.jpg 
 
siRNA can originate from virally transduced shDNA, encoding for shRNA which is 
then processed into siRNA, from long dsRNA precursors or delivered directly from 
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outside the cell. The latter is important in functional studies, where the expression of 
certain genes is abrogated (see Figure 19). 
 
Figure 19  shRNA Mechanism 
By lentiviral infection a shDNA sequence is inserted into the genome. This shDNA transcribes for a RNA 
strand which forms a hairpin structure. After this hairpin is processed by Drosha it is exported into the 
cytosol where Dicer trims it into siRNA which is incorporated into the RISC complex generating 
cleavage of the target mRNA. The bypass mechanism shown is a cleavage independend mechanism and 
rather reported for miRNA        from Dan Cojocari, free to publish 
 
The two main actors of RNAi are siRNA (short interfering RNA) and miRNA 
(microRNA). miRNA is not translated but encoded in the genome, controls gene 
expression and is important in development (Zhao, Ransom et al. 2007). The RNA 
coding gene is much bigger than the miRNA sequence itself, expressing the pri miRNA, 
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a primary transcript which is processed to pre-miRNA by Drosha, an RNase III like 
enzyme, and Pasha, a dsRNA binding protein, in the nucleus. This pre-miRNA has a 
stem-loop structure of about 70 nucleotides length and is exported from the nucleus by 
binding to Exportin 5, which serves as a shuttle through the nucleus pore complex (Yi, 
Qin et al. 2003). Dicer binds and cleaves the dsRNA part of this pre-miRNA producing 
mature miRNA, which integrates into the RISC complex. miRNA and siRNA use the 
same machinery following incorporation in the RISC complex (Gregory, Chendrimada 
et al. 2006) (see Figure 20). 
Unlike siRNAs, miRNAs often bind to partial complementary to mRNA and rather 
inhibit translation, while siRNA is perfectly complementary and leads to degradation of 
their target mRNA (Pillai, Bhattacharyya et al. 2007). However prior to degradation, 
mRNA is cleaved by RISC subsequently inducing P- body components.  P-bodies 
(processing bodies) are granules in the cytoplasm which show high mRNA decay 
(Parker and Sheth 2007). 
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Figure 20  Comparison of the siRNA and the miRNA RNAi 
miRNA can lead to translational repression without RNA cleavage. The siRNA RNAi pathway is 
dependend on this target mRNA cleavage, however miRNA may also use this RISC facilitated cleavage; 
siRNA silencing RNA, miRNA micro RNA, RISC RNA induced silencing complex,  miRNP  
microRNA-containing ribonucleoprotein complexes       from (Meister and Tuschl 2004) 
 
Following degradation of the mRNA the translation is interrupted and the corresponding 
protein levels decrease.  
A substantial problem of siRNA mediated RNAi are off target effects describing the 
unintended regulation of genes apart from the target gene. Important for this is the seed 
region at the 5’ end of the siRNA guide strand (Lin, Ruan et al. 2005) which comprises 
6 nucleotides in the positions 2-7 of the antisense siRNA strand of the siRNA duplex. 
Sequence complementary of any transcripts to the seed region of siRNAs can lead to off 
target effects and this also applies to shRNA driven RNAi (Jackson, Burchard et al. 
2006). 
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siRNA and shRNA mediated RNAi is used in functional studies. One basic approach is 
to deplete a gene of interest and run a subsequent array analysis to monitor 
corresponding changes in expression of other genes or transcripts. A more complex 
functional study is to screen numerous genes in one assay. Libraries of siRNA or 
shRNA are used to identify groups of genes which are of functional relevance in special 
biological processes or in disease metabolisms. Such libraries can contain thousands of 
siRNAs or shRNAs targeting numerous genes. By high-through put RNAi screening 
huge numbers of genes, pathways and networks can be identified. Often such libraries 
also contain several different si/shRNAs per gene. Recently published work showed the 
combinative use of siRNA and shRNA RNAi; genes identified by shRNA screens were 
further functionally tested by siRNA treatment (Shtutman, Maliyekkel et al. 2010). 
Supporting this a recent publication showed that siRNA and shRNA RNAi can be 
useful for functional studies in signalling molecules (Lee, Santat et al. 2009). RNAi 
library screens are widely used in functional genomics and drug target validation.   
 
Nowadays siRNA depletion is a common research tool to investigate protein functions 
and it is expected to be used in the future for treatment of diseases. It can be used to 
deplete important molecules for certain cancer cells thus improving therapy. Cancer 
cells with fusion genes offer unique targets to efficiently specify treatment to the target 
cancer cell. Very recently published work showed the delivery of siRNA by 
nanoparticles to melanoma cells in human patients (Davis, Zuckerman et al. 2010). 
Most importantly they showed the cleavage of target RNA in the patient cells. 
Overall siRNA mediated RNAi is a well established method to investigate target gene 
functions and a potential and specific tool in treating cancers.  
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Hypotheses 
 
 
 
 
1. MLL/AF4 controls engraftment and homing by modulating target 
genes such as FGFR1 and N-cadherin 
 
2. Interaction with the niche affects consequences of MLL/AF4 
depletion 
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1.8 General aims 
 
The general aim of this thesis was to investigate the functions of MLL/AF4 in thereby 
associated leukaemia, which is commonly an Acute Lymphoblastic Leukaemia. 
Understanding the manner of how the fusion gene is involved in the generation and 
maintenance of the disease requires the knowledge of its functions. These are the 
regulation of target genes by transcriptional or non-transcriptional mechanisms. The 
assignment of the downstream functions of those target genes to a fusion gene-derived 
response and the understanding of how those actions influence the malignancy and 
ultimately the disease itself is a prerequisite to further improvements. 
Overall, a better understanding of MLL/AF4 will facilitate the development of better 
treatments which are highly needed, due to the poor prognosis in infant MLL/AF4. 
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Chapter 2: Materials and Methods 
 
2.1 General Materials  
 
2.1.1 Materials 
 
All details and specifications are standard unless stated otherwise. 
General lab equipment was purchased from Scientific Laboratory Supplies (Nottingham, 
UK), VWR (Lutterworth, Leicestershire, UK) or Fisher Scientific (Loughborough, 
Leicestershire, UK). 
 
2.1.2 Equipment 
 
ABI 7000 Real Time detection system Applied Biosystems, Darmstadt, DE 
ABI 7500 Fast Real-Time PCR system Applied Biosystems, USA 
ABI 7000 SDS program Applied Biosystems, USA 
ABI 7900HT Sequence detection system Applied Biosystems, USA 
ABI SDS 2.2 Applied Biosystems, USA 
Agarose gel electrophoresis unit BIO-Rad, Hemel-Hempsted, Herts., UK 
Allegra® X-12 benchtop centrifuge Beckman Coulter, High Wycombe, UK 
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Centrifuge 5415C Eppendorf, Hamburg, DE 
Centrifuge 5415R Eppendorf, Hamburg, DE 
Class II microbiological safty cabinet BIOMAT-2, Medical Air technology Ltd., UK 
D3300 X-ray System, RS320 Chamber, Tube MXR 321, Gulmay Medical, Camberley, 
Surrey, UK  
Electroporation-Impulsegenerator EPI 2500 Heidelberg, DE 
Eppendorf Thermomixer comfort, Eppendorf, Hamburg, DE 
FACSCalibur Beckton Dickinson, Heidelberg, DE 
FACScan Beckton Dickinson, Oxford, UK 
FACS Canto II Beckton Dickinson, Oxford, UK 
Fluorescent microscope: Nikon Eclipse TE2000-U and camera: Digital Sight DS-
2MBWc, Amstelveen, NL 
Hamilton Gastight  #1702, 25µL volume, Bonaduz AG, Switzerland 
L870M Ultracentrifuge Beckman, High Wycombe, UK 
Medimachine + Medicon, sterile, 35µm, BD, Oxford, UK  
MINI-PROTEAN II electrophoresis cell BIO-Rad, Hemel-Hempsted, UK 
Mouse imager: LT-9MARCOIMSYS: Macro Imaging System, Lightools, Canada 
ND-1000 spectrophotometer Nanodrop technologies Ltd., USA 
Spectramax 250 Multiwell plate reader Molecular Devices, Crawley, UK 
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Scanscope CS/GL, Aperio Technologie Inc., USA 
Tissue culture incubator, Heraeus Equpment Ltd., Essex, UK 
Universal Hood II, Gel Doc, BIO-Rad, Hemel-Hempsted, Herts., UK 
Vortex Genie 2, scientific industries Bohemia, New York, USA 
 
2.1.3 Plastics 
 
All plastics were purchased from Greiner Bio-one (Frickenhausen, DE), Eppendorf 
(Hamburg, DE) and Becton Dickinson  (New York, USA) unless stated otherwise. 
 
Thickwall-style polyallomer conical tubes, Beckman Instruments Inc, High Wycombe, 
UK 
Derlin PKGED’1 adapters, Beckman Instruments Inc, High Wycombe, UK 
Falcon culture slide 8 chamber polystyrene vessel, BD, Oxford, UK 
 
2.1.4 Chemicals 
 
All standard chemicals have been purchased either from Fisher 
Scientific (Leicestershire, UK), SIGMA (Poole, Dorset, UK)  
or BDH (Dorset, UK). 
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2.1.5 Buffers 
 
DNA-PAGE (Polyacrylamide gel electrophoresis) 
TBE for 1 l 
53 g of Tris base  
27.5 g of boric acid  
20 ml of 0.5 M EDTA pH 8.0 
 
E.coli transformation 
LB-Medium  
10 g/l Bacto-Trypton (Applichem, Darmstadt) 
5 g/l Yeast Extract 
10 g/l NaCl 
pH 7.4 
sterilised by autoclaving 
 
LB-Agar  
10 g/l Bacto-Trypton 
5 g/l Yeast Extract 
10 g/l NaCl 
15 g/l Agar 
pH 7.4 
sterilised by autoclaving 
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Hybridisation of siRNAs 
siRNA Hybridisation buffer  
100 mM NaCl 
25 mM Tris-HCl, pH7.5 
 
Cell cycle analysis 
Citrate buffer  
0.25 M Saccharose 
40 mM Natriumcitrate, pH 7.6 
 
DNA-staining and lysis buffer 
PBS 
20 μg/ml PI 
0.5% NP-40 
0.5 mM EDTA 
 
Cell cycle wash buffer  
PBS 
0.5% BSA 
 
FACS-buffer  
PBS 
2 mM EDTA 
0.1% BSA 
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2.1.6 Molecular Cloning 
 
2.1.6.1 Restriction Enzymes  
 
Most enzymes were purchased from Fermentas apart from ApoI, BsrGI, PciI and SnaBi 
which were purchased from New England Biolabs NEB. The standard activity was 
10u/l apart from SnaBI which was 5u/l. 
Aat II MunI(MfeI) 
Apa I NcoI 
Apo I NheI 
AscI Not I 
BamHI PagI(BspHI) 
Bgl II PciI 
Bsp1191 (BstBI) PmeI (MssI) 
BspTI(AfL II) Pst I 
BsrGI Pvu I 
Bsu15I(ClaI) Pvu II 
Cfr42I(Sac II) Sac I 
Cfr9I (XmaI) SalI 
DraI (AhaIII) ScaI 
Eco147I (StuI)  Sgs I(Asc I) 
EcoR I Sma I 
EcoR V (Eco321) SnaBI 
HinCII (HindII) StuI 
Hind III Xba I
Kpn I Xho I 
MssI (PmeI)  
 
2.1.6.2 Modifying Enzymes 
 
Klenow fragment, DNA Polymerase I, 5u/l NEB 
Mung bean nuclease, 10u/l NEB  
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T4 DNA Polymerase, 5u/l Fermentas 
T4 DNA Ligase, 5u/l Fermentas  
T4 PNK, Poly Nucleotide Kinase, 10u/l Fermentas 
CIAP, Calf Intestine Alkaline Phosphatase, 10u/l Fermentas 
TSAP, Thermo sensitive Alkaline Phosphatase, 1u/l Promega 
 
2.1.7 Cell analysis  
 
Collagen type I, rat tail, BD Biosciences 
Matrigel, Oxford, BD Biosciences 
 
Antibodies were purchased from Becton Dickinson Pharmingen 
                                                 clone    dilution used 
CD45 PE-Cy7   30-F11    2.5l / million cells 
TER-119 PE-Cy7   TER119   2.5l / million cells 
CD19-APC    SJ25C1   2.5l / million cells 
CD34-PerCP   8G12    10l / million cells 
CD133 PE    293C3 (Miltenyl)  10l / million cells 
CD38 FITC   HB7    10l / million cells 
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2.1.8 Real Time RT-PCR 
 
SYBR Green QCR Supermix w/ROX Invitrogen, Paisley, UK 
RevertAid™H Minus First Strand cDNA Synthesis Kit Fermentas, York, UK 
Electroporation cuvettes 4mm par 50 sans pipet Eurogentec, Southampton, UK 
 
2.1.9 Kits 
 
The following kits were purchased from Qiagen, Crawley, West Sussex, UK 
RNeasy Total RNA Isolation Kit  
QIAquick PCR Purification Kit  
QIAquick Gel Extraction Kit  
Miniprep Plasmid Isolation Kit  
Maxiprep Endofree Plasmid Isolation Kit  
 
 
2.1.10 Synthetic Oligonucleotides 
 
Oligonucleotides were purchased from Purimex (Grebenstein, DE), Alnylam Europe 
(Kulmbach, DE), VHBio (Gateshead, UK), Eurofins-MWG-Operon (London, UK) or 
Qiagen (Crawley, UK) 
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siRNA 
 
siMA6 (siMLL/AF4) sense;   5´-AAGAAAAGCAGACCUACUCCA-3´  
siMA6 antisense;    5´-UGGAGUAGGUCUGCUUUUCUUUU-3´ 
 
siMM sense;     5´-AAAAGCUGACCUUCUCCAAUG-3´ 
siMM antisense;    5’-CAUUGGAGAAGGUCAGCUUUUCU-3’ 
 
siAGF1 (siAML/MTG8) sense;  5´-CCUCGAAAUCGUACUGAGAAG-3´ 
siAGF1antisense;    5´- UCUCAGUACGAUUUCGAGGUU -3´ 
 
siHOXA7 sense;    5’ - CCGUUCCGGGCUUAUACAAUG - 3’ 
siHOXA7 antisense;    5’ - UUGUAUAAGCCCGGAACGGUC – 3’ 
 
siMARS (siMLL/AF4) sense;  5'-ACUUUAAGCAGACCUACUCCA-3'  
siMARS antisense;    5'-UGGAGUAGGUCUGCUUAAAGUCC-3' 
 
 
Primers for RealTime-PCR 
 
HoxA7 forward    5’-GAG GCC AAT TTC CGC ATC TA-3’ 
HoxA7 reverse    5’-GCG GTT GAA GTG GAA CTC CTT-3’ 
 
GAPDH forward    5´- GAA GGT GAA GGT CGG AGT C T-3´ 
GAPDH reverse    5´- GAA GAT GGT GAT GGG ATT TC -3´  
 
HPRT forward    5´-TGA CAC TGG CAA AAC AAT GCA-3´ 
HPRT reverse     5´-AGC TTG CGA CCT TGA CCA TC-3´ 
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TERT forward    5’-GGA GAA CAA GCT GTT TGC GG-3’ 
TERT reverse     5’-AGG TTT TCG CGT GGG TGA G-3’ 
 
DUSP6 forward    5’-AGC TCA AGG ACG AGG GCT G-3’  
DUSP6 reverse    5’-GGA GAA CTC GGC TTG GAA CTT-3’ 
 
 
Self designed primers: 
 
ATP2B3 forward    3’-AGAAAGGCGAGATAGAACAG-5’  
ATP2B3 reverse    3’-GATGCTGGTGAAGTTGTC-5’ 
 
BNIP3 forward    3’-CTCCTGGGTAGAACTGCAC-5’  
BNIP3 reverse    3’-ATCTTCCTCAGACTGTGAGC-5’ 
 
CD69 forward    3’-CTCCAGCAAAGACTTTCACTG-5’  
CD69 reverse     3’-TGTATTGGCCCACTGATAAGG-5’ 
 
DAAM1 forward    3’-CCACAAATGCCCTGAAATCC-5’  
DAAM1 reverse    3’-TCACAAAGAAATCCTGCTGTC-5’ 
 
DCT forward     3’-ATCTCCAGCGACTCATTGG-5’  
DCT reverse     3’-TTACCTATCACAGACAGTTTCCC-5’ 
 
ECE1 forward    3’-CAAGAGCATAGCCACCGA-5’  
ECE1 reverse     3’-TCCTCATCCATCCACTTCAG-5’ 
 
FLJ13639 forward    3’-CCGAGTGATAACCGTCTCC-5’  
FLJ13639 reverse    3’-TTTGTGCATAGACCATAGTTCC-5’ 
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GLE1L forward    3’-GAAACAGAATGAAGACCTCCAG-5’  
GLE1L reverse    3’-GCCCACCAGATTGAACAG-5’ 
 
NAP1L4 forward    3’-GAACCAATCTTGAAACACCT-5’  
NAP1L4 reverse    3’-GTCAATAGTACACCCGTCAC-5’ 
 
PLAT forward    3’-TGCCTGGAAACTTAAAGGAG-5’  
PLAT reverse     3’-CGTCCCTTAAATTCACGG-5’ 
 
PRDM2 forward    3’-CCTTCCCTCCACTCTTACAG-5’  
PRDM2 reverse    3’-GATTACATGAACCCTCAGTCTC-5’ 
 
SCD forward     3’-CCCACCTACAAGGATAAGGA-5’  
SCD reverse     3’-CCATTCATAGACATCATTCTGG-5’ 
 
SLC16A3 forward    3’-CTACTCCGTCTACCTCTTCAG-5’  
SLC16A3 reverse    3’-CATCCAGGAGTTTGCCTC-5’ 
 
TRIM31 forward    3’-GTAGCAAGAAACAGTATCCAC-5’  
TRIM31 reverse    3’-GCCATGACAGAACAACAG-5’ 
 
STS-1 forward    3’-ACGACTCCTCTTACTATCATCTG-5’  
STS-1 reverse     3’-TCTAATAAGGCTTCACCCAC-5’ 
 
IGFBP2 forward    3’-TCAAGTCGGGTATGAAGGAG-5’  
IGFBP2 reverse    3’-ACATCTTGCACTGTTTGAGG-5’ 
 
CIP1 forward     3’-GGACATATCAGGTACATCAGG-5’  
CIP1 reverse     3’-GGTCAATTCTACATCCTTGCT-5’ 
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BUB3 forward    3’-TCCCAGTTCCTGCTTGTC-5’  
BUB3 reverse     3’-GCGTTGGATCGTAGAAGG-5’ 
 
CDK1 forward    3’-TGGAGTTGTGTATAAGGGTAGAC-5’  
CDK1 reverse    3’-AGCACATCCTGAAGACTGAC-5’ 
 
FBXL11 forward    3’-GGCTATACCTTCGTCATTCC-5’  
FBXL11 reverse    3’-TTAACTCCAAATCCATGCTG-5’ 
 
IRX3 forward     3’-TCACAGACTGGTCTCAGC-5’  
IRX3 reverse     3’-CACTACAGCGATCTGTTCC-5’ 
 
CDH2 forward              3’-GCAGCTGGACTTGATCGAGAA-5’          
CDH2 reverse    3’-GTGGCTGTGTTTGAAAGGCC-5’  
 
FGFR1 forward                3’-GAGATGGAGGTGCTTCACTT-5’             
FGFR1reverse    3’-CATGCAGGAGATGAGGAAG-5’ 
 
 
 
2.1.11 Cell-lines 
 
SEM 
The cell line SEM was established from the peripheral blood of a 5 year old girl at 
relapse of ALL. The human B cell precursor leukaemic cells carry the t(4;11) 
translocation with MLL and  AF4  gene portions being fused. This cell line was 
established by Johann Greil in 1989 (Greil, Gramatzki et al. 1994). 
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Primary SEM 
Primary SEM are an early passage of the patient cells from which the SEM cell line had 
been established later. They show a slower growth than cell line SEM described above 
(Greil, Gramatzki et al. 1994). 
SEMcami 
SEMcami are SEM cells transduced with pHR-CMV-DRep/amiAML1-ETO, a 
lentiviral HIV based vector constitutively expressing the EGFP and Dsred reporter 
genes and an AML1-ETO shRNA, the latter target is not present in SEM. SEMcami 
served as control cells for this vector. The vector and the trandsduction was performed 
by Vasily Grinev. 
SEMTeton 
SEMTeton were transduced with vector 1 /Teton vector generated in this work with a 
lentiviral HIV based system. Transduced cells express the reporter gene EGFP (see 
chapter 5). 
RS411 
The RS4;11 cell line was established from the bone marrow of a 32 year old female 
ALL patient. These lymphoblast cells carry the t(4;11) translocation with MLL and  AF4  
gene portions being fused (Stong and Kersey 1985) . 
MV4;11 
MV4;11 cells were isolated from the peripheral blood of a 10 year old boy with 
biphenotypic B myelomonocytic leukemia expressing both myeloid and lymphoid 
markers. This is one of the few t(4;11) positive myeloid cell lines (Lange, Valtieri et al. 
1987). 
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MV4;11Teton 
MV4;11Teton were transduced with vector 1  / Teton vector generated in this work with 
a lentiviral HIV based system. Transduced cells express the reporter gene EGFP (see 
chapter 5). 
Kasumi-1 
The Kasumi-1 cell line was established from the peripheral blood of a 7 year old boy 
with acute myeloid leukaemia. The myeloblast cells bear the t(8;21) translocation with 
the AML1 and MTG8 genes being fused (Asou, Tashiro et al. 1991).  
Kasumi-1 DC 
Kasumi-1 DC are Kasumi-1 cells transduced with pHR-CMV-DRep, a lentiviral HIV 
based control vector expressing the Dsred and EGFP reporter genes but no other genes. 
The vector was generated and transduced by Vasily Grinev. 
SKNO-1 
SKNO-1 cells were isolated from the bone marrow of a 22 year old Japanese woman 
with AML. Myeloblast cells are GM-CSF dependent and bear the t(8;21) translocation 
with the AML1 and MTG8 genes being fused (Matozaki, Nakagawa et al. 1995). 
293T 
The 293T cell line is derived from human embryonal kidney cell line 293. 293T 
additionally express the large T antigen, are of fibroblast morphology and highly 
transfectable (Rio, Clark et al. 1985).  
HS-5 
HS-5 are bone marrow stromal cells from a 30 year old caucasian man. They were 
immortalised with the amphotropic retrovirus vector HPV. The cells of fibroblast  
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morphology produce several haematopoietic growth factors, cytokines and interleukins   
(Roecklein and Torok-Storb 1995). 
M210B4 
M210B4 are murine bone marrow stromal cells. These fibroblasts are known to support 
human and murine myelopoiesis in long term culture (Lemoine, Humphries et al. 1988). 
 
2.1.12 Bacteria 
 
JM109 
JM109 are E. Coli competent cells lacking recA (improves DNA yield in Plasmid 
isolation) and are beta-gal deficient. Genotype: endA1, recA1, gyrA96, thi, hsdR17 (rk–, 
mk+), relA1, supE44, Δ( lac-proAB), [F´ traD36, proAB, laqIqZΔM15], Promega, 
Madison USA. 
HB101 
HB101 are E.Coli competent cells are lacking recA, but are not suitable for blue - white 
screening. Genotype: F–, thi-1, hsdS20 (rB–, mB–), supE44, recA13, ara-14, leuB6, 
proA2, lacY1, galK2, rpsL20 (strr), xyl-5, mtl-1, Promega, Madison USA. 
STBL3 
STBL3 are E.Coli competent cells for the cloning of direct repeats found in lentiviral 
expression vectors. They show a reduced frequency of unwanted homologous 
recombinations. Genotype: F- mcrB mrr hsdS20 (rB-, mB- ) recA13 supE44 ara-14 
galK2 lacY1 proA2 rpsL20 (Strr ) xyl-5 - leu mtl-1, Invitrogen, UK. 
Self produced JM 109 
Self produced JM 109 were made competent using a CaCl2 / PEG protocol.  
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2.1.13 Mice  
 
NSG 
NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ immune deficient mice also called NOD SCID gamma; 
NOD-SCID, IL2Rgammanull; NOD-SCID IL2Rgnull or NSG, were purchased from 
Jackson Laboratory, USA. In this thesis they are referred to as NSG mice. 
 
Rag2/II2rg double knockout 
B10;B6-Rag2tm1Fwa II2rgtm1Wjl immune deficient mice were retrieved from Markus 
Manz Laboratory, Switzerland (Traggiai, Chicha et al. 2004). In this thesis they are 
referred to as R2G (Rag2 knockout, Gamma knockout) mice. 
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2.2 Methods 
 
2.2.1 Methods chapter 3: Array validation 
 
2.2.1.1 Array analysis Ingenuity 
 
The HG-U133 Plus 2.0 oligo array data were provided pre-analysed with Affimetrix 
MAS analysis. Using a perfect match and a mismatch probe on the array, MAS 
calculates if a transcript is present, marginal or absent. Using positive and negative 
probe sets, MAS also calculates the positive / negative ratio which is a performance 
indicator for each probe set. Finally the average difference for expression intensities of 
the transcripts is calculated. 
These pre-analysed data sets from the oligo-array were sorted for strength of fold 
change and only genes with a fold change higher than 2 were used. The Probe ID and 
the gene names were imported together with the mRNA changes. The Ingenuity 
Pathway 8.5 analysis identified the role of genes sensitive to the depletion of MLL/AF4 
and connected them (transcripts) to functions, diseases, physiological systems, networks 
and canonical pathways.  
The results were sorted by p-value which the platform generated from data including the 
strength of the expression level alteration and the ratio between affected genes from the 
array and the number of genes in that group (pathway, system, etc.)  (For further detail 
see chapter 3.3).  
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2.2.1.2 Hybridization of siRNA 
 
The sense and the antisense strand were combined in hybridization buffer at a 
concentration of 20µM each. The mixture was then incubated on a heating block for 30 
sec at 95°C, cooled to room temperature and stored at -20°C. 
 
2.2.1.3 RNAi and Electroporation 
 
To knockdown transcripts by RNAi the cells of interest were adjusted to 1x107 cells / ml 
in full medium and pipetted into an electroporation cuvette (between 100µl and 800µl 
per cuvette). The appropriate siRNA was added to the desired concentration typically 
500nM for siMA6. After addition of the siRNA the mixture was quickly flicked and 
then electroporated usually at 350V, 10msec with the pulse generator EPI2500 (Dr. L. 
Fischer, Heidelberg). The mixture was incubated for 15min and then normally diluted 
1/20 in full medium. 
Different cell-lines, siRNAs or experiments required different siRNA concentrations 
and voltages for optimal results. 
For sequential electroporations with siMa6 and control siRNA, cells were 
electroporated every 48h and if required, cell material was harvested 48hours after each 
electroporation. Up to 3 sequential electroporations were performed. 
 
2.2.1.4 RNA isolation 
 
To isolate RNA from cells the Qiagen RNeasy Kit was used. According to the 
manufactures guidelines up to 5x106 pelleted cells were lysed in RLT + β-
Chapter 2: Materials and Methods 
58 
 
mercaptoethanol (10µl/ml RLT). This lysate was then added to a Qiashredder column 
and spun for 2min at full speed. The flow through was then diluted with 350µl of 70% 
ethanol and the mixture loaded on an RNeasy column which was spun for 1min at full 
speed. After washes and elution according to the manufactures protocol the RNA yield 
was determined by the Nanodrop ND-1000 UV-Vis measurement.  
 
2.2.1.5 cDNA synthesis 
 
To analyse the mRNA after isolation it had to be converted into cDNA by reverse 
transcription. For this the RevertAid™H Minus First Strand cDNA Synthesis Kit from 
Fermentas was used. 1µg of RNA was used, 1 µl random hexamers added and the 
volume adjusted to 12µl with RNAse free H2O. The mixture was incubated in PCR 
tubes in a PCR machine for 5min at 70°C followed by the addition of 4µl reaction 
buffer, 2µl dNTP mix, 1µl RiboLock RNase Inhibitor and 1μl of MuMLV reverse 
transcriptase polymerase. Then the mixture was put back into the PCR machine and 
incubated at 25°C for 10min, at 42°C for 60min and finally at 70°C for 10min. After the 
cDNA synthesis was completed 30µl of RNase free water was added and the samples 
were stored at -20°C.  
 
2.2.1.6 Primer design 
 
The primers were designed with Primer Express 2.0 using standard parameter for RT-
primer design; a melting temperature of 60°C and an amplicon length of typically 50-
150bp, but up to 250bp in length.  
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2.2.1.7 Quantitative Real Time PCR analysis 
 
In the real time PCR the multiplication of the PCR product was monitored via 
Sybrgreen, which intercalates into double strand DNA, in real time. The evaluation of 
the template amount, here an mRNA transcript, is made by calculating the cycle 
threshold (CT) values and plotting on a graph. 
The molar amount of DNA molecules (total DNA or cDNA) multiplied by the time 
correlates to the CT value, which means that the more substrate there is, the earlier a 
signal is detected. Using the CT the amount of mRNA extracted from the cells and 
ultimately the expression levels can be determined. 
Standard primers were diluted from 100μM to 375nM final concentration. The  
MLL/AF4 primers were diluted from 5μM to a final concentration of 62.5nM. The real 
time PCR was performed in two different real time PCR machines. When using the ABI 
PRISM 7000 from Applied Biosystems following protocol was used: 
Following mix was prepared before pipetting into a 96-well plate.  
 
Master-mix using standard PCR primers: 
SYBR©Green  (2x)     7.5  μl 
Primer fw   (100μM to 375nM)   0.05  μl 
Primer rev   (100μM to 375nM)   0.05  μl 
dH2O        4.4  μl 
Σ =        12  μl 
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For MLL/AF-4 primers the following mix was prepared: 
SYBR©Green  (2x)     7.5  μl 
Primer fw   (5μM to 62.5nM)   0.15  μl 
Primer rev   (5μM to 62.5nM)   0.15  μl 
dH2O        4.1  μl 
Σ =        12  μl 
 
The samples were analyzed in triplets. In each 96-well plate well 12μl PCR-Mix + 3μl 
qRT-PCR cDNA was mixed. After loading, the plates were sealed with foil, spun down 
briefly and put into the real time PCR machine (ABI PRISM 7000 Sequence Detection 
System, Applied Biosystems). 
The program included 2min at 50°C, 10min at 95°C followed by 40 cycles of 15sec 
95°C and 1min 60°C. At the end of the run usually a melting curve was performed. The 
data was analyzed with the programs ABI 7000 SDS and Microsoft Excel. 
The ABI 7900HT Sequence detection system offers analysis of up to 384 samples in 
one PCR run. The protocol was changed to reflect the smaller well size however the 
primer concentrations did not change and each sample was prepared in triplets as 
before. 
Master-mix for all standard primers (except MLL/AF4) 
SYBR©Green  (2x)     5 μl 
Primer fw   (100μM to 375nM)         0.03 μl 
Primer rev   (100μM to 375nM)         0.03 μl 
dH2O              2.94 μl 
Σ =        8 μl 
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Master-mix for MLL/AF4 primers only: 
SYBR©Green  (2x)     5 μl 
Primer fw   (5μM to 62.5nM)   0.1 μl 
Primer rev   (5μM to 62.5nM)   0.1 μl 
dH2O        2.8 μl 
Σ =        8 μl 
 
Per multi-plate well 8μl master-mix and 2μl cDNA were combined. For analysis of the 
acquired data the SDS version 2.2 program from Applied Biosystems was used. As 
before a melting curve was performed. Here the temperature was gradually increased 
and a decrease in signal shows the melting point of the amplicon due to SYBR-Green 
only intercalating into double strands. Usually specific primers lead to amplicons with a 
dissociation point of 80°C to 85°C. An unspecific product like primer dimers would be 
expected at a lower temperature. 
 
2.2.1.8 Amplicon control 
 
In addition to dissociation point analysis, the PCR product can be confirmed by DNA-
PAGE. Here the DNA pieces are separated according to length and the size can be 
measured using a DNA ladder of appropriate size. For this an 8% polyacrylamide gel 
was made. A 5ml mix contained 1ml 40% Acrylamide / Bisacrylamide, 1ml 5xTBE 
buffer and 3ml H2O. After mixing 10µl TEMED and 50µl 10%APS were added, mixed 
and the gel poured. Samples were loaded with 6xDNA loading buffer and the gel was 
run in 1xTBE buffer. 
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2.2.1.9 Cell culture 
 
Suspension cell-lines SEM, SEMTeton, SEMcami, MV4;11, MV4;11Teton RS4;11 
Kasumi-1 DC and Kasumi-1 were fed with RPMI1640 (SIGMA, HEPES Modification), 
supplemented with 10% FCS (SIGMA) and 2mM Glutamine (SIGMA). SKNO-1 cells 
were fed RPMI1640 containing 20% FCS, additionally supplemented with GM-CSF (7 
ng/ml). Cells were maintained at a concentration of 0.2 to 1x106 cells / ml. If cells were 
maintained in culture, part of the suspension was discarded and replaced with fresh 
medium. Depending on the growth, the start concentration and the cell-line cells were 
fed twice to thrice a week. 
Adherent cells such as HS-5 and M210B4 were fed with RPMI1640 containing 10% 
FCS and 2mM Glutamine, whereas 293T cells were fed with DMEM (SIGMA) 
containing 10% FCS and 2mM Glutamine. 
To seed or maintain cells, the adherent cell layer was washed with warm PBS, which 
was then removed and the cells were subsequently incubated with a sufficient amount of 
1xTrypsin/EDTA (5mg Trypsin/ml, 2mg EDTA/ml, Sigma) at RT and incubated for 
5min or until the cells lost adhesion. Trypsinisation was stopped by addition of FCS 
containing medium. The cells were then split according to their growth rate and 
experiment design usually 1/10. All cells were kept at 37°C, 5% CO2 and 95% air 
humidity. 
 
2.2.1.10 Freezing and thawing of cells 
 
Cells were frozen by resuspending between 5x106 to 1x107 cells in culture medium with 
10% DMSO and 20% FCS. The mixture was transferred to cryo-vials (Nunc) on ice and 
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slowly frozen, packed in cotton in a -80 freezer. After 2 days they were transferred to a 
liquid nitrogen tank for long term storage. 
For thawing cell vials were removed from liquid nitrogen, transported on ice, quickly 
thawed by hand and resuspended in a larger volume of warm medium as soon they 
began to thaw. Then the cells were spun down and resuspended in medium to remove 
the DMSO.  
 
2.2.1.11 Counting cells 
 
For counting a cell suspension was mixed well by pipetting, an aliquot was taken, 
diluted ½ with Trypan-blue (dilution from 0.4% to 0.2%, Sigma) and a Neubauer 
improved counting chamber was loaded with the mixture. Viable cells exclude Trypan 
blue. Dead cells, however, show intracellular staining with Trypan blue. The chamber 
had been prepared by attaching a cover glass to the moist chamber. The number of cells 
in 4 large squares corresponds to 104 cells/ml.  
 
2.2.1.12 Flow cytometric analysis 
 
Cells were counted, volume adjusted to 200-300µl and saturating volumes of antibody 
were added (see 2.1.7 ). The samples were then left in the dark for 20min with vortexing 
in between. Then 2.5ml 0.2% PBSA was added and the samples centrifuged for 5min at 
500g and 4°C. The supernatant was subsequently discarded and the cells resuspended in 
500µl 0.2% PBSA. The analysis was done on the FACS Canto II machine with DiVa 
v6.1.2 software, using compensation if several dyes had been applied. 
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2.2.1.13 Compensation 
 
If a combination of two or more fluorochromes was used in flow cytometric analysis a 
possible overlap of one fluorochrome emission into another detection channel has to be 
compensated for, otherwise an over spilling signal could be recorded and a false-
positivity for a marker generated. 
To accomplish this, a sample was stained with an antibody combination, but also 
unstained and single stains for each antibody/fluorochrome were prepared. For each 
channel the threshold and PMT voltages were set using the unstained sample. Then the 
single stained samples were recorded. The Diva software used these data to identify 
percentage overspill for each flurochrome into other channels and automatically 
generated a mathematical compensation matrix. Once the compensation was set double 
or more stained samples could be recorded. 
 
2.2.1.14 CFSE staining  
 
Due to toxicity of CFSE and the additional stress by electroporation the concentration of 
CFSE, incubation times and other parameters had to be changed from the standard 
protocol. SEM at 1x106 cells/ml and RS4;11 at 1.5 x106 cells/ml were stained with 0.5 - 
1.5 µM CFSE. Cells were washed with PBS, resuspended in warm PBS with the CFSE 
addition and incubated for 10min at 37°C. Then the cells were spun down at 300g for 
5min and the pellet was resuspended in medium containing FCS. After 30min the 
standart cell culture medium (RPMI1640, 10% FCS, 2% Gln) was changed again. One 
day later the stained cells were electroporated with siMA6 or siAGF1 at 1x107 cells/ml, 
350V and 10msec. They were then diluted 1/40 and incubated in 6-wells. At different 
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time points aliquots were taken, fixed in PBS + 2% formaldehyde and stored in the 
fridge.  
At the end of the experiment the samples were analysed by flow cytometric analysis 
detecting the CFSE signal in the FITC channel. These flow cytometric analysis data was 
analysed by ModFit setting the parent population (generation 0) and the increment 
(width of each population in the fluorescence scale (x-axis), see Figure 21 and Figure 
22). 
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Figure 21  Dilution of CFSE staining in cell membranes due to proliferation 
The membrane of a cell is stained with CFSE (0. generation, left) after each division the signal is 
weakend, CFSE Carboxyfluorescein succinimidyl ester 
 
 
Figure 22  CFSE staining pattern 
Successive populations of CFSE stained cells 1 first generation after staining, 2 second generation etc.,  
CFSE Carboxyfluorescein succinimidyl ester    from www.mcg.edu/cancer/shared/flow/fluorophores.html
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2.2.2 Methods Chapter 4 - Bone Marrow Feeders 
 
2.2.2.1 Growth arrest with MMC 
 
HS-5 layers were incubated with Mitomycin C (MMC) at a concentration of up to 200 
µg/ml medium in 1ml per well (12well) for 5min incubation, subsequently washed 
twice with PBS and then medium was added. The layers were monitored for apoptosis 
and growth over the following weeks. 
 
2.2.2.2 Growth arrest with AMD 
 
A dilution of Actinomycin D dissolved in DMSO was prepared to a concentration of 
1µM and subsequently strongly diluted in medium. Final concentrations from 0.2 to 
6.7nM were used on highly confluent HS-5. The effect on the growth was monitored 
over 2 weeks.  
 
2.2.2.3 Growth arrest with Irradiation 
 
M210B4 were grown to almost 100% confluence which is approximately 2.5x106 cells 
per T25 flask. Then they were washed and trypsinised. After cells lost adhesion 10ml of 
medium was added and the cells spun down at 1200rpm for 5 minutes. The cell pellet 
was resuspended in 2.8ml medium which results in 1mm depth in a T25 flask when 
lying horizontal. The flasks were irradiated for 19.17min at 10mA and 320kV with the 
D3300 X-ray system resulting in a radiation dose of 60Gy. 
Chapter 2: Materials and Methods 
68 
 
The irradiated cells were then diluted in a bigger volume depending on the desired final 
concentration. Typically they were seeded at 0.5x106 cells/ml and 1ml per 48well-plate 
well. The wells had been collagen coated beforehand. For smaller and bigger wells the 
amount was adjusted proportional to the increased surface. This concentration created 
an excess of cells, but due to apoptosis taking place an equal layer was achieved after 3 
days of incubation. Then the feeder layer was ready for co-culture.  
 
2.2.2.4 Collagen coating 
 
A fresh solution of rat tail collagen (BD) was prepared at 0.2mg/ml in 0.1N acetic acid 
under sterile conditions. For 48-well plates 100µl per well were aliquoted and for 6-well 
plates 800µl per well. The plates have then been left to dry over night under a sterile 
hood. The next morning the lids were put on the plates and they were stored at room 
temperature. 
 
2.2.2.5 Co-culture 
 
Leukaemic cells were incubated on growth arrested feeder layers. According to the 
experimental setup the required concentration of the cells was adjusted from 1x103 to 
5x106 cells/ml. When medium colour shifted towards yellow, the upper part of medium 
in the well was replaced by fresh medium. Density and state of the co-cultured cells was 
monitored by microscope.  
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2.2.2.6 Inversion Test 
 
For the inversion test an 8-well chamber slide was collagen coated. Irradiated M210B4 
were seeded and left to form a layer for 2 days. Then non-adherent leukaemic cells were 
co-cultured in various concentrations on the feeder. After one day the wells were 
carefully washed with medium to remove cells in suspension and the lowest layer on 
top of the feeders was photographed under magnification. The chambers were then 
filled with medium to the very top, 2 layers of parafilm were pressed onto the wells and 
the lid put on top of it, ensuring that no air bubbles remained in the chambers. The slide 
was then turned upside down and left for 2 hours standing like this. Cells which had not 
physically attached to the feeder were separated from it by gravity. After the incubation 
the chamber was opened still being upside down, removing the medium with non 
attached cells. Following this the feeder layer was again photographed and the before 
and after images compared for cell-numbers. 
  
2.2.2.7 Discriminating count 
 
Leukaemic cells can be distinguished from the feeder cells by microscopy. Cells like 
SEM, RS4;11, MV4;11 and Kasumi-1 are much smaller, round instead of fibroblast 
shaped and less granular than the feeders. For training, feeders alone and feeders with 
several concentrations of leukaemic cells were used. 
 
2.2.2.8 Flow cytometric analysis based cell count on Feeder 
 
SEM, SEMTeton, irradiated M210B4 and SEMTeton – M210B4 co-cultures with 
different ratios of SEMTeton were prepared. A characteristic green shift was gated 
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using native SEM. M210B4 were used as negative control and the zero concentration 
point for SEMTeton.  The SSC-FSC plot was set allowing to display M210B4 and 
SEMTeton in the same diagram. Furthermore two gates (for M210B4 and SEMTeton) 
were adjusted using size and fluorescence. A standard curve was generated using the 
ratios of counted M210B4 to SEMTeton. These setting were saved and used for further 
determinations of SEMTeton cell numbers on M210B4. 
 
2.2.2.9 Primary Material co-culture 
 
Primary material from patient blood, mouse blood or isolated from mouse organs was 
washed several times with PBS, full RPMI1640 medium with 2-5% Penicillin / 
Streptomycin mix was added and the cells incubated on feeder layers. Due to a high 
number of cells dying high start concentrations were adjusted to 2x106 cells/ml. Used 
medium was carefully removed by aspirating ½ of the well volume from the top and 
replacing it with fresh medium. 
 
2.2.2.10 Determination of viable cells with Annexin-V and PI 
 
Necrotic cells can be intentified using PI incorporation, early apoptotic cells by 
Annexin-V staining, while late apoptotic cells are positive for both. To set up the assay 
several controls were used. Unstained cells were used for all cell-types. As positive 
controls cells were incubated at 65°C for 10min and stained either with PI or with 
Annexin-V to set the shift of necrotic or apoptotic cells into their quadrant. The samples 
which had been analysed for viable cells were stained with both Annexin-V and PI (see 
Table 1). 
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The following table summarises the protocol. 
 
Table 1  Staining protocol for the Annexin-V – PI assay 
BB Binding buffer, PI Propidium iodide 
 
To detect viable leukaemic cells on feeders a more advanced protocol had been 
established using CD19 staining and gating to select leukaemic cells before detecting 
necrotic and apoptotic cells. This demanded extra CD19 controls. Cells were stained 
with 5µl CD19-APC for 20min and then washed as described for the flow cytometric 
analysis. In the triple stained samples the CD19 staining took place before Annexin-V 
and PI staining. 
 
2.2.2.11 Cell cycle analysis 
 
Cell cycle analysis relies on the principle that the DNA amount in one cell changes 
according to its phase in the cell-cycle. After a cell-division a cell is small and contains 
Unstained 
cells 
PI 
positive 
control 
Annexin-V 
positive 
control 
Double stained 
control cells 
Double stained 
samples 
- Cook 
10min 
65°C 
spin 
Cook 10min 
65°C 
spin 
- - 
- - 250µl  
            + 
Binding 
0.325µl 
Buffer (BB) 
Annexin-V FITC 
250µl BB 250µl BB 
+ 
5µl PI 
 + 
5µl PI 
15min 
+ 
5µl PI 
15min 
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a single genome, this corresponds to the the G0 or the G1 phase. In G1 mainly cell 
growth and protein expression takes place. This is followed by the S phase where the 
DNA is synthesized, so that the amount of DNA rises until doubled. The cells enter the 
G2 phase where the cells are growing and protein is expressed. Finally with the same 
high DNA content as the G2 phase the M-phase takes place, preparing the cell for 
segregation, before a new cell cycle starts (see Figure 23).  
 
Figure 23  The cell cycle 
Shown is the length and order of cell phases. M Mitosis, G growth, S DNA synthesis    from Bruce 
Alberts et al., Molecular Biology of the Cell, 4th edition, Wiley-VCH Verlag GmbH&Co.KGaA, 
Germany 
 
Propidium iodide (PI) is a red fluorescent dye which stains DNA. Its signal can be used 
to measure the amount of DNA in a cell. To analyse samples 5x104-1x105 cells were 
washed in PBS and resuspended in 100μl cold citrate buffer. A mix of 400μl propidium 
iodide and 3μl RNaseA was prepared and added to the citrate buffer cell suspension. 
The samples were incubated on ice for 5min and then subsequently analyzed using the 
FACS canto II machine with the software FACS-Diva v6.1.2. (see Figure 24). 
Chapter 2: Materials and Methods 
73 
 
 
Figure 24  Typical Cell cycle analysis 
Shown is a typical FACS Histogramm from a cell cycle analysis, Sub G1/G0 mostly dead and apoptotic 
cells, G1/G0 phase, S phase, G2/M phase    fromVarity Software House 
 
     
2.2.3 Methods Chapter 5 - Lentiviral cloning, 
production and transduction 
 
2.2.3.1 DNA- restriction Digest 
 
To cut DNA, sequence specific endonucleases were used.  The digest was carried out  at 
37°C for 1h with 10U of enzyme and 0.5µg to 1µg of DNA was the standard condition.  
Suitable buffer was chosen according to the manufactures recommendations, normally 
at 1 fold concentration and a final volume of 20µl. The reactions were stopped by heat 
inactivation at 65°C or 85°C for 15 minutes. 
If DNA had to be digested by two enzymes an appropriate buffer and conditions 
including enzyme and buffer concentration were chosen using a web tool from 
Fermentas (http://www.fermentas.com/doubledigest/). Sometimes sequential digests 
had to be performed if the buffer requirements were too different or the enzymes needed 
different digest temperatures.  
Chapter 2: Materials and Methods 
74 
 
2.2.3.2 Gel electrophoresis 
 
After heat inactivation  of the digest the mixture was diluted with loading buffer usually 
1/6 for a 6xDNA-LB. An agarose gel was made by heating agarose with TAE buffer 
until agarose was dissolved and the gel was poured into a tray with a comb. Normally 1% 
agarose for products between 100 and 10000bp were chosen. After the gel had set it was 
transferered into the electrophoresis chamber with TAE buffer and the wells were 
loaded with the digest mixture. The gel was covered with buffer. typically 
electrophoresis was performed at 80V with the positive pole at the opposite end to the 
loaded mixture. After the bands had run far enough the electrophoresis was stopped and 
the gel put into an ethidium bromide bath while shaking. Usually 15min of staining in 
the bath was sufficient, the gel was then taken out of the bath and visualised in a gel 
visualisation device fitted with a camera able to detect the signal emitted by ethidium 
bromide. 
 
2.2.3.3 Gel extraction 
 
Following separation by agarose gel electrophoresis DNA fragments were isolated by 
staining the gel in an ethidium bromide bath, and the desired bands were cut out on a 
UV-light box. The DNA was extracted using the Qiagen Gelextraction Kit Qiaquickspin. 
The gel band was dissolved in the same volume of QC buffer and incubated at 50°C for 
10min while vigorously shaking. The dissolved gel piece was loaded on the kit column, 
spun down, washed with 0.5ml QC buffer and 0.75ml PE buffer and resuspended in 
50µl EB buffer. The amount of DNA was estimated.  
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2.2.3.4 Modification 
 
2.3.3.4.1 Blunting 
 
2.3.3.4.1.1 Klenow 
 
The Klenow enzyme is a fragment from DNA Polymerase I. It was used to fill in 
protruding 5’ ends and cut off protruding 3’ ends. As a standard protocol for the fill-in 
of 5’ protruding ends 10 - 15µl (0.1 - 4µg) of digested DNA (aqueous solution), 2µl of 
10x reaction buffer for Klenow fragment, 0.5µl of dNTP mix, (2mM each), 0.1 - 0.5µl 
(1-5u) Klenow fragment were mixed and topped up to 20µl with nuclease free water. 
The reaction was incubated at 37°C for 10 min and the reaction stopped by heating for 
10min at 75°C.  
 
2.3.3.4.1.2 T4 Polymerase 
 
T4-Polymerase was also used to fill in protruding ends. For blunting DNA with 5’ or 3’ 
protruding Termini  4µl 5x reaction buffer for T4 Polymerase, 1µg of digested 
DNA ,1µl dNTP mix (2mM each), 0.2µl (1u) T4 DNA Polymerase were combined and 
topped up with nuclease free water to 20µl. The reaction was incubated at 11°C for 
20min, or at room temperature for 5 min and stopped heating for 10min at 75°C.  
 
2.3.3.4.1.3 Mung bean nuclease 
 
Mung bean exonuclease was used to remove ssDNA from a mixture also containing 
double stranded DNA (dsDNA). For the removal of single-stranded extensions DNA 
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(0.1 μg/μl) was suspended in 1x Mung Bean Nuclease buffer or 1x NEB buffer 1, 2 or 4.  
1.0 units of Mung Bean Nuclease per μg DNA were added and the mixture incubated at 
30°C for 30 minutes. The enzyme was inactivated by phenol/chloroform extraction or 
by addition of SDS to 0.01%. The DNA was recovered by ethanol precipitation. 
 
2.3.3.4.2 Dephosphorylation 
 
2.3.3.4.2.1 Calf Intestine Alkaline Phosphatase 
 
Calf Intestine Alkaline Phosphatase (CIAP) was used for dephosphorylation of DNA in 
restriction endonuclease buffer. One unit of CIAP was added to the digest. 3’ protruding 
and blunt ended DNA was incubated at 50°C for 5min while 5’ protruding ends were 
incubated at 37°C for 5min. 
Next CIAP was inactivated by addition of EDTA, pH 8 in equal molar concentration to 
the MgCl2 and incubated at 65°C for 15min. 
 
2.3.3.4.2.1 Thermo Sensitive Shrimps Alkaline Phosphatase 
 
Thermo Sensitive Shrimps Alkaline Phosphatase (TSAP) is similar to the CIAP but 
derived from arctic shrimps. The main advantage is that it can be easily heat inactivated 
by heating due to its lower thermostability. 
For streamline restriction digestion and dephosphorylation 15 units of restriction 
enzyme for up to 1µg of DNA were used and 1µl of TSAP added. This mixture was 
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incubated at 37°C for 15min. The reaction was brought to 74°C for 15min to heat 
inactivate TSAP and restriction enzymes.  
 
2.3.3.4.3 Phosphorylation 
 
For ligating oligos or small DNA fragments into a vector-fragment, particularly if the 
vector backbone ends were dephosphorylated, phosphorylation of the oligo / insert was 
used to increase the likelihood of a successful ligation. A reaction mix of 100-200pmole 
DNA, 2µl 10x T4 Kinase buffer, 1µl 10mM ATP and 4u T4 polynucleotide Kinase 
(PNK) was pipetted and topped up with H2O to 20µl. The reaction was incubated at 
37°C for 1h and heat inactivated at 70°C for 10min.  
 
2.3.3.5 Oligo design and synthesis 
 
If a cassette had to be inserted into a new vector backbone, but contained no compatible 
restriction sites to cut the cassette and open the vector this was overcome by the 
generation of an oligonucleotide. A site in the vector where the cassette should be 
included was chosen. Restriction sites needed but not present in the vector were chosen. 
The oligo was designed with the restriction sequences, usually two bases space left in-
between the sites and two sticky end overhangs created one at each end. To avoid 
carrying out additional phosphorylation step, oligos have also been ordered with 
phosphorylated ends. The sequence was checked for additional restriction sites 
generated and for methylation sensitive restriction sites. The two strands, sense and 
antisense, were hybridised at equal molar concentrations in hybridisation buffer, 
comparable to the siRNA hybridisation protocol. 
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2.3.3.6 Ligation 
 
2.3.3.6.1 sticky end 
 
Vector DNA and insert DNA were used in a molar ratio of 1/1 to 1/3 together not 
exceeding 10µl in a 20µl ligation. Then 2µl T4 ligase buffer, 1u T4 ligase (Fermentas) 
and H2O were added to a final volume of 20µl. The ligation was incubated for 2h at 
14°C and subsequently been stopped by heating to 65°C for 15min. A negative control, 
for example vector DNA without insert DNA was always included. 
 
2.3.3.6.2 blunt end 
 
For the blunt end ligation it had to be considered that the insert could be ligated into the 
vector backbone in 2 directions and that the vector could also be religated without insert. 
Therefore the vector fragment was dephosphorylated. To ligate such blunt ended 
fragments dephosphorylated vector DNA and insert DNA were used in a molar ratio of 
1/1 to 1/3 together not exceeding 10µl in a 20µl ligation. Then 2µl T4 Ligase Buffer, 
1µl of PEG, 5u T4 ligase (Fermentas) and H2O were added to a final volume of 20µl. 
The reaction was incubated overnight at 4°C and stopped by heating to 65°C for 15min.  
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2.3.3.7 Transformation 
 
2.3.3.7.1 JM109 
 
The most frequent method of transformation used was heat shock. Bacteria were heat 
shocked at 42°C, which denaturises some proteins, producing gaps in the cell wall. This 
allowed DNA to diffuse in. JM109 cells are endonuclease (endA) deficient, greatly 
improving the quality of miniprep DNA, and are recombination (recA) deficient, 
improving insert stability.  
Cells were removed from –80°C, and placed on ice for 5 minutes then 1–50ng of DNA 
per 100μl of competent cells was added and the tubes quickly flicked several times. The 
tubes were immediately put on ice for 10 minutes and heat-shocked for 45–50 seconds 
at exactly 42°C. Immediately the tubes were returned to ice for 2 minutes. 900μl of cold 
(4°C) SOC medium was pipetted to each transformation reaction and the tubes were 
incubated for 60 minutes at 37°C while shaking at approximately 225rpm. To increase 
the yield of clones the bacteria were briefly spun and the supernatant discarded leaving 
a small volume remaining in the tube (50-200µl). The pellet was resuspended in this 
small volume and plated on LB-Agar plates with the required selective antibiotic. The 
plates were incubated upside-down overnight in an 37°C incubator. 
 
2.3.3.7 .2 STBl3 
 
Stbl3™ E. coli strain was designed for cloning direct repeats found in lentiviral 
expression vectors. These cells reduce the frequency of unwanted homologous 
recombinations of long terminal repeats. The transformation was carried out in a similar 
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way to the JM109 however the incubation on ice for 30min after DNA addition and the 
addition of 250µl SOC were different. 
 
2.3.3.8 DNA Purification 
 
2.3.3.8.1 Quick plasmid isolation 
 
The quick plasmid isolation protocol was used as a fast and easy way to obtain plasmid 
DNA for screening. The purity of the sample was low, but adequate for a simple digest 
to confirm the identity of clones.  
The evening before 3 to 5ml of LB was inoculated with a clone from an agar plate or a 
frozen stock. The next morning 2ml of overnight culture was spun down for 1 min at 
13000rpm and the supernatant carefully discarded. The pellet was resuspended in 100µl 
P1 buffer and lysed with 100µl of P2 buffer for 5min. Lysis was stopped with 100µl of 
P3 buffer and incubated on ice for 5min.  The forming precipitates were spun down for 
10 min at full speed and the supernatant transferred to a new tube. Into this 750µl 
absolute ethanol was added. The precipitate was then centrifuged for 30min at 
14000rpm at 4°C and the supernatant discarded. The resulting pellet was washed with 
500µl ice-cold 70% ethanol and spun for 10 min at 14000rpm at 4°C. Finally the 
supernatant was discarded, the pellet air dried and resuspended in 50µl EB buffer. 
 
2.3.3.8.2 Mini kit, midi kit and maxi kit 
 
Mini, midi and maxi-kits were used according to the guidelines of the manufactures in 
the corresponding handbooks. Likewise the quick plasmid isolation protocol a single 
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colony from a selective plate was picked and a starter culture of 2–5 ml LB medium 
inoculated which contained the appropriate selective antibiotic. This starter culture was 
incubated for approximately 8 h at 37°C with vigorous shaking (approx. 300 rpm). In 
the evening a main overnight culture was inoculated diluting the starter culture 1/50 -
1/100.  The next morning the bacteria were spun down, the pellet resuspended, the cells 
lysed and neutralised with the buffer system in the kits. The DNA was then purified by 
spinning down the membrane-protein-genomic DNA aggregates and the plasmid DNA 
washed. The DNA has then been finally concentrated by a column or by precipitation 
and the dried pellets resuspended in the appropriate buffer.  
 
2.3.3.9 Lentivirus Production 
 
For the lentivirus production the cell line 293T was used. Viable 293T cells were seeded 
at 2x106 cells / 10ml DMEM medium, supplemented with 10%FCS and 2mM L-
Glutamine, into a 10cm Tissue culture dish one day before transfection and cultured 
overnight in an incubator (5% CO2, 37°C, 95% air humidity). The cells reached 
approximately 30% confluence the next day. For the transfection by calcium 
precipitation, a mix of 5μg pMD2. G envelope plasmid, 15μg pCMVdeltaR8.91 
packaging plasmid and 20μg of the 2nd generation lentivirus transfer plasmid were 
prepared in 0.5M CaCl2 and filled up to 500µl with special water. Then 500μl 2xHeBS 
was added slowly and dropwise by gently producing air bubbles from the bottom of the 
Eppendorf tube with a 1ml pipette. The mix was incubated for 30min at RT to allow the 
precipitates to form. Prepared 293T cells were infected by slowly dropping the 
precipitates over the plate. The precipitates were further distributed by carefully shaking 
the plate. Then the cells were put back in the incubator overnight (see Figure 25). A 
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coarse precipitation was distributed over the plate the following day, but not adjacent to 
the cells due to their precipitate uptake. The medium was changed carefully and the 
cells were incubated for three more days. Four days after transfection, all medium was 
collected and spun down to remove cells. Additionally the medium was filtered through 
a 0.45μm filter.  
The virus in the medium was concentrated ultracentrifugation in a Beckman 
ultracentrifuge.  To keep to virus sterile the buckets from a swinging bucket rotor, the 
Beckman Instruments Inc thickwall-style (open-top) polyallomer conical tubes and the 
Derlin PKGED’1 adapters were filled with 70% ethanol, poured out and left to dry 
under a flow. The medium containing the virus was filled into the tubes which were 
then topped up leaving no rim. The buckets were closed, hanged into the rotor and the 
rotor mounted into the centrifuge. The virus was concentrated for 2h at 26,000rpm, 4°C 
and negative pressure.  After completion the buckets were carefully transported and the 
supernatant very carefully poured off. The pellets were usually resuspended in 3ml 
medium, which could then be directly used, kept at 4°C for a week or frozen at -80°C. 
The protocol for the lentiviral production is a modification by Vasily Grinev from the 
University of Minsk (Department of Genetics, Biology Faculty, Belarusian State 
University, Minsk, Belarus) based on a previous protocol from D. Trono’s Laboratory 
of Virology and Genetics (EPFL, Lausanne, Switzerland). 
Figure 25 gives an overview over the process. 
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2.3.3.10 Lentivirus Transduction 
 
The day prior to transduction the leukaemic target cells were seeded in 6-well plates at a 
concentration dependent on the cell line, for SEM 2x106 cells per lentiviral transduction 
were used. The next day 1ml per well of the concentrated lentivirus was mixed with the 
cell suspension in each well.  To prevent leakage of lentiviral medium the plates were 
sealed with parafilm. The centrifuge was pre-warmed to 32°C, and the plates were spun 
at 1500g for 2h. Following the spinocculation the plates were located in an incubator for 
lentiviral work until the next morning. Then to remove free lentiviruses the cells were 
washed with PBS and resuspended in 3ml of new medium. The cells were further 
cultured in their incubator and monitored for marker gene expression such as GFP, 
mCherry or DsRed. 
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Figure 25  Schematic of Lentivirus generation and transduction 
293T cells are transfected with 3 plasmid types comprising a packaging, an enveloping and a lentiviral 
vector. Transfected 293T cells produce lentiviruses and show reporter gene expression (here GFP). After 
purification and concentration the lentivirus is used to transduce target cells, intergrating a sequence from 
the lentiviral vector into the genome of the host cell.     communication Vasily Grinev 
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2.3.3.11 Measurement of Transduction rate 
 
If the virus contained a reporter gene such as  GFP the transduction was monitored 
using fluorescent microscopy which gave an approximation of the proportion of cells 
transduced. Often the signal was not strong enough to be visible by fluorescent 
microscopy. 
For the determination of the transduction rate a more accurate and sensitive method was 
used, detecting the fluorescent signals of the reporter genes by flow cytometric analysis. 
For this an aliquot of cells was taken and cells were washed and resuspended in PBS. 
As a control non transduced cells of the same cell-line corresponding to the transduced 
samples were used to set the normal, basic fluorescence of each cell type. Then the shift 
in the fluorescent signal could be detected. By determining the cell numbers in the 
control gate and the fluorescence positive gate the percentage of transduced cells were 
retrieved. 
 
2.3.3.12 Sort 
 
On the day before sorting the sorter was sterilized with bleach. 
The next morning the sorter was sterilized with ethanol, washed with sterile water and 
with medium. About 1x106 cells were prepared in 3ml medium in a FACS-tube. The 
cells were used to set and calibrate the sorter. When set a pre-sort flow cytometric 
analysis was performed on the sorter and the gates set at which size or signal intensity 
cells should were sorted. The sorted cells were collected in a FACS-tube recording the 
number of sorted cells of the desired parameters. After each sort a flow cytometric 
analysis was recorded as well, checking the purity of the cells. Often cells were spun 
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down after sorting to concentrate them in a higher density and the cells were left usually 
a week or two to recover from the physical stress of sorting.  
 
2.3.3.13 Test of Function 
 
To test the functionality of the Teton vector, 293T cells were co-transduced with the 
Teton and a tetO β-Gal virus. The tetO β-Gal plasmid contained a tetoperator sequence 
to which the tet activator, after induction by doxycycline could bind. This drove the 
expression of β-Galactosidase which converts X-Gal as a substrate into a blue dye. By 
this the amount of blue cells in the double transduction compared to controls gave an 
impression if the tet activator was expressed by the Teton vector. 
This experiment was performed by Vasily Grinev, Minsk. 
 
  
2.3.4 Methods Chapter 6 - Mouse work 
 
2.3.4.1 Handling 
 
Mice were handled according to the animal project license, number PPL60/3846. 
Animals were regularly checked for food and drink supply and any signs of distress or 
pain. If handled or procedures were carried out they were kept under a laminar flow 
hood using aseptic techniques to avoid infections in these immune deficient mice. 
Painful procedures were accompanied by anaesthesia, Carprofen injection and suffering 
animals were euthanatized.     
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2.3.4.2 Injections  
 
2.3.4.2.1 Intraperitoneal injection, i.p. 
 
The mouse was fixed by scruffing the loose skin at the nape of the neck and also the tail 
and the legs were restrained by holding them down with the small finger of the same 
hand. A needle with up to 2x107 cells in 400µl was injected into one of the lower 
quadrants of the abdomen. The first resistance was overcome and the needle pushed 
deeper. Up to 200µl were injected slowly, ensuring that no sample backflow occurred 
after the needle was removed.  
 
2.3.4.2.2 Intrafemoral injection, i.f. 
 
For intrafemoral injection mice were anaesthetized with isoflurane and the knee to be 
injected shaved. Through the knee, parallel to the femur and towards the hip an incision 
hole was made with a bigger needle by turning it slightly and then a thinner needle with 
the suspension was used to inject a small volume into the bone marrow. Mice were 
marked by ear clipping and were given Carprofen subcutaneously as an analgesic.  
  
2.3.4.2.3 Intrahepatic injection, i.h. 
 
5x105 SEM in 30µl PBS were prepared and kept on ice. Before use a Hamilton syringe 
was filled and kept bubble free. Two day old Newborn R2G mice were tightly scruffed. 
The Hamilton needle was injection in the middle of the body below the sternum and 
parallel to the body surface and moved under the skin above the liver. When the needle 
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was at the position of the liver, the needle was turned towards oneself so that the tip of 
the needle incised into the liver. 10µl were carefully and slowly injected. Animals were 
marked by ear marking and returned to their cage. Before and between each injection 
the Hamilton needle was flushed with PBS and ethanol. 
 
2.3.4.3 Section of mice 
 
To harvest bone marrow, tumours and organs the mouse was sacrificed by cervical 
dislocation and weighed. The abdomen was opened with a vertical incision and the 
organs or tumour isolated and cut out and weighed and size measured. Tissues were 
washed with PBS and then either used for a cell harvest or fixed in formalin, stained and 
analysed by microscopy. 
To retrieve the bone marrow the femurs and tibiae were removed from skin and muscles, 
the tips of the bones cut on each side and the bone marrow was flushed out by a needle 
with PBS. The bone marrow was then used for flow cytometric analysis. 
Blood was taken either by the tail vein or by cardiac puncture of an anaesthetized mouse 
before sectioning it. 
 
2.3.4.4 Cell harvest 
 
Tissues from organs were cut into small pieces and a shredder (BD, Medicon, sterile, 
35µm) filled with it. The shredder was also filled with 1ml of medium and put into the 
Medimachine (Becton Dickinson). After some seconds of shredding the container was 
removed and opened to check if the tissue pieces were thoroughly homogenised. If so 
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medium with single cells was sucked out while carefully pipetting up and down. 
Usually cells retrieved from live organs were kept in 2% Pen/Strep, initially kept at a 
high concentration and monitored over a time or directly used for analysis.  
 
2.3.4.5 Imaging 
 
For developing the imaging techniques culled mice were used. Several degrees of 
preparation were necessary. From furry, to shaved (hair clipper), to removed fur (Veet), 
to skinned and finally to muscles above bones removed.  
Veet treatment allowed removing hairs with follicles, which also blocked light from 
going into the body and out of it. In principle this technique could also be applied to live 
animals, only regions with sensitive mucosa should be spared. Mice were shaved (hair 
clipper) and Veet was applied over the desired region with a gloved hand. After 5-
10min the Veet and the hairs were washed off and the mice put into the imaging device. 
For mice injected with SEMcami cells (dsRed + GFP) white light for absorption and a 
green or a dual green, red filter for capturing were chosen.  
 
 
 
 
 
 
  
 
 
 
Chapter 3 
Array analysis and validation 
Chapter 3 Array analysis and validation 
91 
 
Chapter 3 Array analysis and validation  
 
3.1 Introduction  
 
The investigation of the transcriptional expression of a gene can elucidate its regulation. 
But how to identify such genes, which could be differentially expressed due to genetic 
events, such as mutations, translocations, deletions or amplifications? 
Expression array analysis is a powerful tool to screen the global transcriptome 
expression which is differentially regulated due to a certain factor. It makes use of the 
hybridisation of nucleic acids, e.g. mRNA, to probes which have been synthesized 
complementary to sequences of any already sequenced mRNA and located at a certain 
spot representing a gene locus.  Fluorescent labelling, for example of to be analysed 
transcripts, allows detection and quantification.  
After identification of interesting genes, these can then be validated in more detail by 
analyses such as Western Blot, qRT-PCR or functional studies.  
 
In 2005 a micro array platform enriched for leukaemic cDNA (cDNAs retrieved from 
leukaemic bone marrow) was developed to screen for differentially expressed 
transcripts with relevance to paediatric ALL. This analysis showed distinct gene 
expression patterns of several ALL subtypes, i.e. T-ALL, B-ALL and B-ALL with the 
MLL/AF4 fusion. They stated that microarray analysis allows the identification of new 
genes involved in leukaemogenesis (De Pitta, Tombolan et al. 2005). 
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3.2 Aims 
 
The aim of this section of my work was to identify possible target genes of MLL/AF4. 
The knockdown of a gene, in particular this fusion gene, is a convenient way of 
investigating its functions by detecting associated changes in global transcript 
expression. This was accomplished by cDNA - and oligo-Array analysis. Further 
validation of interesting and strongly affected genes substantiated these generated data. 
This validation relied on the knockdown of MLL/AF4 by RNAi and subsequent 
validation of the induced transcript level alterations by quantitative Real Time PCR 
analysis. 
 
 
Specific aims: 
 
 
1. To interrogate cDNA and oligo-array data from MLL/AF4 knockdown cells in 
order to identify putative direct and indirect transcriptional targets. 
 
 
2. To validate changes in gene expression of putative MLL/AF4 targets using real-
time PCR. 
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 3.3 Results Array Analysis and validation 
 
3.3.1 Array analysis 
 
3.3.1.1 Oligo array (Affimetrix U133 Plus 2.0) Ingenuity 
analysis 
 
 
Figure 26  Flow chart of using Ingenuity Pathway Analysis for array data analysis 
Flowchart how data have been handeled from the experiment to the array, the array output and the 
processing in Ingenuity Pathway Analysis (IPA) 
For the Affimetrix U133 Plus 2.0 Array SEM cells had been depleted of MLL/AF4 for 2 
days and isolated mRNA was used to perform the analysis. This experiment was 
performed by my predecessor Maria Thomas (Thomas, Gessner et al. 2005). To 
introduce the generated data into the Ingenuity Pathway analysis the array data were 
sorted for strongest change and a minimum fold change of 2.  
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The Ingenuity Knowledge Base (KB) is the basis of all Ingenuity Pathway analyses and 
it is the largest knowledge base of its kind. It comprises millions of connections 
between genes, complexes, proteins, drugs, cells, tissues and diseases. These data are 
further translated into correlated functions by Ingenuity Ontology also integrating 
biological and chemical information. Several parameters such as species, tissue context 
and direction of change can be selected. The type of connection can be specified such as 
molecular, cellular and organism specific. Ingenuity is most up to date by weekly input 
from experts including experimentally demonstrated findings from full text journals 
covering more than 300 top journals. The sources of databases include Entrez gene, 
RefSeq, OMIM, GWAS Database, Gene ontology, KEEG and many more.  
The Ingenuity Pathway analysis connected the MLL/AF4 depletion responsive genes 
(transcripts) to functions, diseases, physiological systems, networks and canonical 
pathways (see Figure 26).  
The functional analysis of an expression dataset shows biologically most important 
functions connected to those data. The 500 top functions are displayed if they have a p-
value smaller than 0.05. Functional Analysis comprises 3 main categories: “Molecular 
and Cellular Function”, “Physiological System Development and Function” and 
“Diseases and Disorders”. These 3 categories are subdivided hierarchically into more 
than 85 subcategories, defined as “high level functional categories”, of which each has 
several specified subgroups, termed “low level functions” and “lowest level functions”. 
One such hierarchy would be cancer – haematological disease – leukaemia.  
The statistical probability that altered transcription levels from the array analysis have a 
connection to a function, process or physiological pathway is calculated with the right 
tailed Fisher exact test. The bigger the p-value is, the greater is the chance that this 
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connection is due to random chance. Here, p-values smaller than 0.05 are considered as 
statistically significant and the association as non random. The right tailed Fisher exact 
test uses the number of molecules participating in that function and the total number of 
molecules associated in that function to calculate this p-value. In the case that a high 
level function comprises for two or more specific functions a range of significances is 
generated. The top 5 high level functions of the several main categories are those with 
the lowest p-value or p-value range, representing the top 5 categories with the highest 
significance. 
The following tables show these sorted results. 
Diseases and Disorders p-value # Molecules 
Cancer 2.02E-19 - 5.11E-03 456 
 
Skeletal and Muscular Disorders 1.35E-13 - 3.95E-03 440 
 
Reproductive System Disease 8.03E-10 - 5.11E-03 282 
 
Inflammatory Disease 1.11E-09 - 4.64E-03 412 
 
Genetic Disorder 1.99E-09 - 4.83E-03 899 
 
Table 2  Oligo-array Ingenuity analysis: The top 5 subcategories of Diseases and 
Disorders    sorted on p-value,   generated using Ingenuity Pathway Analysis; Ingenuity Systems Inc. 
 
In the category “Diseases and Disorders” (Table 2) “Cancer” was the most significant 
disease; connected to 456 affected molecules on the array. “Diseases and Disorders” is 
one of the 3 main functional categories. The high level function “Cancer” is defined as 
a cancer associated function, such as transformation or metastasis. It could also show a 
connection to tumours, cancer cells or cancer tissue. This function is a very sensible and 
expectable finding.  
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With 440 involved molecules the second top high level function is “Skeletal and 
Muscular Disorders” which includes diseases and abnormalities in the skeletal and 
muscular system. It may not be very obvious how a leukaemic fusion protein 
contributes to genes involved in those diseases, but as several cell types involved in 
skeletal diseases such as osteoblasts and fibroblasts, are important in the interactions 
with both haematopoietic and leukaemic stem cells, this category may show an 
influence of those cell types. Additionally, the cytoskeleton could contribute to these 
categories, which is required for functions as migration and homing. 
The third high level function “Diseases and Disorders” is “Reproductive System 
Disease” with 282 affected molecules, and categorizes diseases and abnormalities of the 
reproductive system. Again the link to leukaemia is not clear; possibly stemness and 
self-renewal capacity genes associated with reproductive cell types (De Felici, Farini et 
al. 2009; Golestaneh, Beauchamp et al. 2009) might provide a link to leukemia.  
Furthermore, 412 molecules comprise the forth category “Inflamatory Disease”. The 
association with inflammatory diseases may contribute to the involvement of immune 
defence cells in inflammatory responses (Luster, Alon et al. 2005) as well as an 
interferon response to the siRNA treatment (Reynolds, Anderson et al. 2006) which will 
be discussed later.  
Finally, the 5th of 5 top categories is “Genetic Disorder” with 899 related molecules, 
including diseases and disorders resulting from genetic defects. As MLL/AF4 is a 
genetic lesion itself and as several leukaemia types are caused or promoted by genetic 
disorders, such as trisomy 21(Pui, Robison et al. 2008), the depletion of MLL/AF4 
probably generates the gene pattern comprised by this category. 
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The 5 most significant molecular and cellular functions connected to this array were 
cellular growth and proliferation, followed by cell death, cellular movement, cell to cell 
signalling and interaction and finally cell morphology (see Table 3). 
Molecular and Cellular Functions p-value  # Molecules 
Cellular Growth and Proliferation 3.72E-15 - 5.11E-03 325 
 
Cell Death 5.34E-11 - 5.11E-03 271 
 
Cellular Movement 8.03E-11 - 4.50E-03 182 
 
Cell-To-Cell Signalling and Interaction 2.32E-10 - 5.11E-03 232 
 
Cell Morphology 7.24E-08 - 4.68E-03 87 
 
Table 3  Oligo-array Ingenuity analysis: The top 5 of Molecular and Cellular Functions 
sorted on p-value generated using Ingenuity Pathway Analysis; Ingenuity Systems Inc. 
 
 
With 325 affected molecules i.e. IGFBP5, “Cellular Growth and Proliferation” is the 
most significant “Molecular and Cellular Function” describing functions associated 
with the growth and the proliferation of cells. As this is one of the main properties of 
cancer in general it links nicely to leukaemia (Table 3).  
“Cell Death” as the the second category is also coherent with leukaemia, as modulation 
of cell death factors helps leukaemic cells to resist apoptotic stimuli. 271 molecules 
associated with this category i.e. MAP2K5, were found to be affected on the array.  
On the 3rd place is “Cellular Movement”, with 182 affected molecules i.e. KITLG. It 
associates to movement and localization of cells. Amongst affiliated processes are 
immune cell connected processes such as chemotaxis, rearrangement, transmigration of 
cells but also cancer associated infiltration.  
“Cell-To-Cell Signalling and Interaction”, the fourth of five top functions comprises 
232 affected molecules, i.e. IL8, linked to intercellular interactions like communication, 
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stimulation, binding detachment and more specifically intercellular junction 
components. These processes are also most important for immune cells and for 
interactions of haematopoietic cells with niche environments.  
Finally the fifth group “Cell Morphology” with 87 involved molecules, i.e. TNC, 
includes associated processes such as cell size, transformation of cells, enlargement and 
fluidy, i.e. remodelling of the cytoskeleton. Again this is linked to immune cell 
processes and niche interactions. 
Table 4 shows the last main function category top 5 summary 
Physiological System Development and Function p-value # Molecules 
Tissue Development 
 
1.13E-08 – 
 5.11E-03 
131 
Hematological System Development and Function 1.85E-07 –  
5.11E-03 
140 
Lymphoid Tissue Structure and Development 
 
6.80E-07 –  
1.93E-03 
14 
Immune Cell Trafficking 
 
1.46E-06 –  
4.31E-03 
60 
Haematopoiesis 
 
5.46E-06 –  
5.11E-03 
59 
Table 4  Oligo-array Ingenuity analysis: The top 5 of Physiological System 
Development and Function      sorted on p-value, generated using Ingenuity Pathway Analysis; 
Ingenuity Systems Inc. 
 
 
Above it is shown that amongst the 5 top “Physiological Systemic Developments and 
Function” categories “Tissue Development” is followed by “Haematological System 
Development and Function”, “Lymphoid Structure and Development” and “Immune 
Cell Trafficking and Haematopoiesis” (see Table 4).   
With 131 involved molecules “Tissue Development” comprises functions associated to 
normal development and differentiation of tissues as well as the formation of tissue 
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through the association of cells. These include survival of tissue, accumulation and 
adhesion of cells. 
Secondly, “Hematological System Development” and Function with 140 affected 
molecules, associates functions to “normal development and function of cells, tissues 
and organs that make up the hematological system as well as functions specific to the 
hematological system”. 
The 3rd top “Physiological Systemic Development and Function” category is “Lymphoid 
Tissue Structure and Development”, with 14 involved molecules. It describes links to 
“physical structure of immune organs including vasculature and sub-organ tissue 
organization and the processes of their formation”. 
“Immune Cell Trafficking” ranks forth and includes 60 altered molecules describing 
movement-associated functions for all cell types. Some examples are accumulation, 
activation, adhesion, cell-cell adhesion, cell movement, chemoattraction, chemokinesis, 
delay in infiltration, delay in migration, homing, localization, migration, mobilization, 
and transdifferentiation.  
Finally, there is “Haematopoiesis” with 59 altered molecules. It is restricted to 
lymphocytes, myeloid and mesenchymal cell types and their subclasses linked to 
processes associated with haematopoiesis.   
The next type of analysis is the IPA network generation (see Figure 27). A set of 
molecules, defined by the array analysis that interacts with other molecules in the 
Ingenuity Knowledge base, is indentified as “Network Eligible Molecules”. These are 
combined into networks to maximize the interconnectedness of each molecule to all. 
Smaller networks are connected to larger ones by using additional molecules from the 
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Ingenuity Knowledge base with maximally 35 molecules per network. The scoring uses 
the number of network eligible molecules” in the network and ranks networks according 
to their degree of relevance. Besides the number of network eligible molecules in the 
network, it uses its size, the total number of Network Eligible molecules analyzed and 
the total number of molecules in the Knowledge Base which could be included in the 
network. For calculation of the hypergeometric distributed score the Fisher’s right tailed 
Exact test is used.  
To exemplify the scoring, a network of 35 molecules is supposed with a Fisher’s exact 
test result of p= 1x10-6. By calculating the negative logarithm of this value the network 
score of 6 is generated. This score shows how each network fits to the network eligible 
molecules (descriptions of IPA computational processes are based on quotations of the 
IPA manual) (Figure 27). 
 
 
Figure 27  IPA Network Generation, Ingenuity Feature descriptions 
generated using Ingenuity Pathway Analysis; Ingenuity Systems Inc. 
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The next table (Table 5) lists associated network functions that are linked to altered 
genes on the oligo array. Interestingly the highest score is found for “Cancer, Endocrine 
System Development and Function, Small Molecule Biochemistry”, and the second 
highest for “Cellular Movement, Skeletal and Muscular System Development and 
Function, Cellular Growth and Proliferation”. 
But also the other network functions give interesting information about the connection 
of the affected genes. 
 Associated Network Functions Score
1  Cancer, Endocrine System Development and Function, Small 
Molecule Biochemistry  
26  
2  Cellular Movement, Skeletal and Muscular System Development and 
Function, Cellular Growth and Proliferation  
24  
3  Behaviour, Reproductive System Development and Function, 
Infection Mechanism  
22  
4  Cellular Movement, Inflammatory Response, Cell-To-Cell Signalling 
and Interaction  
21  
5  Cell-To-Cell Signalling and Interaction, Cellular Growth and 
Proliferation, Hematological System Development and Function  
18  
Table 5  Oligo-array Ingenuity analysis: The top 5 of Associated Network Functions 
sorted on scoring, generated using Ingenuity Pathway Analysis; Ingenuity Systems Inc. 
 
 
Each of the networks is called after the 3 top high level functions it is containing. The 
network scored at the highest, 26, is “Cancer, Endocrine System development and 
Function, Small Molecule Biochemistry”. This network seems to comprise cancer 
signalling functions, which is clearly relevant in leukaemia (Table 5).  
The second network with a score of 24 is “Cellular Movement, Skeletal and Muscular 
System Development and Function, Cellular growth and Proliferation”. The probable 
link to leukaemia is the niche context.  
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Thirdly, with a score of 22, the network “Behaviour, Reproductive System Development 
and Function, Infection Mechanism” is found. Behaviour in this context means 
functions of multi-cellular organisms associated with behaviour such as feeding. 
Infection mechanism includes processes associated with organismic response to virus 
infections. This network may contribute to the stemness, developmental and B-cell 
related genes affected by MLL/AF4. 
“Cellular Movement, Inflammatory Response, Cell-To-Cell Signalling and Interaction” 
is the next network, scoring with 21. It shows some functions associated with immune 
cell behaviour.  
The last network category is “Cell-To-Cell Signalling and Interaction, Cellular Growth 
and Proliferation, Hematological System Development and Function” and links strongly 
to leukemic cell functions. 
In the pathway analysis the dataset of altered genes on the array is linked to canonical 
pathways by the ratio which is the number of genes affected per total number of genes 
in that pathway, and the significance via the p-value, which describes if the association 
between a specific pathway and the altered array genes is likely. 
The smaller the p-value, the more significant the association. The ratio mainly tells 
which pathways were most affected i.e. illustrated by percentage of altered genes in that 
pathway. 
However, the judgment how a pathway is modulated has to be made by considering the 
effect of the altered gene in that pathway. For example, if inhibitors are up-regulated 
and activating parts are down-regulated then a pathway would be considered as down-
regulated. 
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In the following table, (Table 6) a list of the 16 most significant canonical pathways 
correlated to the oligo array data is displayed. 
Ingenuity Canonical Pathways 
 ‐log 
(p‐
value)  Ratio 
altered 
genes  / 
total 
Hepatic Fibrosis / Hepatic Stellate Cell Activation  4.44  0.23  30/ 128 
G‐Protein Coupled Receptor Signalling  3.11  0.18  38/ 210 
Coagulation System  2.97  0.30  11/ 37 
cAMP‐mediated Signalling  2.57  0.19  29/ 157 
Macrophages,  Fibroblasts  and  Endothelial  Cells  in  Rheumatoid 
Arthritis  2.41  0.15  48/ 313 
Metabolism/ Xenobiotics by Cytochrome P450  2.38  0.19  18/ 97 
Complement System  2.17  0.27  9/ 34 
Role/  Cytokines  in Mediating  Communication  between  Immune 
Cells  2.04  0.23  12/ 52 
LPS/IL‐1 Mediated Inhibition/ RXR Function  2.03  0.16  31/ 197 
Acute Phase Response Signalling  2.02  0.17  29/ 173 
Wnt/β‐catenin Signalling  2.01  0.17  28/ 166 
VDR/RXR Activation  2.00  0.21  16/ 78 
Communication between Innate and Adaptive Immune Cells  1.94  0.19  14/ 75 
Pathogenesis/ Multiple Sclerosis  1.91  0.44  4/ 9 
Serotonin Receptor Signalling  1.83  0.24  8/ 33 
LXR/RXR Activation  1.83  0.18  14/ 76 
Table 6  Oligo-array Ingenuity analysis: The 16 most significant Canonical pathways 
 sorted on p-value, generated using Ingenuity Pathway Analysis; Ingenuity Systems Inc. 
 
The top canonical pathway sorted by significance is “Hepatic Fibrosis / Hepatic Stellate 
Cell Activation” (Table 6). Of 128 genes associated to that pathway, 30 are affected by 
MLL/AF4. In the pathway array related genes like FGF1, FGF2, FGFR1, FGFR2, 
IGF1, EGF and IL-6R are found. These genes probably explain why this pathway was 
scored despite hepatic cells not being related to leukaemia.  
The pathways “G-Protein Coupled Receptor Signalling” (2nd), “cAMP-mediated 
Signalling” (4th) are generally important pathways in a huge number of signalling events. 
“Coagulation System” (3rd) and “Complement System” (7th) pathways are mostly linked 
to leukaemia by their haematological functions.   
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The “Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis” 
pathway may show stromal and inflammatory gene patterns.  
“Role/ Cytokines in Mediating Communication between Immune Cells” (8th), 
“Communication between Innate and Adaptive Immune Cells” (9th) and “LPS/IL-1 
Mediated Inhibition/ RXR Function” (13th) pathways are mainly describing immune 
system functions and those may contribute to leukaemia.  
The “Metabolism/ Xenobiotics by Cytochrome P450” pathway (6th) could help 
MLL/AF4 positive cells to survive chemotherapy by metabolizing these agents.  
“Wnt/β-catenin Signalling” (11th), “VDR/RXR Activation” (12th) and “LXR/RXR 
Activation” (16th) are very important signalling pathways which can be leukaemogenic 
processes like growth, survival and niche interactions.  
In summary there are many signalling pathways affected that regulate cellular processes, 
but also pathology-associated pathways such as inflammation related pathways linked 
to fibrosis, arthritis, sclerosis, acute phase signalling. As previously mentioned, it is 
possible that this is due to siRNA mediated interferon response or an effect of 
MLL/AF4 knockdown affected genes. This issue will be discussed more thoroughly in 
the discussion.  
 
A different way of displaying this data was chosen for the next pie chart. The pathways 
were sorted on the ratios (the number of genes affected per total number of genes in that 
pathway, Figure 28).  
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Figure 28  Pie chart of canonical pathways 
sorted on ratios of altered genes from the array to total number of genes per pathway, generated using 
Ingenuity Pathway Analysis; Ingenuity Systems Inc. 
 
 
The sort by ratio slightly changes the order of the top pathways (Figure 28). Two of the 
strongest affected pathways are Coagulation System and Complement System with 11 
of 37 and 9 of 34 genes involved, respectively. Both pathways link to the innate 
immune system functions such as chemotaxis and vascular permeability. Here, the 
signalling pathways and the inflammatory pathways dominate.  
Both ways of sorting the pathways use relatively high ratios and high significances 
informative and are equally.  
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The following schemes illustrate altered genes on the oligo-array in the most significant 
canonical pathways from the Table 6. 
 
Figure 29  Early signalling in hepatic stellate cells 
Oligo-array Ingenuity canonical pathway analysis, scheme of pathway:  Early signalling in hepatic 
stellate cells, colours indicate gene up/down-regulated on array:  Red: strongly up-regulated, light red: up-
regulated, green: down-regulated, green-red: various family members differentially expressed, generated 
using Ingenuity Pathway Analysis; Ingenuity Systems Inc. 
 
 
The scheme above (Figure 29) shows the illustration of the canonical pathway “Early 
signalling events in hepatic stellate cells”. Here it is shown that the knockdown of 
MLL/AF4 had an influence on VEGF receptor which is regulating proliferation, the 
EGF / EGFR pathway which is involved in cell migration, on the IGF1 receptor via 
IGF1 and in FGFR1/2 and its ligands FGF1/2 and its ligands FGF1/2 as well which are 
involved in proliferation amongst others. 
The next 2 pathways the “G-protein signalling” (Figure 30) and “cAMP mediated 
signalling” (Figure 31) both show the involvement of MKP1/2/3/4 (MAP Kinase 
Phosphatase). One example of those found on the array is DUSP6. Both pathways also 
show the involvement of CREB. and comprise very important cell regulation systems 
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like MAPK and ERK which signalling regulate manifold processes in a cell. But also 
important regulators like NF-κB and IκB are affected. “G-protein coupled signalling” 
and (Figure 30) “cAMP mediated signalling” (Figure 31) are connected to diverse 
pathways and regulative systems in the cell. 
 
Figure 30  G-protein coupled receptor signalling 
Oligo-array Ingenuity canonical pathway analysis, scheme of pathway:  G-protein coupled receptor 
signalling; colours indicate gene up/down-regulated on array:  Red: strongly up-regulated, light red: up-
regulated, green down-regulated, green-red: various family members differentially expressed, generated 
using Ingenuity Pathway Analysis; Ingenuity Systems Inc. 
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Figure 31  cAMP mediated signalling 
Oligo-array Ingenuity canonical pathway analysis. scheme of pathway:  cAMP mediated signalling, 
colours indicate gene up/down-regulated on array:  Red: strongly up-regulated, light red: up-regulated, 
green down-regulated, green-red: various family members differentially expressed, generated using 
Ingenuity Pathway Analysis; Ingenuity Systems Inc. 
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Figure 32  Wnt / β-Catenin signalling 
Oligo-array Ingenuity canonical pathway analysis. scheme of pathway:  Wnt / β-Catenin signalling, 
colours indicate gene up/down-regulated on array:  Red: strongly up-regulated, light red: up-regulated, 
green down-regulated, green-red: various family members differentially expressed, generated using 
Ingenuity Pathway Analysis; Ingenuity Systems Inc. 
 
 
The Wnt / β-Catenin pathway shown above (Figure 32) is a very central pathway in the 
mammalian cell, as coloured genes affected by the MLL/AF4 depletion input via the N, 
E, P, VE –Cadherins as well as factors like APC on β-Catenin. But also the 
Wnt/Frizzled receptor and connected genes influence the β-Catenin level. Down-stream 
of β-Catenin RAR, SOX, Cyclin D1 and LEF/TCF are affected. The above mentioned 
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LEF/TCF transcription factor is additionally affected by the TGFβR family member 
ACVR1B, which is also altered on the array. 
 
Figure 33  Role of Oct4 in Mammalian embryonic stem cell pluripotency 
Oligo-array Ingenuity canonical pathway analysis. scheme of pathway:  Role of Oct4 in Mammalian 
embryonic stem cell pluripotency, colours indicate gene up/down-regulated on array:  Red: strongly up-
regulated, light red: up-regulated, green down-regulated, green-red: various family members differentially 
expressed, generated using Ingenuity Pathway Analysis; Ingenuity Systems Inc. 
 
 
The pathway “Role of OCT4 in mammalian embryonic stem cell pluripotency” (Figure 
33) shows genes influencing OCT4. OCT4 is also known to play a role in the 
haematopoietic stem cell regulation. Amongst the influenced genes are OCT4, SOX2, 
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RARα and HOXB1. OCT4 signalling regulates processes such as cell cycle, apoptosis, 
DNA repair, chromatin structure regulation and pluripotency. 
Already in the previous pathways RXR was mentioned. RXR is very important in the 
vitamin D induced regulation. The following pathway “VDR/ RXR activation” (Figure 
34) shows MLL/AF4 depletion sensitive genes such as PKC, RXR and VDR which 
regulate processes such as calcium homeostasis, cell differentiation, growth regulation, 
bone metabolism and cell proliferation. 
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Figure 34  VDR / RXR activation 
Oligo-array Ingenuity canonical pathway analysis. scheme of pathway:  VDR / RXR activation, colours 
indicate gene up/down-regulated on array:  Red: strongly up-regulated, light red: up-regulated, green 
down-regulated, green-red: various family members differentially expressed, generated using Ingenuity 
Pathway Analysis; Ingenuity Systems Inc. 
 
3.3.1.2 Array comparison and validation of possible target 
genes 
 
The depletion of the target fusion gene MLL/AF4, used in both array analyses was 
confirmed by Real Time-PCR and the conformation of MLL/AF4 depletion was a 
prerequisite for all experiments relying on the depletion of the fusion gene. 
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Figure 35  MLL/AF4 depletion in SEM 
MLL/AF4 transcript qRT-PCR analysis after MLL/AF4 knockdown in SEM for 96h. Mock: electroporated 
without siRNA, siMA6: anti MLL/AF4 siRNA siAGF1: active siRNA control. Shown are relative mRNA 
expression levels and averages of 3 independent experiments. Error bars show SD values. The 
knockdown of MLL/AF4 transcript was highly statistically significant with p = 0.003 (Students t-test). 
 
The 70% knockdown of MLL/AF4 in SEM was found to be highly statistically 
significant with a p-value of 0.003 as determined by Students t-test (Figure 35). The 
siRNA targeting the fusion transcript in SEM was siMA6. Due to several breakpoints in 
the fusion region MLL/AF4 transcripts differ between the t(4;11) positive cell lines 
SEM, RS4;11 and MV4;11. The electroporation control was Mock, which was 
performed in parallel to the other samples but without siRNA and which was usually set 
to 1. Conversely, the siAGF1 control is an active siRNA against the fusion gene 
AML/MTG8, a fusion gene not present in the cell line SEM. This was found to be a 
suitable siRNA control for MLL/AF4 knockdown and due to its proven activity in cell 
lines carrying AML/MTG8 to be superior to scrambled siRNA controls.    
The two array data sets from the oligo- and the cDNA array sorted for genes with more 
than 2 fold change and a p-value higher than 0.05 were compared for concordance 
(Table 7). The tables of the genes found in cDNA and oligo array analysis are shown in 
Chapter 3 Array analysis and validation 
114 
 
the appendix. The following list of genes validated by qRT-PCR summarizes these 
candidates. 
 
 
Table 7  Genes overlapping in cDNA- and oligo array analysis of MLL/AF4 depleted 
leukaemic SEM cells 
 
As mentioned also data from a cDNA array were available. Here, MLL/AF4 was 
depleted in SEM cells for a period of 144h. The most significantly changed genes from 
the cDNA array were validated by qRT-PCR for which primers were designed. The 
generated amplicons were checked by DNA-PAGE analysis. All 3 data sets, from the 
oligo array, the cDNA array and qRT-PCR were compared for concordance of their 
effects, meaning up or down regulation. Only a restricted number of genes were 
analyzed by all 3: oligo, cDNA array and qRT-PCR.  
Following diagrams show the fold changes of these (Figure 36 A, B and C).  
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Figure 36  Genes affected by MLL/AF4 Knockdown  
Comparison of fold change of genes in oligo-array, cDNA-array and qRT-PCR   (A) Panel of genes with 
high fold changes in expression up to 14 times, DAAM1 was upregulated, all other transcripts were 
downregulated upon MLL/AF4 depletion   (B) Panel of genes with intermediate fold changes up to 5 
times   (C) Panel of genes with lower fold change up to 3.5 times  Blue: qRT-PCR,  Red: fold change on 
oligo-array and Green: cDNA array; missing colums represent genes not cover by all 3, qRT-PCR, cDNA 
- and oligo array. 
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This comparison shows a good concordance of the compared genes. Genes down-
regulated (all of the shown except DAAM1 which was upregulated) were found down-
regulated in all 3 assays if included. The data from the qRT-PCR tended to have a 
stronger fold change than the array data. 
Two of those genes which were strongly altered in qRT-PCR are shown below (Figure 
37). DAAM1, which is involved in the cytoskeleton amongst other functions, was 
strongly up-regulated. BNIP3 involved in processes such as apoptosis, was found 
strongly down-regulated. 
 
  
Figure 37  qRT-PCR validation of DAAM1 and BNIP3 
qRT-PCR transcript analysis after MLL/AF4 knockdown in SEM for 48h. (Left diagram) relative 
expression levels of DAAM1   (Right diagram) relative expression levels of BNIP3  Shown are triplicates 
of one single representative experiment. Mock: electroporated without siRNA, siMA6: anti MLL/AF4 
siRNA siControl: control siRNA   
 
Next, possible target genes of MLL/AF4 were investigated by determining their mRNA 
levels in comparison to the controls. This was based on the thought that if other 
transcripts levels change consistently due to the depletion of MLL/AF4, they may be 
influenced directly or indirectly by MLL/AF4. Because MLL/AF4 contains transcript 
factor properties it can be assumed that genes downstream of MLL/AF4 underlie its 
regulation.  
One of this proposed target genes already found on both arrays is DUSP6. 
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DUSP6 is a dual specificity protein phosphatase which inactivates its target kinases by 
dephosphorylation. These cytoplasmic kinases are involved in pathways such as 
MEK/ERK. Thus DUSP6 is known to regulate proliferation and differentiation. 
 
 
Figure 38  DUSP6 expression analysis 
DUSP6 transcript qRT-PCR analysis after MLL/AF4 knockdown in SEM for 96h. siMA6: anti MLL/AF4 
siRNA, siMARS: siRNA control. Shown are relative mRNA expression levels of DUSP6 and averages of 
3 independent experiments. Error bars show SD values. The knockdown of DUSP6 transcript was highly 
statistically significant with p = 0.0026 (paired student’s t-test). 
 
Following depletion of MLL/AF4, qRT-PCR analysis showed more than 50% depletion 
of DUSP6 with p = 0.0026 (Figure 38).  The data were normalised to the siRNA control 
siMARS. Like siAGF1, siMARS is also an active siRNA control targeted to a fusion 
transcript. In case of siMARS, the target transcript is MLL/AF4 but with a different 
MLL/AF4  breakpoint.  
As mentioned previously MLL/AF4 genes can have different breakpoints. The fusion 
gene in SEM cells contains MLL exons 1 to 9 and AF4 exons 4 to 20 (e9-e4). siMA6 
targets this fusion gene. The fusion gene in RS4;11 cells contains MLL exons 1 to 10 
and  AF4  exons 4 to 20 (e10-e4). The breakpoint in RS4;11 cells is targeted by 
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siMARS which is not specific to the SEM fusion transcript. The MV4;11 fusion gene 
contains MLL exons 1-9 and  AF4  exons 5-20 (e9-e5).  
Another target gene of MLL/AF4 was HOXA7. HOXA7 belongs to the homeobox gene 
cluster A. These transcription factors play an important role in regulating definitive 
hematopoiesis. HOXA7 is especially known to be disregulated in MLL-rearranged acute 
leukaemias and AML.  
 
 
Figure 39  HOXA7 expression analysis 
HOXA7 transcript qRT-PCR analysis after MLL/AF4 knockdown in SEM for 96h. siMA6: anti MLL/AF4 
siRNA, siAGF1: active siRNA control. Shown are relative mRNA expression levels of HOXA7 and 
averages of 3 independent experiments. Error bars show SD values. The knockdown of HOXA7 transcript 
showed highest statistical significance with p = 0.0006 (paired student’s t-test). 
 
Figure 39 shows the roughly 90% depletion of HOXA7 mRNA (p = 0.0006) in response 
to MLL/AF4 depletion. The data are normalised to the active siRNA control siAGF1. 
Next, (Figure 40) analysis of FGFR1 transcript levels subsequent to MLL/AF4 
depletion are shown. FGFR1 was found to be down-regulated on both arrays, which 
was confirmed by qRT-PCR. Knockdown of FGFR1 by more than 60% normalised to 
siAGF1 was found to be highly statistically significant with p = 0.0022. FGFR1 is the 
Fibroblast Growth Factor Receptor 1 and is known to be involved in important cell 
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functions such as proliferation. Moreover it is thought to be a regulator in the 
haematopoietic stem cell niche. 
 
Figure 40  FGFR1 expression  analysis 
FGFR1 transcript qRT-PCR analysis after MLL/AF4 knockdown in SEM for 96h. siMA6: anti MLL/AF4 
siRNA, siAGF1: active siRNA control. Shown are relative mRNA expression levels of FGFR1 and 
averages of 3 independent experiments. Error bars show SD values. The knockdown of FGFR1 transcript 
was highly statistically significant with p = 0.0022 (paired student’s t-test). 
 
Finally the reduction of N-cadherin (CDH2) transcript levels by 40% is shown, 
normalised to control siRNA (Figure 41). This reduction is also highly statistically 
significant with p = 0.0039. N-cadherin protein is calcium-dependent and expressed on 
the surface. But it also involved in signalling and adhesion. Together with FGFR1, N-
cadherin can form heterodimers and is thought to be implicated in the regulation of the 
haematopoietic stem cell niche as well. 
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Figure 41  N-cadherin expression analysis 
CDH2 (N-cadherin) transcript qRT-PCR analysis after MLL/AF4 knockdown in SEM for 96h. siMA6: 
anti MLL/AF4 siRNA, siAGF1: active siRNA control. Shown are relative mRNA expression levels of N-
cadherin and averages of 3 independent experiments. Error bars show SD values. The knockdown of N-
cadherin transcript was highly statistically significant with p = 0.0039 (paired student’s t-test). 
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3.3.1.3 Evaluation of N-cadherin Surface expression 
 
As mentioned before, N-cadherin is expressed on the cell surface. Additional to 
transcript level changes in SEM following MLL/AF4 depletion its surface expression 
was investigated. 
 
 SEM       RS4;11 
Figure 42  N-CADHERIN surface expression analysis 
Flow cytometric analysis of N-cadherin expression levels.  (Left histogram) SEM  (Right histogram) 
RS4;11     N-cadherin-PE antibody signal is shown in the FL2-H channel. Lilac: control cells not stained 
with anti N-cadherin, green curve: N-cadherin stained cells   
                                      
 
SEM and RS4;11 cells were analysed for the surface expression of N-cadherin by flow 
cytometric analysis (Figure 42). Several controls like unstained cells and isotype 
controls were run to solidify the data. SEM showed N-cadherin surface expression, 
RS4;11 did not.   
 
  
SEM N-Cadherin RS4 11 N-Cadherin
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3.4 Discussion Array Chapter 
 
The aim of this chapter was to identify target genes of MLL/AF4. RNAi mediated 
knockdown of MLL/AF4 transcripts in t(4;11) positive SEM cells subsequently reduces 
encoded fusion protein levels, as shown by the Heidenreich group (Thomas, Gessner et 
al. 2005). In principle, a target gene of MLL/AF4 should be affected by its depletion; 
but MLL/AF4 activity can regulate gene expression at different levels, either as direct 
target genes, or indirectly via other affected pathways. The further downstream genes 
are, the greater the potential number of genes affected. Therefore gene expression 
patterns associated with MLL/AF4 depletion reflect several levels of MLL/AF4 
dependent regulation. Differential gene expression in result of MLL/AF4 depletion was 
accessed using transcriptome profiling. SEM cells transfected with siMLL/AF4 were 
analysed by cDNA and oligo-arrays.  
The functional analysis of expression data sets from the oligo arrays comparing control 
SEM cells with siMLL/AF4 transfected SEM cells was performed using the Ingenuity 
Pathway Analysis software. MAS software pre-analysed oligo array data were filtered 
for a minimum fold change of 2 and sorted for strength of fold change of expression.  
Differentially expressed genes were categorised in following main functions: “Diseases 
and Disorders”, “Molecular and Cellular Functions and Physiological System 
Development and Function”, “Associated Network Functions” and “Canonical 
Pathways”.  
Independent from the Ingenuity Pathway Analysis MLL/AF4 depletion responsive gene 
expression found on the oligo and cDNA arrays were sorted for their significance. A 
comparison of overlapping genes from both arrays showed a set of genes with the same 
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direction of fold change. These and other and functionally interesting candidates were 
validated by qRT-PCR (Figures 35-41).  
For the comparison of oligo-, cDNA-array and qRT-PCR transcript analysis the 
different time points after MLL/AF4 depletion have to be considered. The oligo array 
shows transcript level responses after two days, the cDNA array after 4 days and qRT-
PCR up to 6 days of MLL/AF4 depletion. Therefore oligo array analysis mostly shows 
early responses to MLL/AF4 depletion, this could be transcripts with a high turnover, a 
low stability or direct targets. 
In order to interpret these data retrieved from array and qRT-PCR analysis in the 
context of MLL/AF4 and the leukaemogenesis, the different features of a cancer cell in 
general have to be considered.  
A cancer cell has the ability of increased proliferation; for that restrictions to unlimited 
growth have to be overcome. These are cell cycle checkpoints, growth inhibition by cell 
to cell contact in tissues and dependence on growth factors. Cancer cell must be also 
able to resist to apoptosis signals. Cancer cells often have mutations or other genetic 
lesions which would normally induce apoptosis if not repaired. Additionally, 
chemotherapeutic agents often generate apoptotic stimuli, providing advantage for 
cancer cells with apoptosis resistance. Cancer cells must be able to self renew, a least a 
fraction, to provide maintained proliferation in the cancer cell population. Somatic, 
differentiated cells have restricted numbers of divisions e.g. by telomere shortening 
which can lead to senescent cells - cancer cells show increased proliferation, therefore 
this restriction has to be overcome by cancer cells.  
Migration, invasion and homing are further important properties associated to cancer 
cells allowing them to spread over the whole organism to settle and form new tumours. 
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The process of homing into a niche and becoming quiescent like a haematopoietic stem 
cell may additionally give a cancer cell the chance to survive chemotherapeutic 
treatment, which mainly affects proliferating cells, and moreover start proliferation 
again leading to a relapse.  
In agreement with these considerations the Ingenuity Pathways Analysis (Figures 28– 
34) showed a link of MLL/AF4 responsive genes to leukaemia and cancer in general as 
affected genes were sorted in the categories “Diseases and Disorders”, amongst which 
“Cancer” most significantly; “Molecular and Cellular Functions” and “Associated 
Network Functions”. 
The MLL/AF4 fusion gene is a genetic event causing acute mixed lineage leukaemias 
(Domer, Fakharzadeh et al. 1993). The correlation to “Genetic Disorder” by Ingenuity 
shows several pathways frequently altered in genetic events, which are presumably 
important for the malignant biology of the cancer cell. 
The mentioned required ability of cancer cells to proliferate was correlated to MLL/AF4 
responsive genes in “Cellular Growth and Proliferation”, in “Associated Network 
Functions” such as “Cell-to-Cell Signalling and Interaction, Cellular Growth and 
Proliferation, Haematological System Development and Function” and in “Canonical 
Pathways” such as “G-Protein Coupled Receptor Signalling”, “cAMP-mediated 
Signalling” and “WNT/-Catenin Signalling”. Signalling by G-proteins such as Ras 
GTPases and NF-kB are known to be is important for proliferation and cancer relevant 
(Nadella, Blumer et al. 2010). cAMP signalling has an influence on proliferation and is 
linked to cancer in general (Abramovitch, Tavor et al. 2004). The WNT/-Catenin 
pathway has a critical role in regulating proliferation and is also linked to cancer (Jiang, 
Yu et al. 2010). Moreover it was found to be required for MLL/AF9 fusion gene 
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positive AML (Wang, Krivtsov et al. 2010). These growth related findings agree with 
published work where MLL/AF4 depletion reduces proliferation of t(4;11) positive cells 
(Thomas, Gessner et al. 2005). 
Another important property of cancer cells mentioned is the ability to overcome cell 
cycle checkpoints and progress in the cell cycle. This was correlated to the array data by 
Ingenuity Pathway Analysis in the already mentioned “WNT/-Catenin Signalling” 
which influences the cell cycle and differentiation (Williams, Oh et al. 2010). The 
“VDR/RXR” canonical pathway was also connected to MLL/AF4 functions by Ingenuity 
with affected and correlated genes such as RXRG (retinoid X receptor gamma), PTH 
(parathyroid hormone) and CSF2 (colony stimulating factor 2). VDR/RXR (vitamin D 
receptor / retinoid X receptor) polymorphisms are relevant to leukaemia; e.g AML 
derived translocations products block the vitamin D receptor induced differentiation by 
impairing the VDR localisation into the nucleus (Puccetti, Obradovic et al. 2002). The 
importance of cell cycle regulation by MLL/AF4 was published; MLL/AF4 depletion 
caused cell cycle arrest (Thomas, Gessner et al. 2005) and targets cell cycle genes. 
Furthermore it was stated that cancer cells must be able to resist to apoptotic signals. 
These can originate from the cell itself, e.g. due to genetic events, from immune cells 
such as killer cells or be caused by chemotherapeutic agents. Ingenuity correlated 
MLL/AF4 depletion to apoptosis relevant functions such as “Cell Death” and “Cell-to-
Cell Signalling and Interaction”, which could be the mentioned interaction with a killer 
cell. The resistance to chemotherapeutic induced apoptosis could be facilitated by 
inducing the metabolism of such; the canonical pathway assignment “Metabolism / 
Xenobiotics by Cytochrome” by Ingenuity agrees with this. Thomas et al. and others 
(Gaussmann, Wenger et al. 2007; Palermo, Bennett et al. 2008) have shown that 
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MLL/AF4 effectively suppresses apoptosis e.g. by up-regulating anti-apoptotic proteins 
and down-regulating pro-apoptotic proteins. Additionally, Ronald Stams group found 
that prednisolone resistance in MLL-rearranged infant ALLs is associated with high-
level MCL-1 expression (Stam, Den Boer et al. 2010). MCL-1 is known to enhance cell 
survival by inhibiting apoptosis and inhibition of MCL-1 was found to be effective in 
overcoming steroid resistance (Liedtke and Cleary 2009).  
A second group of functions connected to MLL/AF4 responsive genes can be drawn for 
the haematopoietic / niche context. This was another of the requirements for a cancer 
cell stated before.  The haematopoietic niche is based on interactions between 
haematopoietic cells and stromal cells such as osteoblasts, in the bone environment. 
Several Ingenuity Pathway Analysis categories such as “Skeletal and muscular 
Disorders”, “Cell Morphology”, which could be inter cellular cyto-skeletal structures 
required to anchor surface adhesion molecules; and “Associated Network Functions” 
showed a correlation in this context. The latter function involved here was “Cellular 
Movement, Skeletal and Muscular System Development and Function, Cellular Growth 
and Proliferation” which shows properties required in the niche. Ingenuity also 
assigned canonical pathways such as “WNT/-Catenin Signalling” known to be a 
regulative pathway in the bone marrow and endothelial niche; and “VDR/RXR” 
controlling functions such as cell differentiation, bone metabolism, growth and Wnt 
signalling regulation (Cianferotti, Cox et al. 2007).  
In the niche, interactions between stromal cells such as osteoblasts, fibroblasts and 
endothelial cells with haematopoietic cells occur by surface proteins and secreted 
factors. Both are important regulators of this process (Shiozawa, Havens et al. 2008). 
Ingenutiy Pathway Analysis links “Cell-To-Cell Signalling and Interaction” and “Cell-
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To-Cell Signalling and Interaction, Cellular Growth and Proliferation, Haematological 
System Development and Function” to MLL/AF4 depletion in this context. 
Haematopoiesis, which is taking place in the niche, is linked by “Tissue development”, 
“Haematological System Development and Function”, “Lymphoid Tissue Structure and 
Development” and especially by “Haematopoiesis”. The regulation in the niche could 
also be supported by canonical pathways such as “Role/Cytokines in Mediating 
Communication between Immune Cells” found to be correlated here. Furthermore 
“Lymphoid Tissue Structure and Development” generates a strong correlation between 
MLL/AF4 functions and haematopoiesis. In this context also the homing of a 
haematopoietic cell is important. As previously discussed, it could give a cancer cell the 
possibility to reside in the niche. Ingenuity analysis functions such as “Cellular 
Movement” and “Immune Cell Trafficking” agree with this.  
Finally, the cancer cell was stated to require self renewal potential. The correlation of 
MLL/AF4 depletion to “Reproductive System Disease” is presumably based on the fact 
that reproductive cells have stem cell properties and activate similar pathways (Lee, 
Jung et al. 2010). In the array data Oct4 (Pou5F1) is upregulated more than 5fold. The 
importance of Oct4 in t(4,11) ALL has recently been emphasized (Eberle, Pless et al. 
2010). This pathway was not amongst the top 16 pathways (Table 6), but still judged as 
significant. It is known to be an important pathway in haematopoiesis. Controlling 
processes such as cell cycle, apoptosis, and pluripotency. 
 
The last group of functions connected by Ingenuity Pathway Analysis to the expression 
changes upon MLL/AF4 depletion is inflammation. Recently inflammation signalling in 
cancer has been more and more in discussion. In order to maintain the ability to self 
renew and maintain a cancer cell population, cancer cells block differentiation. 
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However, that can lead to an arrest in cell cycle progression. One possible explanation 
for the importance of inflammatory pathways could be that they provide stimuli for cell 
cycle progression, thereby enabling cancer cells to be both rather immature and highly 
proliferative (Hamsa and Kuttan 2010). For the fusion gene TEL-AML1 it was shown 
that sensitivity for TGF-beta induced proliferation inhibition was reduced by binding to 
SMAD3 (Ford, Palmi et al. 2009).  
Ingenuity Pathway analysis generated a correlation of MLL/AF4 responsive genes and 
inflammation by functions such as “Inflammatory Disease”, “Cellular Movement, 
Inflammatory Response, Cell-To-Cell Signalling and Interaction” and “Cellular 
Movement, Inflammatory Response, Cell-To-Cell Signalling and Interaction”. Also 
several canonical pathway assignments such “Hepatic Fibrosis/Hepatic Stellate Cell 
Activation”, “Macrophages, Fibroblast and Endothelial Cells in Rheumatoid Arthriris”,  
“LPS/IL-1 Mediated Inhibition /RXR Function; Acute Phase Response Signalling” and 
“Communication between Innate and Adaptive Immune cells and Pathogenesis / 
Multiple Sclerosis”, which can be connected to in inflammatory processes, support this. 
 
However, the Heidenreich group has previously shown that MLL/AF4 depletion by 
siRNAs like siMA6 induces no interferon response (Thomas, Gessner et al. 2005). 
Interestingly, amongst the MLL/AF4 depletion responsive genes on the array is also 
NF-B. A very recent publication links MLL/AF4 to Interferon (IFN) response, 
showing that the two tested MLL/AF4 cell lines SEM and RS4;11 were not IFN 
resistant, despite many other ALLs. The proposed required transcription factor in this 
pathway was NF-B (Tracey, Streck et al. 2010). 
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The gene comparison brought up genes such as BNIP3, an apoptosis related gene; 
CD69, a proliferation and lymphocyte signalling linked gene; DAAM1, important in 
regulating the cytoskeleton and WNT; DUSP6, a MAP kinase phosphatase; FGFR1, an 
mitogenesis and differentiation regulation gene and PLAT, involved in cell migration 
and tissue remodelling. Interestingly, DAAM1 leads to inhibition of endothelial cell 
proliferation, migration, and angiogenesis (Ju, Cirone et al. 2010). PLAT is also related 
to endothelial cells, found in tumour cells and involved in angiogenesis and cell 
migration (McMahon and Kwaan 2008).  
The gene array comparison (Figure 36) and qRT-PCR validation (Figures 36-41) 
brought up genes which could be contributing to leukaemia by  increasing proliferation 
(CD69, DUSP6, FGFR1, N-CADHERIN, SCD, BMI1), regulating the HSC niche (N-
CADHERIN, FGFR1, DAAM1, MEF2C, NAP1L4), regulating differentiation (SCD, 
CD69, DUSP6, FGFR1, HOXA7), self-renewal (MEF2C, BMI1), immortality (TERT, 
HOXA7), cell cycle regulation (CDK1, MEIS1) and  migration (IGFBP2, NAP1L4). 
depleted 
mRNA 
by depletion 
affected gene 
selected  functions involved pathways 
      M CDH2 cell adhesion, niche regulation WNT/beta, cellular 
signalling 
      L FGFR1 niche regulation, differentiation MAPK, PI3-K/AKT, 
NOTCH 
      L DAAM1 cytosceleton, motility, adhesion PCP(cell polarity), WNT 
      / DUSP6 proliferation, differentiation MEK/ERK, SAPK/JNK, 
p38 
      A MEF2C self renewal, angiogenesis, apoptosis MAPK, p38 
      F CD69 proliferation, lymphocyte activation CD69-pathway, ERK 
      4 SCD cell growth, differentiation PPAR, AMPK 
 NAP1L4 cell migration, nucleosome assembly BCR, CTLA4 
 
 
Table 8  Selected genes affected by MLL/AF4 depletion 
orange reduced transcript levels, green increased levels 
 
Among the genes significantly reduced in the qRT-PCR validation was DUSP6 (Figure 
38), which is a member of the dual specificity protein phosphatase subfamily 
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inactivating target kinases by dephosphorylation. DUSP6 regulates members of the 
MAP kinase family (ERKs) which is a pathway highly important in proliferation. It was 
linked to FGFR1, another growth related gene, in many papers. For example DUSP6-/- 
mice represented a phenotype usually found with FGFR1 and FGFR2 constitutive 
activation (Bermudez, Pages et al. 2010). The down regulation of DUSP6 in MLL/AF4 
depleted cells might indicate that DUSP6 has to be precisely regulated and that DUSP6 
may have different effects if strongly up regulated. Another highly significant altered 
gene was HOXA7 (Figure 39) a member of the Homeobox gene family Cluster A which 
is important in development, gene expression, morphogenesis and differentiation. Also 
significantly altered is FGFR1 (Figure 40), the fibroblast growth factor receptor 1, it has 
both signalling and adhesion function. FGFR1 was reported to be required for the 
regulation of HSCs (Weinreich, Lintmaer et al. 2006).  
Finally, a significant reduction upon depletion in MLL/AF4 was found in N-cadherin 
mRNA levels (Figure 41). Neuronal cadherin belongs to the family of cadherins. It is 
dedicated to roles such as regulation of the of HSC niche interaction, in particular in 
retaining haematopoietic stem cells in the niche. Recently, it has also been reported to 
play a role in chemotherapy resistance (Zhi, Wang et al. 2010) and engraftment of HSCs 
(Hosokawa, Arai et al. 2010).  
Surprisingly, the cell line SEM expressed N-cadherin on the surface, while RS4;11 did 
not (Figure 42). A possible explanation could be that RS4;11 cells are more mature than 
SEM cells and therefore N-cadherin could not be required anymore. This is supported 
by the finding that SEM express CD133; indicating an immature cell (Thomas, Gessner 
et al. 2005). However, controversially some authors doubt that N-cadherin is required 
for the HSC (Kiel, Radice et al. 2007)   
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Chapter 4 Bone marrow feeder interaction  
 
4.1 Introduction and Theory 
 
4.1.1 Stem cells 
 
Hallmarks of stem cells are their ability to self-renew and to differentiate into two and 
more different lineages. Self-renewal is the ability to produce progeny identical to the 
parental cell. The capability to differentiate into numerous types of cells defines the 
potency of a stem cell, which can be toti- (e.g. zygote), pluri- (ES cells) or multipotent 
(adult stem cells). Stem cells can principally be classified either as embryonic stem cells 
found in blastocytes or adult stem cell found in adult tissues. Adult stem cells provide 
cells for tissue to either replace normally dying cells or to repair damaged tissue.   
 
4.1.2 The haematopoietic niche 
 
In 1978 Schofield (Schofield 1978) developed the niche hypothesis defining the 
microenvironment which supports haematopoietic stem cells. In human adults HSCs are 
located in the bone marrow which is present in the trabecular cavities of large bones 
(Fig. 45 a+b). The bone marrow niche is formed by stromal cells including fibroblasts, 
osteoblasts, endothelial cells and adipocytes (Taichman 2005). These stromal cells in 
the bone marrow are derived from mesenchymal stem cells and probably form the niche 
physically (Shiozawa, Havens et al. 2008). In addition, they also regulate HSC by cell- 
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cell adhesive interactions as well as by cytokines thereby affecting proliferation, 
differentiation and self-renewal (Miura, Gao et al. 2006).  
The following model (Figure 43) comprises hypotheses regarding the niche. In this 
model special osteoblasts form the endosteal niche adjacent to trabecular bone, while 
endothelial form the vascular niche cells in adjacent vessels (c). The entrance and the 
exit of HSC in the endosteal niche is regulated by the vascular niche. In this model 
HSCs can enter the endosteal niche, interact with osteoblast and become quiescent. The 
process of localising back into the bone marrow is called homing. A quiescent HSC can 
also be mobilized, locate to the vascular niche, proliferate and differentiate (d). The 
osteoblast is regulating the HSC by surface molecules such as adherence factors, 
receptors and by soluble factors (e) (Shiozawa, Havens et al. 2008). 
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Figure 43  Model of the haematopoietic stem cell niche 
The HSC niche is located in large bones (a)  within the trabecular structure (b)  which provides osteoblast 
surfaces and high vascularisation (c).  HSC can reside at their osteoblast niche or migrate to adjacent 
vessels differentiate and proliferate into blood cells (d). The osteoblast HSC interaction involves 
adherence factors, receptors and soluable factors (e)  from (Shiozawa, Havens et al. 2008)  
 
Haematopoiesis as described before originates from haematopoietic stem cells 
differentiating into committed progenitors (CPs) whilst increasing proliferation.  If all 
HSC ultimately differentiated into CPs the stem cell niche would be finally exhausted 
stopping the further supply for blood cells. However, if HSCs did not differentiate into 
CPs HSC numbers in the niche would increase but the supply for blood cells would stop 
as well. In the normal healthy steady state an asymmetric division is required providing 
CPs and maintaining the HSC pool. After asymmetric division one daughter cell 
remains undifferentiated maintaining and retaining HSCs in the niche while the second 
daughter cell differentiates into CPs and finally blood cells leaving the niche (Wilson, 
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Murphy et al. 2004). For the regulation of the asymmetric division of a HSC the c-MYC 
levels are important. Low c-MYC levels induce HSC quiescence in the niche by 
interaction with spindle-shaped, N-cadherin-positive osteoblasts (SNO) (Zhang, Niu et 
al. 2003). In the HSC niche model of Wilson, Murphy et al. (Wilson, Murphy et al. 
2004) high c-MYC levels reduce cell adhesion molecules which promotes the  cell to 
leave the niche environment and differentiate into committed progenitors (CP) (Figure 
44). If after division c-MYC levels are low in one HSC and high in the future CP, this 
will lead to the result of asymmetric division leaving one HSC bound to the niche while 
the other differentiates and leaves the niche. 
 
 
Figure 44  Regulation of a HSC in the bone marrow niche 
(a) symmetric division of a HSC  (b) asymmetric division of a HSC and (c) symmetric division into two 
progenitor cells.  N-cadherin, LFA-1, ICAMs and Intergrins are cell adhesion factors and receptors, SNO 
spindle shaped N-cadherin positive osteoblasts  from (Wilson, Murphy et al. 2004) 
 
As described in Figure 44 there are several adhesion factors which retain the HSC in the 
niche by interacting with factors such as 21 / 51 integrins, ICAMs, LFA-1 and N-
cadherin. In addition to N-cadherin, integrins are involved in homing and mobilization 
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of HSCs in the bone marrow (Whetton and Graham 1999) by providing cell adhesion, 
thus retaining a HSC in the niche environment. 
 
4.1.3 Surface molecules regulating the niche 
 
4.1.3.1 Neuronal cadherin 
  
Neuronal cadherin (CDH2) is known to be upregulated in invasive cancer cell lines 
(Hazan, Kang et al. 1997) and to promote migration and invasion (Nieman, Prudoff et al. 
1999; Hazan, Phillips et al. 2000). N-cadherin is an intercellular cell adhesion molecule 
which is calcium dependant and interacts in a homophilic manner. It is a member of the 
cadherin family which regulate tissue morphogenesis, cell recognition and are required 
in solid tissue maintenance (Takeichi 1991; Gumbiner 1996).  
The CDH2 gene translates into a 135kDA transmembrane glycoprotein with 5 
extracellular repeats, a transmembrane domain and a cytoplasmic tail which interacts 
with -catenin and the cytoskeleton via -catenin. Extracellular cleavage of N-cadherin 
by the metalloprotease ADAM10 influences cell-cell adhesion and -catenin signalling 
by liberating it and thus increasing the cytoplasmic pool. This cleavage represents a 
signalling switch from external N-cadherin to lymphocyte enhancer binding factor-1 
(LEF-1) driven gene expression of -catenin target genes (Reiss, Maretzky et al. 2005). 
WNT/-catenin signalling is crucial for regulating self-renewal in HSCs (Staal and Luis 
2010) in particular the decision self-renewal versus differentiation. 
N-cadherin was also found to be interacting with platelet derived growth factor receptor 
 (PDGFR) in a complex with -catenin and the scaffold protein NHERF whilst 
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modulating the actin cytoskeleton and regulating cell motility (Theisen, Wahl et al. 
2007). 
4.1.3.2 Fibroblast growth factor 
 
Fibroblast growth factor 2 (FGF-2) was reported to amplify N-cadherin derived effects, 
therefore N-cadherin and the FGF receptor (FGFR1), were suggested to act 
synergistically especially in inducing invasiveness (Hazan, Phillips et al. 2000). 
Furthermore FGFR1 and N-cadherin were proposed to interact via the HAV (cell 
adhesion recognition sequence) motif on FGFR1 and the EC4 on N-cadherin (Williams, 
Williams et al. 2001). This interaction also increased FGFR1, stability and MAPK-ERK 
signalling (Suyama, Shapiro et al. 2002). 
Fibroblast growth factors are heparin binding proteins and comprise more than 20 
ligands that can induce signalling. The FGF family is involved in differentiation, 
migration, proliferation morphogenesis and angiogenesis (Ornitz and Itoh 2001; 
Coumoul and Deng 2003). One of the 4 receptors FGFR1, a tyrosine kinase, is involved 
in haematopoietic differentiation (Faloon, Arentson et al. 2000); constitutive activation 
by translocation was found in myeloproliferative and T-cell lymphoma syndromes 
(Roumiantsev, Krause et al. 2004). 
Weinreich et al (Weinreich, Lintmaer et al. 2006) claimed that receptors such as FGFR1 
are a new class of haematopoietic regulators with activities exceeding effects of growth 
factors such as G-CSF and GM-CSF (Granulocyte and Granulocyte –Macrophage 
colony stimmulating factor) .  
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Finally the FGF pathway with its intermediates FGFR1, GRB2, SOS, RAS and MAP-
kinases is required in haematopoiesis and thus niche regulation. FGF receptor is a 
marker of HSCs and critical for HSC proliferation (de Haan, Weersing et al. 2003). 
 
4.1.3.3 -catenin 
 
The regulation of the HSC by surface receptor-ligand signalling has already been 
mentioned for -catenin, FGFR1 and N-cadherin. -catenin is an essential part of the 
classical Wnt pathway which is started by the binding of Wnt to the Frizzled/LRP 
receptor complex outside the cell, activates dishevelled which then inhibits a complex 
of axin, GSK-3 and APC. This complex would normally induce -catenin degradation 
by ubiquitylation; therefore, its inhibition leads to -catenin accumulation which drives 
target gene expression in the nucleus via LEF/TCF. Haematopoietic tissues express Wnt 
ligands and frizzled and activation induces HSC proliferation and expansion (Austin, 
Solar et al. 1997; Reya, Duncan et al. 2003). -catenin was found to be up regulated in 
human and mouse HSCs (Bug, Gul et al. 2005). However, other pathways such as 
Notch, might replace -catenins’ role (Ross and Li 2006); results obtained by 
conditional inactivation of -catenin suggested that haematopoiesis is not necessarily 
dependent on it (Cobas, Wilson et al. 2004).  
 
4.1.3.4 Notch 
 
Such a pathway complementing WNT signalling is Notch. Wnt3 influences Notch 
target genes. But without Notch WNT signalling cannot affect self-renewal (Duncan, 
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Rattis et al. 2005). Notch signalling is initiated by binding of the Jagged ligand to the 
Notch receptor resulting in cleavage induced liberation of NICD (Notch intracellular 
domain) which translocates to the nucleus to regulate its target genes. Calvi et al (Calvi, 
Adams et al. 2003) have shown that HSC expansion is supported by high titers of 
jagged produced by osteoblasts. This might reflect two different results of niche 
regulation; either quiescence where the cells adhere or differentiation where the cells 
start to proliferate. However the role of Notch signalling as an important actor of the 
HSC compartment has recently been challenged as HSC-generated reconstitution of 
haematopoiesis in mice was not affected by conditional inactivation of Notch1 and 
Jagged1 (Mancini, Mantei et al. 2005).  The following figure (Figure 45) summarizes 
some of the already mentioned pathways in the regulation of a HSC. 
 
 
Figure 45  Schematic of the regulation of a HSC 
The proliferation and differentiation of a HSC is regulated by several pathways including Wnt/-catenin 
signalling where beta catenin increases HSC proliferation, Ang-1/Tie2 signalling inhibits HSC 
proliferation, Notch signalling inhibits c-myc level up regulation and thereby differentiation  and N-
cadherin is downregulated by high c-myc levels which reduces adhesion.  Ang-1 Angiopoietin-1, Tie2 
Angiopoietin receptor     from (Moore and Lemischka 2006) 
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4.1.3.5 BMP 
 
Bone morphogenic protein (BMP) signalling negatively controls the endosteal niche 
size negatively and thus maintains HSCs in mice (Zhang, Niu et al. 2003). BMP binds 
to its receptor BMPR inducing several Smads to complex and regulate gene 
transcription in the nucleus. BMP belongs to the TGF- super-family and TGF- 
signalling is involved in the regulation of haematopoiesis including precursors and adult 
HSCs (Larsson and Karlsson 2005). 
There is also evidence for a connection between BMP and Sonic hedgehog (SHH) 
signalling in mammalian HSCs (Bhardwaj, Murdoch et al. 2001). SHH binds to its 
receptor Patched (PTC) thus releasing Ptc inhibition on Smo; the latter transcription is 
regulated by GLI proteins which are transcription factors determining cell fate. SHH 
signalling is necessary for the generation of HSCs which also depends on intact Notch 
signalling as shown in zebrafish (Gering and Patient 2005). 
 
The following diagram (Figure 46) comprises these pathways with the allocation to, if, 
possible, the endosteal or the vascular niche. This separation has previously been 
described. 
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Figure 46  Pathways regulating the HSC in the endosteal and vascular niche 
Shown are receptors and ligands of pathways   SCF stem cell factor, BMP(R) bone morphogenic 
protein(receptor), Ang-1 Angiopoietin-1, gp130 glycoprotein 130, Ptc Patched, hh hedgehog, mpl 
myoproliferative leukaemia, TPO thrombopoietin, FGF(R) Fibroblast growth factor (receptor)  from 
(Ross and Li 2006) 
 
An interesting view on the niche was made by Y Shiozawa (Shiozawa, Havens et al. 
2008) by suggesting that the microenvironment and the mechanisms in maintaining 
HSCs could be used by neoplastic cells, functioning as “molecular parasites of the 
niche”. One such example is prostate cancer which preferably metastasizes into bone 
and form tumours there but also remodel the bone. This migration is thought to be 
induced by factors provided by the bone, while the bone remodelling is thought to be 
caused by factors such as VEGF secreted by the prostate cells. The authors propose a 
general mechanism where cancer stem cells could interact with a type of niche and start 
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dormancy programs. Like LSCs (leukaemic stem cells) which exhibit many HSC 
similarities they are expected to interact with the niche environment (Figure 47). By 
residing in the niche metastatic cells could escape chemotherapy and radiotherapy. 
 
 
Figure 47  Summary of niche interactions 
The vascular and the endosteal niche which interact with HSCs and MSCs could also provide a niche for 
metastasis. Mesenchymal stem cells (MSC) provide for niche relevant cells such as osteoblast and 
endothel . MSCs and HSCs which provide for all cells in the niche are thought to be generally regulated. 
Metastatic cells could use both niches and act as “molecular paracites of the niche”     MSC Mesenchymal 
stem cell,  HSC Haematopoietic stem cell        from (Shiozawa, Havens et al. 2008) 
 
Haematopoietic stem cells are quiescent when they reside in the niche. If a cancer cell 
activates quiescence while settling in the niche likewise a HSC, it could provide an 
enormous advantage to it, as most chemotherapeutic agents mainly affect proliferating 
cells. The involvement in tumorigenesis could define a neoplastic or leukaemic niche. 
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4.2 Aims 
 
The finding that several validated genes are involved in the bone marrow 
haematopoietic stem cell niche, resulted in the endeavour of establishing an artificial 
niche model to examine stem cell - niche interactions and the effect of this interaction 
on the stem cells. As many of the leukaemic cells with which we work have stem cell 
properties, this promised to be relevant to other types of leukaemia. 
 
Specific Aims: 
 
1. To establish an artificial model with bone marrow fibroblasts to test niche 
interactions 
 
2. To relate the Array data to the stem cell niche hypothesis proposed in this thesis 
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4.3 Results Bone marrow feeder interactions 
 
4.3.1 Establishment of Feeder layer 
 
To be able to co-culture leukaemic cells on a bone marrow fibroblast layer it is 
important that the feeder layer does not grow and shed off the co-cultured cells.  This is 
especially true if the co-culture has to be maintained over several weeks. 
 
4.3.2 Examination of HS-5 for feeder layer properties 
 
HS-5 is a human bone marrow stromal cell line transformed by amphotropic retrovirus 
HPV (human papilloma virus) virus. HS-5 expresses E6E7 genes, which are known to 
affect tumor-suppressor proteins such as p53 and Rb, which suppress cell cycle arrest 
(Roecklein and Torok-Storb 1995). HS-5 were originally isolated from a male 
Caucasian donor and show fibroblast morphology. HS-5 cells secrete several factors 
such as granulocyte -, granulocyte-macrophage - and macrophage colony stimulation 
factors (G-CSF, GM-CSF and M-CSF), Kit ligand (KL), macrophage-inhibitory 
protein-1 alpha, interleukin-1 alpha (IL-1alpha), IL-1beta, IL-1RA, IL-6, IL-8, IL-11, 
and leukaemia inhibitory factor (LIF). HS-5 is known to support proliferation of 
haematopoietic progenitor cells, removing the need for serum supplementation for in 
vitro culture. 
For this reason HS-5 was chosen as the feeder cell-line for co-cultures to test effects 
similar to the leukaemic stem cell – bone marrow fibroblast interaction. According to 
protocol HS-5 were irradiated at 15, 20, 40, 60 and 80 Gy of γ-radiation and monitored. 
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Unfortunately, the treatment seemed to kill a fraction of the HS5 cells, proportional to 
the radiation dose used.  Cells which did not receive a lethal dose started to proliferate 
again after a maximum interval of two weeks. According to protocols for other 
fibroblast cells-lines, Actinomycin D and  Mitomycin C (MMC) treatment at various 
concentrations and incubation times were used to induce growth arrest. The effect was 
in principle similar, depending on the dose the toxicity was increased but parameters 
where all cells were arrested could not be found, the output was apoptosis versus 
proliferation. The following images of HS-5 (Figure 48) show an example of those 
experiments. Starting from a homogeneous fibroblast layer, cells were treated with 
MMC at two concentrations and various incubation times. After one week there were 
areas where cells had undergone apoptosis, leaving gaps. In other areas cells were quite 
dense, even forming foci where they were growing over each other. 
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Figure 48  HS-5 feeder layers treated with Mitomycin C 
(A i. and ii.) HS-5 fibroblast layer with gaps due to cell death   (B i.) foci of HS-5 growing on top of each 
other   (B ii.) dense layer of re-growing HS-5   (C i. and ii.) edges of foci, gaps in close proximity to foci, 
magnification 200x 
 
 
To investigate why the HS-5 could not be arrested under conditions successfully applied 
to other cell lines, a genotype analysis was made. 
The resulting karyotype was: 
 
 42~45, XY, -2[3], -7[3], del(7), (q2?), der (10) t(2;10)q1?2;q26[7], -13[4], -
16[3], -19[5], -19[3], -20[6], -21[3], -22[4], -22[3], 1-5mar[4], inc[cp6]/70~86, 
idem 
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The HS-5 showed a complex abnormal genotype, inter cell variation, unbalanced 
translocations, hyperdiploidy and polyploidy. (Dr N P Brown, Northern Genetics 
Service Cytogenetics Laboratory, Newcastle) 
Parallel to this a cell cycle analysis was performed. Shown is the DMSO control for a 
range of MMC concentrations tested (see Figure 49 and Figure 50). 
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Figure 49  Cell cycle analysis dot plots of HS-5 
Untreated HS-5 were subjected to PI (propidium iodide) cell cycle analysis (Left)  SSC-FSC Dot plot of 
PI stained HS-5 cells   (Right) PE-A/PE-W Dotplot of PI stained HS-5   Red: cells gated in P2 (right), 
these cells were inserted into histogram analysis below     
      
 
 
Figure 50  Cell cycle analysis Histogram of HS-5 
HS-5 were stained with PI and the PI signal detected in the PE-A channel   P1 represents apoptotic cells, 
particles 
 
The cell-cycle showed an abnormal pattern (Figure 50). Usually a high G1/G0 peak is 
present followed by a flat, stretched S phase and then a G2/M peak. The HS-5 showed, 
probably due to their polyploidy, two big G1 peaks of different ploidy. The second G1 
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peak was at the position where the flat S-phase should be located. These results suggest 
two cell-cycles, of different ploidy, were superimposed onto one another.    
 
 
Figure 51  HS-5 cell cycle Modfit Analysis using Aneuploid and Diploid mode 
PI stained HS-5 cells analysed for cellcycle distrubution, DIP G1, G2, S:  diploid cell cycle phases,  
AN1 G1, G2, S: aneuploid cell cycle phases.  
 
In the diagram above (Figure 51) a ModFit analysis of HS-5 cell cycle was performed. 
A special mode which can fit the cell phases to cells with diploidy and aneuploidy was 
used. However this was not sufficient to determine exact cell cycle phase distribution 
and so cell cycle arrest arrest could not be demonstrated.   
The heterogeneity of this cell-line and the presence of E6E7- HPV gene functions 
mentioned before, were probably the reasons why it could not be arrested. If one 
subgroup was arrested, the others were going into apoptosis or were proliferating. 
Nevertheless, for a limited period of time until HS-5 layers reached confluence, it was 
possible to co-culture HS-5 and MV4;11 (Figure 52). 
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Figure 52  HS-5, MV4;11 and co-culture 
Images of HS-5 monoculture, MV4;11 monoculture and HS-5 MV4;11  (A) HS-5 half confluent layer                 
(B) MV4,11 culture       (C) HS-5 -  MV4;11 co-culture,   magnification 200x 
 
MV4;11 cells, which have no tendency to adhere to surfaces, seemed to be attached to 
HS-5 co-cultures as shaking under the microscope did not move MV4,11 on top of the 
HS-5 feeders (Figure 52).  
 
4.3.3 Test of M210B4 
 
The M210B4 cell line is derived from mouse bone marrow stromal cells. They show a 
fibroblast morphology, express laminin and collagen IV and growth factors such as KL 
(Kit ligand), IL3 (Interleukin 3) and G-CSF (Granulocyte colony stimulating factor) 
(Lemoine, Humphries et al. 1988). M210B4 are known to support human and murine 
myelopoiesis as well as several pre-B cell lines (Lemoine, Krystal et al. 1988). In LTC-
IC (long term culture initiating cell) assay protocols, the usage and growth arrest of 
M210B4 by irradiation was described. Therefore, this cell-line was chosen as alternative 
to the HS5 cell line to produce a feeder layer. 
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4.3.3.1 Growth arrest 
 
M210B4 cells were irradiated at 60 to 80Gy and monitored by microscopy for re-
growth and cell death. Additionally, a cell cycle analysis before and after the treatment 
was performed to validate those observations (Figure 53 and Figure 54).  
 
Figure 53  Cellcycle Dotplots of untreated M210B4 cells 
Flow cytometric analyisis of untreated M210B4 cells in cell cycle analysis   (Left)  SSC-FSC Dotplot of 
PI stained M210B4       (Right) PE-A/PE-W PI signal Dotplot of PI stained M210B4 
 
 
Figure 54  Cellcycle histogram of untreated M210B4 
Histogram of P2 gated cells from Figure 53 The PI signal was detected in the PE-A channel  P1: 
Apoptotic fragments, P3: G1/Go, P4: S-Phase, P5: G2/M 
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This cell-cycle above (Figure 54) showed a normal cell-cycle with a strong G1/G0 peak 
(P3), a flat S-phase (P4) and a small G2 peak (P5). P1 represented the apoptotic fraction. 
According to this 66% of M210B4 were in G1/G0 phase, 17% in S phase and 17% in 
G2 phase. 
One week after irradiation the cell cycle of M210B4 showed an increase in the apoptotic 
fraction P1 compared to the non-irradiated cells (Figure 55 and Figure 56). Apoptotic 
cells were gated out to better display the cell cycle fractions. The G1/G0 peak (P3) was 
significantly reduced and the G2 peak (P5) correspondingly bigger.  
 
Figure 55  Cell cycle Dotplots of M210B4 cells irradiated at 80 Gy 
Irradiated M210B4 were subjected to cell cycle analysis  (Left) SSC-FSC Dotplot of PI stained irradiated 
M210B4    (Right) PE-A/PE-W PI signal Dotplot of PI stained   irradiated M210B4   
         
 
Figure 56  Cell cycle of irradiated M210B4 
Cells from the P2 gate of Figure 55 are shown in this histogram. The PI signal was detected in the PE-A 
channel  P1: Apoptotic fragments, P3: G1/Go, P4: S-Phase, P5: G2/M 
Chapter 4 Bone marrow feeder interaction 
153 
 
Right of P5 the histogram shows a basal signal, probably due to background and 
doublets of fibroblasts (Figure 56). As this was not found in the un-irradiated M210B4 
it was probably due to irradiation. According to this analysis 43% of irradiated M210B4 
were in G1/0 phase, 16% in S phase and 41% in G2 phase. This showed a strong 
increase of G2 from 17% to 41% by irradiation representing a pronounced G2 arrest. 
Growth arrested M210B4 were monitored for over 4 weeks and no proliferation was 
found. Therefore the arrest of M210B4 proved to be feasible. 
 
4.3.3.2 Incubation of M210B4 feeders with SEMTeton 
 
Growth arrested M210B4 were seeded on collagen coated wells and left to form a 
feeder layer for two days. Then different concentrations of fluorescent SEMTeton were 
seeded on those wells. These were SEM cells which had been transduced with the 
lentiviral Teton-vector and consequently expressed GFP (see chapter 5). Fluorescent 
SEM cells were used for a better discrimination of leukaemic from feeder cells. After 
incubation of 10 days, these feeder - fluorescent cell co-cultures were captured with and 
without fluorescence imaging using a fluorescent microscope (see Figure 57).   
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Figure 57  SEMTeton cultured on M210B4 feeder layers 
SEMTeton were co-cultured on M210B4 feeders in several dilutions for 10 days  (i.) Light-microscopic 
photographs  (ii.) Fluorescence filtered photographs   (A) 0.2x106,  (B) 1x106,  (C)  4x106, (D) 10x106 
cells / ml,  magnification 200x  
 
Fluorescent SEM were seeded on homogeneous feeder layers in concentrations of 
0.2x106 (top), 1x106 (2nd from top), 4x106 (3rd from top), 10x106 (lowest) cells / ml 
(Figure 57). Cells on the left were captured using normal light microscopy, while cells 
on the right were captured in the GFP-channel. These images showed that the GFP 
signal provides an effective way to distinguish between feeder and leukaemic cells. 
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Furthermore, both these methods demonstrate a strong correlation between the seeding 
concentration and imaging results.    
To get a more accurate analysis of cell numbers and to determine how distinguishable 
co-cultured cells are in a flow cytometric analysis, cells were trypsinized to remove 
SEMTeton bound to M210B4.  Cell suspensions were analysed by flow cytometry, 
using SEM, SEM Teton and M210B4 cells as controls (Figure 58 and Figure 59). The 
number of M210B4 cells was kept constant with approximately 105 cells per 48 well 
plate. Consequently, the number of fluorescent leukaemic cells should always 
correspond to the ratio of detected M210B4 and leukaemic cells.  
 
 
Figure 58  SSC – FSC Dot-Plots for M210B4 and SEMTeton 
Flow cytometric analysis of M210B4 and SEM control cells.  SSC – FSC Dot-Plots for M210B4 (Left) 
and SEMTeton (Right), red P1 (gated for M210B4), green P2 (gated for SEM), black (ungated cells).  
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Figure 59  Flow cytometric analysis of M210B4, SEMTeton and co-cultures 
A dilution of SEMTeton grown on feeders for 10 days (Right) and controls (M210B4, SEMTeton alone) 
were analysed by flow cytometry  (TOP) Dot-plots SSC vs. green fluorescence (FITC),  (Bottom)  
Histograms counts vs. Green fluorescence    (Left) solely M210B4  (Middle) solely SEMTeton  (Right) 
co-culture of M210B4 and 1x105 SEMTeton, red P1 (gated for M210B4), green P2 (gated for SEM), 
black (ungated cells). Shown is one single experiment. 
 
 
 
 
Figure 60  Flow cytometric analysis of M210B4 - SEMTeton co-cultures 
Several dilutions of SEMTeton cells co-cultured on M210B4 for 10 days were analysed by flow 
cytometry   (TOP) Dot-plots SSC vs. green fluorescence (FITC)   (Bottom) Histograms counts vs. Green 
fluorescence  co-cultures with  (Left) 5x105, Middle: 20x105  (Right) 50x105 SEMTeton, red P1 (gated 
for M210B4), green P2 (gated for SEM), black (ungated cells). Shown is one single experiment. 
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The flow cytometric analysis plots and graphs above show the gating of the M210B4 
fraction and the SEMTeton according to their size and fluorescence (Figure 58, Figure 
59 and Figure 60). Since M210B4 showed strong auto-fluorescence itself, an intentional 
gap was left between the two gates to reduce the overspill of one cell-line into another 
gate. This unusual gate setting was necessary to distinguish between the two cell lines. 
The histograms show SEMTeton in green and M210B4 in red. The corresponding 
statistics are shown in table 9. They show how, using this analysis, it was possible to 
distinguish feeders from fluorescent cells using the numbers seeded to form the ratio, 
Fluorescent gate : M210B4 (p2/p1) gate. This relied on the fact that in a mix of these 
co-cultured cells and 10000 cells counted in the flow cytometric analysis, the ratio 
should have got bigger the more SEMTeton cells were present in the sample. 
Although the ratio of numbers in the fluorescent gate were concentration dependant to 
the seeded amounts between 0.2 x106 and 4x106 cells per ml, the range of 
concentrations showing proportionality between seeded and measured SEMTeton 
numbers were limited (see Table 9 and Figure 61). 
  
Events  M210B4  SEMTeton 1x105  5x105  20x105  50x105  
p1  4182  82 325 102 98  399
p2  422  9570 5862 8600 8962  7811
p2/p1  0.1  116.71 18.04 84.31 91.45  19.58
Table 9 Cells counts of M210B4, SEMTeton and co-cultures 
Several dilutions of SEMTeton grown on M210B4 for 10 days and single cellline controls (M210B4, 
SEMTeton) were analysed by flow cytometry  P1 M210B4 gate, P2 SEM Teton gate, p2/p1: part of 
SEMTeton to M210B4 
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Figure 61  Cell counts of M210B4 and SEMTeton and co-cultures 
Several dilutions of SEMTeton grown on M210B4 for 10 days and single cellline controls (M210B4, 
SEMTeton) were analysed by flow cytometry. Ratios of p2 (SEMTeton gate) against p1 (M210B4 gate) 
were related to seeded concentrations   p2/p1: part of SEMTeton to M210B4 (p1 M210B4-, p2 SEMTeton 
gate). Shown is one single experiment. 
 
The same analysis was performed for MV4;11Teton co-cultured on M210B4 feeder 
layers. These are MV4;11 cells transduced with the lentiviral Teton vector, as with 
SEMTeton (see Figure 62, Figure 63 and Figure 64). 
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Figure 62  M210B4 and MV4;11Teton controls 
M210B4 and MV4;11Teton controls were analysed by flow cytometry  (Left) M210B4  (Right) 
MV4;11Teton. Shown are SSC – FSC Dotplots. The colours refer to the gates shown in Figure 64. Shown 
is one single experiment. 
 
 
Figure 63  M210B4, MV4;11Teton  and co-cultures analysed by flow cytometry 
A dilution of M210B4 - MV4;11Teton co-cultured for 10 days and two controls (M210B4, MV4;11 alone) 
were analysed by flow cytometry  (TOP) Dot-plots SSC vs. green fluorescence (FITC)  (Bottom) 
Histograms counts vs. green fluorescence  (Left) solely M210B4  (Middle) solely MV4;11Teton  (Right) 
co-culture of M210B4 and 1x105 MV4;11Teton. Shown is one single experiment. 
 
 
Figure 64  Flow cytometric analysis of M210B4 - MV4;11Teton co-cultures 
M210B4 - MV4;11Teton co-cultured for 10 days in several dilutions were analysed by flow cytometry 
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(TOP) Dot-plots SSC vs. green fluorescence (FITC)   (Bottom) Histograms counts vs. Green fluorescence 
co-cultures with  (Left) 5x105  (Middle) 20x105  (Right) 50x105 MV4;11Teton. Shown is one single 
experiment. 
   
The flow cytometry plots and graphs above (Figure 62, Figure 63 and Figure 64) show 
the gating of the M210B4 fraction and the MV4;11Teton according to their size and 
fluorescence. The histograms show MV4;11Teton in green and M210B4 in red peaks. 
The corresponding statistics are shown in table 10. They show that this analysis was 
able to distinguish feeders from fluorescent cells using the numbers seeded and the ratio 
Fluorescent gate / M210B4 (p2/p1) gate. The range of concentrations showing 
proportionality between seeded and measured MV4;11Teton numbers was limited (see 
Table 10 and Figure 65. 
  
Events  M210B4  MV4;11Teton 1x105  5x105  20x105  50x105  
p1  4182  847 1671 1293 1948  2289
p2  422  8209 8009 7242 6246  5393
p2/p1  0.1  9.69 4.79 5.6 3.21  2.36
Table 10  Cells counts of M210B4, MV4;11Teton and co-cultures 
Several dilutions of MV4;11Teton grown on M210B4 for 10 days and single cell controls (M210B4, 
MV4;11Teton) were analysed by flow cytometry.  P1 M210B4 gate, P2 MV4;11Teton gate, p2/p1: part 
of MV4;11Teton to M210B4 
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Figure 65  Cell counts of M210B4, MV4;11Teton and co-cultures 
M210B4 – MV4;11 co-cultures were cultured for 10 days numbers determines by  flow cytometry. 
Numbers (x10E5) indicate MV4;11Teton cells per ml and a constant level of 1x105 M210B4 cells per 
well,  sp2/p1: part of MV4;11Teton to M210B4  (p1 M210B4-, p2 SEMTeton gate). Shown is one single 
experiment. 
 
4.3.3.3 Establishment of a flow cytometry based cell count 
assay 
 
The majority of growth data of leukaemic cells on feeder layers in this thesis was 
generated by visual discrimination of leukaemic cells and M210B4 and by counting in 
triplicates. To develop a more automated and robust method the fact that, in a dense 
layer of growth arrested M210B4, the cell number per well was stable was used. For 
samples analysed by flow cytometry a certain number of cells were counted, here 10000 
cells. The more leukemic cells there were in a well with a stable number of M210B4, 
the bigger the ratio between M210B4 and leukaemic cells was. In this method, the 
fluorescence of SEMTeton was used to distinguish the SEM from M210B4 as well. The 
most important differences to the previous flow analysis of M210B4 – SEM co-cultures 
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was the use of a different Flow cytometer (FACS Calibur) with less automated settings, 
logarithmic setting of the SSC channel and the use of irradiated M210B4 to set the gates 
(Figure 66 and Figure 67). 
  
 
Figure 66  Flow cytometry discrimination of Feeders and SEMTeton 
Flow cytometric analysis of SEM (Top row),  SEMTeton (2nd row) and irradiated M210B4 (3rd row). 
The gating for the discrimination of M210B4 was set using SEM, fluorescent SEMTeton and irradiated 
M210B4. The size and granularity was used to distinguish M210B4 from SEMTeton. M210B4 were 
gated in R1 and SEM in R2. SEMTeton green shift was recorded in the FL1 channel.   (Left) SSC-FSC 
dot plot  (Middle) GFP-FSC dot plot and  (Right) counts-GFP histogram. Shown is one single experiment. 
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Figure 67  Flow cytometry discrimination of SEMTeton dilutions on feeders 
10,000 cells of cell-mixtures from a M210B4 well of a 48 well plate (approx. 105 cells) and dilutions of 
SEMTetonwere were recorded by flow cytometry while the number of cells per M210B4 gate (R1) and 
SEMTeton gate (R2) was determined. Different numbers of SEMTeton were added per M210B4 well:     
+ 1,000 (1st row), + 10,000 (2nd row), + 100,000 (3rd row), + 1,000,000 (4th row)   (Left) SSC-FSC dot 
plot  (Middle) GFP-FSC dot plot and  (Right) counts-GFP histogram . Shown is one single experiment. 
 
SEMTeton and M210B4 were gated by size and fluorescence (Figure 67 and Figure 66). 
Cells were counted in the SEMTeton gate and the M210B4 gate. As controls SEM, 
SEMTeton and irradiated M210B4 were analysed. Then SEM in increasing numbers 
were added to wells with feeders.  
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Sample  M210B4  SEMteton 
SEMTeton/ 
M210B4 
seeded cell  
number 
M210b‐SEM E3 598 104 0.173913  1000
M210b‐SEM E4 575 289 0.502609  10000
M210b‐SEM E5 131 942 7.19084  100000
M210b‐SEM E6 88 5933 67.42045  1000000
Table 11  Statistics of Figure 66 and Figure 67 
Numbers of M210B4 and SEMteton detected from co-cultures, according to flow cytometry analysis 
shown in Figure 67. 
 
The ratio of M210B4/SEMTeton showed a good linearity to the seeded cell numbers 
(see Table 11 and Figure 68). 
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Figure 68  Niche proliferation standard curve 
Standard curve of detected SEMTeton/M210B4 ratios against seeded concentrations of SEMTeton. 
SEMTeton were seeded at 103,104,105 and 106 cells per M210B4-feeder layer well. Data represent those 
in Table 11.  Flow cytometric analysis was run using controls for greenshift (SEM, irradiated M210B4) 
and controls for  SEMTeton gating and M210B4 (no feeders, SEMTeton and M210B4 irradiated). Shown 
is one single experiment. 
 
The plot shows (Figure 68) that this method was practicable and proportional to the 
actual cell numbers throughout a wide range of concentrations. This provides a quick 
and reliable measure of cell number which is especially useful for large scale 
experiments, when different parameters are tested. 
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4.3.3.4 Co-cultures of SEMTeton and MV4;11Teton on 
M210B4 
 
To further investigate how well leukaemic cell-lines like SEM and MV4;11 can be 
visually distinguished from the feeder cells by size and shape further co-cultures of 
SEMTeton or MV4;11Teton with M210B4 feeder layers were incubated and captured 
by light-microscopy (see Figure 69).     
 
Figure 69  Co-culture images of Mv4;11Teton on M210B4 feeders 
Growth arrested M210B4 feeder layers were co-cultured with dilutions of MV4;11Teton numbers  (A i.) 
M210B4  (B i.) 103-,  (B ii.) 104 -,  (C i.) 105 - and  (C ii.) 106 -MV4;11TETon,  magnification 200x.  
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The co-culture imaging (Figure 69) shows the basic M210B4 feeder layer (A) and the 
increasing numbers (from B i. to ii. to C  i. and  ii.) of small round bodied MV4,11Teton 
cells. 
 
Figure 70  Co-culture images of SEMTeton on M210B4 feeders 
Growth arrested M210B4 feeder layers were co-cultured with dilutions of SEMTeton.   (A i.) 103-,  (A ii.) 
104 -,  (B i.) 105 - and (B ii.) 106 –SEMTETon, magnification 200x 
 
The co-culture imaging above (Figure 70) shows the increasing numbers (from A i. -left, 
- A ii. to B i.  and B ii.) of small round bodied SEMTeton cells. The basic M210B4 
feeder layer can be found in the previous image panel (Figure 69 A i). 
These two image-panels (Figure 70 and Figure 69) showed that in a wide concentration 
range the small, round bodied leukaemic cells can be easily distinguished from the 
fibroblast feeders. Additionally the focal level is different between them, as the 
leukaemic cells are found on top of the M210B4 cells. 
Chapter 4 Bone marrow feeder interaction 
168 
 
4.3.3.5  Inversion test 
 
The next question to be asked of the growth arrested M210B4 layers was if they were 
able to interact physically with the leukemic co-cultured cells, as bone marrow 
fibroblast cells would - by homo and hetero dimeric interactions of surface proteins. 
Visually, cells on top of the M210B4 seemed to adhere to them, because when shaken, 
leukaemic cells in the supernatant moved but not the ones directly on top of the feeders.  
To rule out binding unrelated to feeder layer adherence molecules and to show real 
physical interaction of the cells, an inversion test was adapted to this system. SEM cells 
have not been used because they show a slight tendency to adhere to culture surfaces. 
Therefore, two non-adherent leukaemic cell-lines were chosen to demonstrate that it is 
the interaction with M210B4 which immobilizes the cells (see Figure 71). 
These myeloid leukaemic cells were Kasumi-1 and SKNO-1, which are both t(8;21) 
positive AML-cell lines.  
 
 
Figure 71  Images of M210B4 co-cultures with Kasumi-1 or SKNO-1 
Growth arrested M210B4 layers co-cultured with Kasumi-1 or SKNO-1  (A) KASUMI-1 on M210B4 (B) 
SKNO-1 on M210B4, magnification 200x 
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In the previous images (Figure 71) co-cultures of M210B4 and SKNO-1 or Kasumi-1 
are shown. The SKNO-1 cells especially, have a tendency to form clusters. They 
appeared similar under the microscope and were cultured like ALL-cells. 
The principle of this test was that the co-culture was turned upside down; cells not 
bound by interactions to the feeder layer sunk down, moved away by gravity and were 
removed after 1-2h incubation by gravity leaving only fibroblasts and cells attached to 
them (see Figure 72). 
  
 
Figure 72  Inversion experiment on M210B4 Feeder 
Cells grown on M210B4 feeders were inverted and separated from the feeders by gravity if they were not 
physically attached to them. The principle is shown in the schematic in the middle.  (Top) before 
inversion   (Bottom) after inversion   (Right) Kasumi-1   (Left) SKNO-1,   magnification 200x 
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These images (Figure 72) showed that after incubation the cell-numbers on the feeder 
did not decrease much. This result supported the finding that cells are attached to 
M210B4 by stronger interactions. 
 
4.3.4 Fusion gene knock down and feeder interaction 
 
After developing and testing the bone-marrow-fibroblast - leukaemic-cell interaction 
assay, the effect of those interactions on growth, and hence doubling times, was 
investigated.  
Several questions were addressed in the following experiments: 
1. Does co-culture of leukaemic cells on feeders affect the knockdown of the 
corresponding fusion gene by siRNA? 
2. If not, how does the feeder affect the phenotypic consequences of MLL/AF4 or 
AML1/MTG8 knockdown? 
 
Before siRNA treatment of SEM, SEMTeton and Kasumi-1 DC (lentivirally transduced 
by Vasily Grinev, expressing Dsred) and feeder co-cultures was performed, it had to be 
shown that, firstly, successful knockdown of fusion genes could be demonstrated in 
siRNA treated cells in M210B4 co-culture, and secondly, that the two transduced cell 
lines SEMTeton and Kasumi-1 DC are still accessible to siRNA mediated fusion gene 
depletion. This is addressed in the two following diagrams (Figure 73 and Figure 74). 
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Figure 73  AML/MTG8 knockdown in Kasumi-1 DC 
Electroporation of Kasumi-1 DC with siAGF1 and siMA6, cultured with and without feeders. The 
relative mRNA level of AML/MTG8 was detected by qRT-PCR. siAGF1: siRNA against AML/MTG8, 
siMA6: active siRNA control (in Kasumi), Mock: no-siRNA control; red columns: cultured on feeders, 
blue columns: cultured without feeders. The relative mRNA levels were corrected to Mock. Shown is one 
representative experiment 
 
 
 
Figure 74  MLL/AF4 expression in siRNA treated SEM and SEMTeton 
SEM and SEMTeton were electroporated with siAGF1 and siMA6.The relative mRNA levels of 
MLL/AF4 were detected by qRT-PCR. siAGF1: active siRNA control (in SEM, SEMTeton), siMA6: 
siRNA against MLL/AF4. The relative mRNA levels were corrected to AGF1. Shown is one 
representative experiment. 
  
 
 
The transcript expression data (Figure 73 and Figure 74) show that fusion gene 
depletion was present not only in control cells, but also in co-cultured cells. Single 
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control wells with M210B4 did not provide enough mRNA for cDNA synthesis, only if 
several wells were pooled. The fusion gene transcripts could not be detected even in 
increased concentrations of RNA input. This showed that the M210B4 did not influence 
these results. 
This answers the first question stated above; incubation on feeder did not substantially 
affect the degree of knockdown of either fusion gene.  
When qRT-PCR was performed with primers for MLL/AF4 in Kasumi1-DC negative 
for MLL/AF4 and primers for AML/MTG8 in SEMTeton negative for AML/MTG8, the 
Ct-values for MLL/AF4 and AML/MTG8 were high. The Cts were detected 
approximately 15 cycles later than in cell lines expressing the fusion product. This 
proves that using siMA6 to deplete MLL/AF4 in SEM and as a control siRNA in 
Kasumi-1 while using siAGF1 to deplete AML/MTG8 in Kasumi-1 and as a control in 
SEM, is a reliable system to investigate transcript levels of those cells on M210B4.  
To answer the second question raised before, SEM were electroporated with no siRNA 
(Mock), MLL/AF4 siRNA (siMA6) or siControl (siAGF1). 
After knockdown the cells were either diluted 1/20 or 1/40 from the standard culture 
condition of 0.5x106 cells/ml, which corresponds to 0.25 or 0.125x105 cells / ml and 
incubated on feeders for 8 days (see Figure 75 and Figure 76). 
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Figure 75  SEM electroporated and co-cultured on feeder in 1/20 dilution 
SEM were with siMA6 and siAGF1, diluted to 0.25x105 cell/ml and cultured on feeders.     (Left axis, 
blue columns) number of SEM counted x105    (Right axis, red columns) doubling time in days   siAGF1: 
active siRNA control (in SEM), siMA6: siRNA against MLL/AF4, Mock: no siRNA control. Shown is 
one representative experiment. 
 
 
 
Figure 76  SEM electroporated and co-cultured on feeder in 1/40 dilution 
SEM electroporated Mock, with siMA6 and siAGF1 diluted to 0.125x105 cell/ml and cultured on feeders 
(Left axis, blue columns) number of SEM counted x105   (Right axis, red columns) doubling time in days  
siAGF1: active siRNA control (in SEM), siMA6: siRNA against MLL/AF4, Mock: no siRNA control. 
Shown is one representative experiment. 
 
The resulting cell counts (Figure 75 and Figure 76) showed decreased numbers in 
MLL/AF4 depleted cells compared to controls and hence increased doubling times.  
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To investigate the influence of the feeder co-culture on cell functions such as 
proliferation, gene expression and apoptosis, two cell-lines; one ALL (SEM) and one 
AML (Kasumi-1) were compared following fusion gene knockdown and culture with 
and without a feeder layer. 
The fusion-transcript of SEM MLL/AF4 was depleted with siMA6 and the fusion 
transcript of Kasumi-1 AML/MTG8 was depleted with siAGF1. Because the SEM cells 
transcribe no AML/MTG8 and Kasumi-1 transcribe no MLL/AF4, siAGF1 has also 
been used as an active siRNA control in SEM and siMA6 in was used in Kasumi-1 vice 
versa.  
Following this validation, SEM and Kasumi-1 were electroporated with siRNA to 
knockdown their fusion genes and then seeded in different concentrations on feeder and 
control wells without feeder. The cultures were analysed by counting after trypisination 
and visual discrimination, as explained before (Figure 77 and Figure 78).  
 
Chapter 4 Bone marrow feeder interaction 
175 
 
 
Figure 77  siRNA treated SEM seeded in dilutions with and without feeders 
SEM electroporated with siMA6 and siAGF, seeded in a high concentration range (0.01, 0.1, 1 and 10 
x10x105 cells/ml) with or without feeders and cultured for 48h. The y-axis shows counted leukaemic cell 
numbers displayed as x105 cells/ml in a logarithmic scale. siMA6 is targeted against MLL/AF4 while 
siAGF1is the siRNA control.   right: simulated display at which concentration cells were seeded; violet 
columns 10x10x105 -, green columns 1x10x105-, red columns 0.1x10x105- and blue columns 0.01x10x105 
- cells/ml. Shown is one single experiment. 
 
The diagram above (Figure 77) shows SEM with anti MLL/AF4 siRNA (siMA6) 
treatment and an active siRNA control (siAGF1) either cultured in normal wells (no 
feeders) or on M210B4 feeders. Cells were seeded in parallel at different concentrations 
(0.01, 0.1, 1 and 10 x10x105 cells/ml) and incubated for 2 days. The seeded numbers are 
shown in the right.  
As expected, cells electroporated with the control siRNA, siAGF1, show higher cell 
numbers with feeders than without feeders. This effect is more pronounced with lower 
cell numbers seeded considering the logarithmic scale. In the group of the same seeded 
concentration, SEM cultured on feeders showed higher concentration of cells. The 
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lowest concentration (AGF1 no feeder) and the two lowest concentrations (MA6 no 
feeder) were too small to count. Comparing the cells kept on feeders and the ones 
cultured alone there is a strong tendency towards the following: the lower the 
concentration of cells, the more their cell number benefit from the feeder interaction. 
Whether this is due to increased proliferation, decreased apoptosis or both will be 
addressed later. 
 
Figure 78  siRNA treated Kasumi-1 seeded in dilutions with and without feeders 
Kasumi-1 were electroporated with siMA6  and siAGF, seeded in a high concentration range (0.01, 0.1, 1 
and 10 x10x105 cells/ml) with or without feeders and cultured for 48h. The y-axis shows the cell 
concentrations as x105 cells/ml in a logarithmic scale. Here siMA6 is the siRNA control while siAGF1is 
the siRNA against the fusion gene AML/MTG8  right: simulated display at which concentration cells were 
seeded violet columns 10x10x105 -, green columns 1x10x105-, red columns 0.1x10x105- and blue 
columns 0.01x10x105 - cells/ml. Shown is one single experiment. 
 
The Figure 78 shows Kasumi-1 with anti AML/MTG8 siRNA (siAGF1) treatment and 
an active siRNA control (siMA6) either cultured in normal wells or on M210B4 feeders. 
Cells were seeded in parallel at different concentrations (0.01, 0.1, 1 and 10 x10x105 
cells/ml) and incubated for 2 days.  
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On the very right the seeded numbers are shown. Cells electroporated with the control 
siRNA siMA6 show slightly higher cell numbers when cultured with feeders than 
without feeders. With lower seeded cell numbers this effect is more pronounced 
considering the logarithmic scale. When the same concentration was seeded, Kasumi-1 
kept on feeders showed higher concentration of cells. The lowest concentration (MA6 
no feeder) and the two lowest concentrations (AGF1 no feeder) were too small to count. 
Comparing the cells kept on feeders and the ones cultured alone there is a strong 
tendency towards: the lower concentration at which cells are kept, the more their cell 
number benefit from the feeder interaction. Again the question of increased proliferation, 
decreased apoptosis will be addressed for SEM later. 
In both cell lines, when grown on feeders, the lowest seeded group showed more cells in 
the fusion gene depleted samples than the controls. This seems to be contradictory to 
what is expected and published. However this was usually measured in concentrations 
almost 1000 fold higher than the lowest concentrations here (blue column). The 
explanation for higher numbers of fusion gene depleted cells than control siRNA treated 
ones when grown on feeders, could be inexact counting in low concentrations. The 
higher concentrations show expected effects (about twice as many cells in control 
siRNA groups). The most important effects on cell numbers were shown by the 
comparison with and without feeder culture.  
The two cell-lines showed a similar result. At high concentrations of 1x106 cells/ml 
there was no difference in cell numbers between co-cultured and non co-cultured cells. 
At the lower the concentrations, a more substantial difference between co-cultured and 
control cells was seen.  
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4.3.5 Investigation of feeder influence on fusion gene 
depletion derived gene expression and viability 
 
SEMTeton and Kasumi-1 DC treated with siRNA to knockdown their fusion genes 
were seeded in different concentrations on feeder and control wells. The cultures were 
analysed by counting leukaemic cells and images of feeder co-cultures were captured 
(Figure 79). 
 
Figure 79  MLL/AF4 depletion in SEMTeton on feeders 
SEMTeton treated with siAGF1 (i.)  and siMA6 (ii.) seeded in 3 dilutions on M210B4.  (A) 1/10 - 
0.5x105 cells/ml  (B) 1/5 - 1x105 cells/ml and  (C) ½ - 2.5x105 cells/ml dilution, magnification 200x 
 
On the left side of Figure 79 (i.), SEMTeton treated with siAGF1 (control siRNA) were 
seeded in 3 concentrations: lowest (0.5x105 cells/ml) (A), double (1x105 cells/ml) (B) 
and 5-fold (2.5x105 cells/ml )(C). On the right side (ii.) SEMTeton were treated with the 
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fusion gene specific siRNA (siMA6). They were seeded as the siAGF1 treated cells had 
been. 
These images showed that the cell number is decreased in the siMA6 group, which is 
best seen in the density difference at highest concentration. The corresponding cell 
numbers of co-cultured cells and feeder free cells are shown in the following diagrams 
(Figure 80 and Figure 81). 
 
Figure 80  Cell numbers of MLL/AF4 depleted SEMTeton without feeders 
Relative cell numbers of SEMTeton treated with siMA6 and siAGF1, cultured without feeders. Cells 
were diluted after electroporation and cultured without feeders.  (Left) 1/10 dilution - 0.5x105 cells/ml   
(Right) 1/5  -1x105 cells/ml.  Blue columns: siMA6 treated, Red columns: siAGF1 treated, siMA6: fusion 
transcript directed and siAGF1 control siRNA.  Shown is one representative experiment. 
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Figure 81  Cell numbers of MLL/AF4 depleted SEMTeton on feeders 
Relative cell numbers of SEMTeton treated with siMA6 and siAGF1; cultured on feeders.  (Left) 1/10 - 
0.5x105 cells/ml dilution   (Right) 1/5 - 1x105 cells/ml dilution after electroporation   Blue columns: 
siMA6, Red columns: siAGF1; siMA6: fusion transcript directed siRNA and siAGF1: control siRNA 
Shown is one representative experiment. 
 
The same experiment was performed with Kasumi-1 DC cells to show a broader 
relevance of the feeder’s interactions with leukaemic cells (see Figure 82). 
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Figure 82  Fusion gene depletion in Kasumi-1 DC  on feeders 
Kasumi-1 DC were treated with siAGF1 and siMA6 and seeded in 3 dilutions on M210B4. 
(A) 1/10 - 0.5x105 cells/ml   (B) 1/5 - 1x105 cells/ml and   (C) ½ - 2.5x105 cells/ml dilution. 
i.  siAGF1 and ii.   siMA6, magnification 200x 
 
 
On the left side (i.) of Figure 82, Kasumi-1 DC treated with siAGF1 (Fusion gene 
specific) were seeded in 3 concentrations: 1/10 (0.5x105 cells/ml) (A), 1/5 (1x105 
cells/ml) (B) and 1/2 (2.5x105 cells/ml) (C). On the right side (ii.) Kasumi-1 DC were 
treated with the control siRNA (siMA6). They were seeded as the siAGF1 treated cells 
had been. 
These images show that the cell number is decreased in the siAGF1 group, which is best 
seen in the density difference at highest concentration. 
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The corresponding cell numbers of co-cultured cells and feeder free cells are shown in 
the following diagrams (Figure 83 and Figure 84). 
 
 
Figure 83  Relative cell numbers of Kasumi-1 DC treated with siMA6 without feeders  
Kasumi-1 DC were treated with siMA6 and siAGF1, diluted after electroporation and cultured without 
feeders.    (Left) 1/10 - 0.5x105 cells/ml     (Right) 1/5 - 1x105 cells/ml   Blue columns: treated with 
siMA6,  Red columns: treated with siAGF1. Shown are averages of triplicates of one single experiment.  
 
 
 
Figure 84  Relative cell numbers of Kasumi-1 DC treated with siMA6 on feeders 
Kasumi-1 DC were treated with siMA6 and siAGF1, diluted after electroporation and cultured on feeders. 
(Left) 1/10 - 0.5x105 cells/ml     (Right) 1/5 - 1x105 cells/ml   Blue columns: treated with siMA6, Red 
columns: treated with siAGF1. Shown are averages of triplicates of one single experiment.  
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From this point, after establishing the feeder –leukaemic cell interaction assay, studies 
to investigate the role of fusion genes in bone marrow fibroblast - leukaemic interaction 
used only the MLL/AF4 positive ALL cell line SEM.  
In the previous chapter, interesting possible target genes of MLL/AF4 were identified.  
Several of those genes strongly pointed towards a role in niche biology. The most 
interesting candidates, like FGFR1 and N-CADHERIN were tested with this established 
system. 
SEM were treated with siMA6 and siAGF1 and then either cultured in normal wells or 
on M210B4 feeders. After 4 days, these SEM were harvested and an analysis of their 
transcript-levels was performed (see Figure 85). 
 
 
Figure 85  Gene expression changes of MLL/AF4 depleted SEM kept on feeders 
Electroporated SEM cells were kept on feeders for 96h.  Blue columns: siMA6 treated cells,   Red 
columns: siAGF1 (control) treated cells. The relative mRNA levels were normalised to siAGF1. Shown is 
one representative experiment. 
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The diagram above (Figure 85) shows relative transcript levels normalized to GAPDH 
as a housekeeping gene and to AGF1, the siRNA control, which was set to 1. The blue 
columns show transcript levels of cells treated with siMA6 while red columns represent 
siAGF1 treated cells. These cells were kept on M210B4 feeders for 4 days. 
 
 
Figure 86  Gene expression changes of MLL/AF4 depleted SEM without feeders 
SEM were electroporated with siMA6 and siAGF1 and cultured for 96h without feeders.  Blue columns: 
siMA6 treated cells,    Red columns: siAGF1 treated cells.  The relative mRNA levels were normalised to 
siAGF1. Shown is one representative experiment. 
 
The diagram above (Figure 86) shows relative transcript levels normalized to GAPDH 
as a housekeeping gene and to AGF1, the siRNA control, which is set to 1. The blue 
columns show transcript levels of cells treated with siMA6 while red columns represent 
siAGF1 treated cells. These cells were cultured without feeders for 4 days as a control. 
Both of these results demonstrate a greater reduction in transcript levels in the cells 
cultured without feeder cells.  
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As the bone marrow fibroblast – leukaemic cell interaction affected the cell numbers of 
leukaemic cells in a wide concentration range the question was if this effect was due to 
decreased apoptosis, to increased proliferation or to both. This promised also to give 
information about the function and type of interaction taking place between bone 
marrow fibroblasts and leukaemic cells. 
To further determine the effect on apoptosis of the feeder contact, SEM were depleted 
of MLL/AF4 and cultured on or without M210B4. The proportion of viable cells was 
measured using the Annexin-V – PI assay (Figure 87, Figure 88 and Figure 89 ).  
 
Figure 87  SEM controls for PI and Annexin-V staining 
SEM were heated and stained with either PI or Annexin-V and subsequently analysed by flow 
cytommetry as positive controls.   (Left) SEM heated at 65C for 5min, stained with PI, used to set 
necrotic Q1 quadrant    (Right) SEM heated at 65C for 5min, stained with Annexin-V to set apoptotic   
Q4 quadrant. PE-A channel: used to recod PI fluorescence, FITC-A channel: used to record Annexin-V 
FITC. Quadrants: Q1 necrosis, Q3 viable cells, Q2 late apoptosis, Q4 early apoptosis. Shown is one 
representative experiment. 
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Figure 88  Apoptosis in siMA6 treated SEM 
SEM were treated with siMA6, cultured for 5 days with and without feeders and then stained with PI and 
Annexin-V.  They were also subjected to CD19 staining (B-cell marker) and gated on this.  (Left) grown 
on feeders   (Right) grown without feeders. PE-A channel: used to recod PI fluorescence, FITC-A channel: 
used to record Annexin-V FITC, Quadrants: Q1 necrosis, Q2 late apoptosis, Q3 viable cells and Q4 early 
apoptosis.  
        
 
Figure 89  Apoptosis in siAGF1 treated SEM 
SEM were treated with siAGF1, cultured for 5 days with and without feeders and then stained with PI and 
Annexin-V.  They were also subjected to CD19 staining (B-cell marker) and gated on this.  (Left) grown 
on feeders   (Right) grown without feeders. PE-A channel: used to recod PI fluorescence, FITC-A channel: 
used to record Annexin-V FITC, Quadrants: Q1 necrosis, Q2 late apoptosis, Q3 viable cells and Q4 early 
apoptosis.  
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Table 12  Statistics of Figures 88 and 89 
Number of SEMs in 4 quadrants according to the Annexin-V – PI assay shown in Figure 88 and Figure 
89. SEM were siRNA treated for 5 days cultured under normal conditions or on feeders and then 
harvested for the determination of viability. Compromised cells: sum of cells in quadrants Q1, 4 and 2 
(not fully viable) 
 
 
 
Figure 90  Feeder Influence on MLL/AF4 derived apoptosis 
SEM treated with siMA6 and siAGF1 (control) for 5 days, comprising two electroporations on day 1 and 
day 3.  Half of the batch was kept in control wells and the other half were cultured on feeders at the same 
concentration. CD19 gating was used for the selection of B-cells and selected cells were detected in 4 
quadrants according to their Annexin-V and PI staining. This diagram displays the data from Figure 88, 
Figure 89 and Table 12. Shown is one single experiment. 
 
The diagram (Figure 90) and the table (Table 12) above show that cells kept on 
M210B4 clearly had a larger fraction of viable cells. Furthermore, co-cultured cells 
showed a much smaller difference between MLL/AF4 depleted cells and cells treated 
MA6 coculture AGF1 coculture MA6 control AGF1 control
Q1 necrosis 3.5 2.6 15.6 0.7
Q4 early Apoptosis 5.3 2.3 18.1 15.3
Q2 late Apoptosis 6.7 4.4 24.4 14.9
Q3 viable cells 84.4 90.6 41.8 69.1
Q 1,4,2 compromised cells  15.5 9.3 58.1 30.9
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with the corresponding siRNA control compared to the cells with no feeder contact. 
Late apoptosis and necrosis increased in feeder free cultured cells, however especially 
necrosis seemed to rise in siMA6 treated cells (15.6% necrosis) without M210B4 
contact compared to siAGF1 treated cells (0.7% necrosis).  
This result showed that feeder contact reduced apoptosis in SEM after siRNA treatment 
but also reduced the MLL/AF4 depletion derived cell death. 
 
4.3.6 Track of daughter populations after MLL/AF4 
knockdown 
 
From previous work within the Heidenreich group it is known that depletion of 
MLL/AF4 increases apoptosis and leads to cell cycle arrest. M Thomas et al. (Thomas, 
Gessner et al. 2005) have shown that due to MLL/AF4 knockdown anti-apoptotic 
markers such as BCLXL decreased while apoptotic markers like cleaved Caspase 3 
increased in expression. Moreover a G1 cell-cycle arrest was found in MLL/AF4 
depleted cells. Further data on growth curves showed reduced proliferation for 
MLL/AF4 depleted cells. This raised the question of whether the different cell numbers 
are due to a bigger proportion of cells being affected by apoptosis or by inhibited 
proliferation.  
To accomplish this, SEM were tracked throughout proliferation while being 
electroporated on day 1, 3 and 5, introducing the CFSE assay which allowed tracking of 
the daughter cell populations (see Figure 91).  
 
 
Chapter 4 Bone marrow feeder interaction 
189 
 
 
Figure 91  CFSE tracking of  daughter  populations in siRNA treated SEM 
CFSE stained SEM were treated with siRNA on day 1,3 and 5; Daughter populations were tracked by 
detecting the CFSE signal. The blue peak (Right) represents the parent population, each peak left of it 
represents a daughter population of the peak before. The x-axis represents the number of cells detected 
and the y-axis the signal strength (population). On the right also the foward-sideward scatterplots are 
shown for day 9 and the gating. siAGF1: control siRNA, siMA6: siRNA targeting MLL/AF4. Shown is 
representative experiment. 
 
The schematic above (Figure 91) shows tracked daughter populations from siMA6 
(targeted to fusion gene transcript) and siAGF1 (control) treated cells throughout 9 days 
of MLL/AF4 depletion and monitoring. The blue peak on the right represents the parent 
population. All peaks to the left in different colours represent daughter populations.   
 
The data showed that MLL/AF4 depleted cells were not just proliferating slower than 
the siRNA control, they seemed to split into different populations, from cells with a low 
rate of proliferation (siMA6, day 9, intense green peak, most right) to cells with high 
proliferation (siMA6, day 9, lighter green peak, most left). Compared to the control 
cells, where the majority of cells were present in 3 populations of highest proliferation, 
the MLL/AF4 depleted cells were distributed in 7 detectable populations. 
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4.3.7 The feeder as an assay system for interactions 
 
4.3.7.1 MLL/AF4 influence on HOXA7 and TERT 
 
In the Heidenreich group we have found that two genes TERT (Telomerase reverse 
transcriptase) and HOXA7 (Homeobox gene, cluster A) are not only influenced by the 
depletion of MLL/AF4 but are also interacting with each other. Upon MLL/AF4 
depletion, the telomerase activity was reduced. Furthermore HOXA7 binds to the 
promoter of TERT (Gessner , Thomas et al. 2010). 
Firstly the levels of TERT and HOXA7 transcript were analysed following depletion of 
MLL/AF4. SEM treated with siAGF1 (control), siMA6 (anti MLL/AF4) and siHOXA7 
(anti HOXA7) were analysed for their transcript levels of MLL/AF4, TERT and HOXA7 
two days after the first and two days after the second electroporation (Figure 92).  
 
Figure 92  Gene expresion levels of a 96h timecourse in siRNA treated SEM without 
feeders 
SEM treated with siAGF1, siMA6 and siHOXA7 for 2 days (1elp) and for 4 days (2elp). Normalised 
relative transcrip levels (normalised to 1 using AGF1 1elp and AGF1 2elp)  of MLL/AF4 (blue columns), 
TERT (red columns) and HOXA7 (green columns) are represented by the x-axis showing relative mRNA 
levels.Shown is one representative experiment. 
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The diagram (Figure 92) shows that siMA6 reduced levels of MLL/AF4 two days after 
the first and two days after the second electroporation. Treatment with siMA6 also 
reduced TERT levels after the second electroporation by 30%, while after the first 
electroporation TERT levels were hardly changed. Finally siMA6 reduced HOXA7 
transcript levels by 70 (1st -) to 80 (2nd electroporation) percent.  
The siRNA siHOXA7 which is targeted against the HOXA7 transcript reduced its target 
mRNA by 60 (1st -) to 70 (2nd electroporation) percent, however levels of MLL/AF4 and 
TERT mRNA were not substantially reduced. 
That HOXA7 is substantially reduced by MLL/AF4 depletion was  known already 
(Gessner, Thomas et al. 2010). 
To monitor those transcript levels over an extended period of MLL/AF4 and HOXA7 
depletion, a timecourse was performed using 3 consecutive electroporations as well as 
harvesting for analysis every 2nd day. To evaluate if the interaction with feeders does 
change these results for example by keeping cells with low HOXA7 levels alive, two 
seperate strands of this experiment were performed. One under normal culture 
conditions, the other on feeders (Figure 93).  
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Figure 93  Gene expression levels of a 144h timecourse in siRNA treated SEM  
SEM treated with siAGF1, siMA6 and siHOXA7 for 48h, 96h and 144h.  Normalised relative transcript 
levels normalised to 1 using corresponding AGF1 per timepoint.  Blue columns: MLL/AF4 transcript, 
Green columns: TERT  and Red columns: HOXA7.  The x-axis represents relative mRNA levels of those 
transcripts  (A) cultured without feeders   (B) co-cultured on feeders. Shown is one representative 
experiment. 
 
The diagrams (Figure 93) show depletion of MLL/AF4 and HOXA7 for 144h. The 
control time course where SEMs were cultured under normal culture conditions in 
between the electroporations resulted in approximately 60% depletion of MLL/AF4 by 
siMA6. In parallel, HOXA7 levels sunk from 50 (48h), to 70 (96h) to almost 90 (144h) 
percent. TERT levels were mainly reduced after 144h siMA6 treatment by 40%. 
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Furthermore treatment with siHOXA7 reduced HOXA7 mRNA levels by 40 (48h), 70 
(96h) and 65 (144h) percent.  Levels of MLL/AF4 showed no consistent reduction as 
expected but also transcript levels of TERT showed no consistent effect. 
Finally, the data from the time course experiment of SEM cells cultured on feeders 
showed slightly different results. Anti MLL/AF4 treatment (siMA6) reduced the 
corresponding mRNA levels by roughly 70 percent throughout the time course while 
the transcript levels of HOXA7 were reduced by 65 (48h), 80 (96h) and 30 (144h) 
percent.  By the same treatment TERT levels were reduced by 30 (48h), 20 (96h) and 40 
(144h) percent. Surprisingly siHOXA7 altered corresponding transcript levels to 60 (48h) 
and 70 (96h) percent reduction but then to 20 percent increase. As seen previously, 
MLL/AF4 mRNA levels were not consistently changed by siHOXA7, while TERT levels 
were not reduced substantially after 48h and 96h but at 144h  a 20 percent reduction was 
seen. 
Comparing those two parallel experiments, the interaction with M210B4 seemed to 
reduce HOXA7 depletion after 144h to just 30 percent, compared to 90 percent 
reduction in the non co-cultured cells. Vice versa, the feeder interaction resulted in a 20% 
reduction of TERT by after 144h compared to 45 percent increase in the non co-cultured 
cells. 
 
4.3.7.2 The feeder and primary patient material  
 
Unlike cell lines such as SEM, primary material from patients is difficult to culture due 
to increased cell death. To test the suitability of feeder systems for mid and long-term 
culture of primary ALLs, cells from MLL/AF4 patients were used to check if co-
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culturing on M210B4 increases the time they can be cultured.  This is important due to 
limited availability of primary patient material. In our experience these cells hardly 
grow under normal cell culture conditions. To determine how long primary cells 
remained viable in feeder layer co-culture, cells were analysed with the Annexin-V PI 
assay. Frozen white blood cell aliquots from an infant MLL/AF4 positive patient were 
thawed and cultured on M210B4 feeders for two weeks. Using several controls such as 
viable SEM cells, SEM incubated at 65°C for 15min and either stained for PI or 
Annexin-V, for setting the necrotic and the early apoptotic quadrant infant MLL/AF4 
cells were analysed for their viable fraction compared to fibroblasts alone (Figure 94, 
Figure 95 and Table 13).      
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Figure 94  Infant –MLL/AF4 patient viability 
Infant-Patient MLL/AF4 positive cells grown on M210B4 for 2 weeks were gated for B-lymphocytes and 
stained with PI and Annexin-V.   (Left) dot-plot: SSC against FSC with lymphoblast gate (Right) dot-plot: 
PI (FL2-H, necrosis) against Annexin-V (FL1, apoptosis). The quadrants were set using positive controls 
for necrosis and early apoptosis. The Upper left quadrant (UL) shows necrotic cells, the lower right 
quadrant (LR) shows early apoptotic cells, the upper right quadrant (UR) shows late apoptotic cells and 
the lower left quadrant (LF) shows viable cells. Shown is one single experiment. 
 
  
 
Figure 95  Cell viability fibroblast control 
Irradiated M210B4 were gated with the lymphophcyte gate and stained with PI and Annexin-V. (Left) 
dot-plot: SSC against FSC with B-lymphocyte gate  (Right) dot-plot: diagram PI (FL2-H, necrosis) 
against Annexin-V (FL1, apoptosis). The quadrants were set using positive controls for necrosis and early 
apoptosis. The Upper left quadrant (UL) shows necrotic cells, the lower right quadrant (LR) shows early 
apoptotic cells, the upper right quadrant (UR) shows late apoptotic cells and the lower left quadrant (LF) 
shows viable cells. Shown is one single experiment. 
 
 
 
R1
R1
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Quadrant  %  MLL/AF4 Infant Fibroblasts 
UL  Necrosis  0.97 3.01 
LR  early Apoptosis 9.36 37.88 
UR  late Apoptosis 27.08 32.83 
UL+LR+UR  damaged cells 37.41 73.72 
LL  viable cells  62.59 26.28 
Table 13  Summary of quadrant cell numbers from Figures 94 and 95 
 
This data (Table 13) showed that the majority of MLL/AF4 cells were alive after 2 
weeks on M210B4 layer. Unfortunately, M210B4 gave the same pattern of Annexin-V -  
PI staining, making them  indistinguishable from leukaemic cells. Nevertheless, in this 
experiment there was an excess of MLL/AF4 cells to M210B4, so that their influence 
on the quadrant numbers could be disregarded. 
However to overcome this problem the Annexin-V - PI assay was further developed by 
gating off leukaemic cells using CD19 staining as a B-cell marker previous to the 
distribution over the 4 quadrants.    
Firstly it was tested how sensitive to CD19 this pre-gating is. For this, two 
concentrations of MLL/AF4 patient cells were seeded on feeder layer wells and 
analysed for the CD19 shift (Figure 96 ). 
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Figure 96 MLL/AF4 patient cells CD19 shifts 
MLL/AF4 patient cells co-cultured in two dilutions on feeders, stained with CD19; the APC channel 
shows CD19 positivity (B-cell marker); P2 gate: cells with CD19 shift compared to control cells, P1: cells 
with no CD19 shift.    (Left) 105 MLL/AF4 patient cells per well   (Right) 106 MLL/AF4 patient cells per 
well. Shown is one representative experiment. 
 
The ratio P2/P1 gave an indication of how concentration dependent the CD19 shift was 
(Figure 96). The ratio means MLL/AF4 leukaemic cells divided by fibroblasts. The 
higher the ratio the more MLL/AF4 cells were present. For 106 seeded cells per well the 
ratio was 0.47 and for 105 cells per well 0.24. 
In addition to the controls used for Annexin-V – PI analysis, additional controls were 
introduced for CD19 staining. Cells positive for CD19 were used to display the 4 
quadrants.  The MLL/AF4 cells were incubated for three weeks on M210B4. Because of 
restrictions in patient material, only co-cultures and irradiated M210B4 cells were used 
for flow cytometric analysis (Figure 97).  
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Figure 97  MLL/AF4 patient cells after 3 weeks on M210B4 feeders 
MLL/AF4 patient cells (1x106 cells /well) kept on M210B4 feeders for 3 weeks, stained and pre-gated 
with CD19(B-cell marker), stained with PI and Annexin-V for cell viability determination  (Top row) 
MLL/AF4 – M210B4 co-culture CD19 staining only (10e6 CD19)   (2nd row) irradiated M210B4 only 
(m2 IR)   (Bottom row) MLL/AF4 – M210B4 co-culture CD19, PI and Annexin-V staining ( 10e6 All) 
(Left) SSC-FSC plot   (Middle) PI - Annexin-V plot + quadrants   (Right) count-APC (CD19) histogram; 
Q1 necrosis, Q2 late apoptosis, Q3 viable cells and Q4 early apoptosis, 10e6: 1x106. Shown is one single 
experiment. 
 
 
The result (Figure 97) confirmed that 77% of infant MLL/AF4 cells were still viable 
after 3 weeks on M210B4 feeders. 
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4.4 Discussion Feeder Chapter 
 
The aim of this chapter was to investigate the strong references from the previous 
chapter towards the HSC – niche context. Therefore the endeavour to establish a model 
to investigate the bone marrow – HSC, or leukaemic (stem) cell interactions was made.  
In a first attempt HS-5, (Roecklein and Torok-Storb 1995) a human bone marrow 
fibroblast line immortalised by human papilloma virus HPV, was examined for this 
interaction. HS-5 cells were used to increase survival of human B-CLL patient cells 
(Seiffert, Stilgenbauer et al. 2007) and also shown to support B-Lymphoma by 
expression of B cell-activating factor (BAFF) (Lwin, Crespo et al. 2009). Another group 
showed increased proliferation of the leukaemic cell line K562 if co-cultured with HS-5 
(Lee, Chiou et al. 2008). 
In contrast to co-cultures in the literature where the main objective was to keep 
haematopoietic cells alive by co-culturing them with feeders, the interaction system to 
be developed had to provide a stable environment. This should ensure that interactions 
between feeders and haematopoietic cells can be monitored without disturbing 
influences. Therefore feeder layers had to be growth arrested, which had not been 
published for HS-5. 
HS-5 feeders could not be growth arrested by irradiation, Actinomycin D or Mitomycin 
C treatment (Figure 48), tested at several doses. Actinomycin is known to induce cell 
cycle and subsequential growth arrest (Kim, Kong et al. 2005). Mitomycin C had been 
described as an alternative to irradiation for feeders (Ponchio, Duma et al. 2000). The 
microscope observation always showed an increased toxicity with dose, and cells were 
either surviving and growing again or dying. Cell cycle (Figure 50) and genotype 
analysis showed that HS-5 were quite heterogeneous with inter cell variation such as 
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unbalanced translocations, hyperdiploidy and polyploidy. This observation raised the 
question if these were really pure, non contaminated HS-5. Considering the handling 
procedures and that only one fibroblast cell line was cultured that time, contamination is 
very unlikely. If a mixed culture of HS-5 and another cell line had been used as “HS-5”, 
then most likely it would have to be in the original HS-5 vials. However, considering 
how HS-5 were immortalised using HPV, which transduced cells with its genes E6 and 
E7 known to interfere with p53 and Rb and thereby preventing cell cycle arrest, it is 
quite feasible that these genes generated genetic instability and subsequently 
heterogeneity. This could be seen quite nicely in the images of MMC treated HS-5 
(Figure 48). They showed foci of HS-5, resulting from strong proliferation, surrounded 
by gaps which had been generated by died HS-5. 
As an alternative the murine bone marrow fibroblast cell line M210B4 (Lemoine, 
Humphries et al. 1988) was chosen. For over 10 years it was used for LTC-IC (long 
term culture initiating cell) assays and is accessible to growth arrest by irradiation 
(Prosper, Vanoverbeke et al. 1997). Growth arrest of M210B4 by 80Gy irradiation 
could be shown by cell cycle analysis, showing a G2 arrest (Figure 56). Although 80Gy 
is mortal to many cell types, a substantial fraction of M210B4 is viable after treatment. 
However increased apoptosis levels the first 2-3 days after irradiation requires seeding 
of high numbers of M210B4 to form nearly confluent layers that can be maintained for 
more than 4 weeks.   
For initial tests of M210B4 growth arrested feeders, fluorescent SEMTeton (GFP) were 
used. Apart from the morphological and size differences, fluorescence of co-cultured 
cells provided an additional marker for the distinction from feeders (Figure 57). This 
provided the advantage that the distinction of feeders and leukaemic cells not only 
relied on morphological and size differences. The pre test of co-cultures showed that the 
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feeders and leukaemic cells can be distinguished under the microscope, as fluorescent 
signals matched the light microscopic images. The initial assumption that these 
fluorescent SEM and the feeders should be easily distinguishable in Flow Cytometry 
analysis proved to be wrong. For this co-cultures of M210B4 and SEMTeton or 
MV4;11Teton had been used (Figure 59, Figure 60 Figure 61). As it was shown later, 
leukaemic cells tested adhered on feeder layers (Figure 72). A simple shake of cells or 
washing, as it was published in M210B4 (Burger, Spoo et al. 2003), does not remove 
those cells directly attached to the feeder, only cells in suspension. This is sufficient for 
maintaining and analysing cells in higher concentrations, but as leukaemic cells in lower 
concentrations seem to be mainly located on the feeders, shaking off is not suitable in 
retrieving those cells. Therefore co-cultures had to be trypsinized in total, resulting in 
suspension of M210B4 and leukaemic cells. 
The distinction of those M210B4 SEMTeton or MV4;11Teton co-cultures by Flow 
Cytometry analysis using size and granularity left a remaining fraction of cells over 
spilling into each M210B4 and leukaemic cells gate. Although M210B2 are bigger, 
fibroblast shaped with a certain granularity, they show a certain distribution of sizes and 
granularity and not a strongly defined population. This could be due to irradiation, 
where cells are arrested in different stages of growth and additionally due to different 
genetic mutations induced by the irradiation which might lead to different 
morphological phenotypes. This could be seen by comparing FSC-SSC Dot plots of 
normal and irradiated M210B4, showing that irradiation results in a different pattern. 
Additionally these irradiated cells show a high auto-fluorescence.  
Several dilutions of SEM- or MV4;11Teton cells on M210B4 feeders showed a limited 
range of concentration dependence of flow cytometry feeder or leukaemic cell gating 
(Figure 60 and Figure 64). 
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This approach was further improved by establishing a Flow Cytometry based cell count 
assay to determine fluorescent SEM on M210B4 feeders. Instead of counting numerous 
wells by hand in triplicates per sample, which relied on the visual discrimination of 
M210B4 and SEMTeton cells, flow cytometric statistics of two gates was used. Due to 
the constant number of M210B4 per well, the more leukaemic cells are grown per 
M210B4 well, the higher the ratio of leukaemic cell numbers to M210B4 numbers per 
10000 events should be (Figure 68). 
The successful development of this method was also based on changes to the previous 
flow cytometric analysis. The most important changes were the use of a different Flow 
Cytometry machine (FACS Calibur) with less automated settings, a logarithmic SSC 
channel and irradiated M210B4 to set the gates to allow this. A standard curve showed 
that this approach was highly correlative and linear from 103 to 106 cells per well. 
This method provides easier and more extended experiments on feeders. However the 
majority of the feeder leukaemic interaction was assessed using visual discrimination 
and used non fluorescent leukaemic cells which cannot be counted with this assay.  
The discrimination of M210B4 from leukaemic cells in an counting chamber had been 
trained by using trypsinised M210B4 and fluorescent cells separately. Normal light 
microscope images distinguished both SEMTeton and MV4;11Teton from M210B4.  
It was mentioned previously that leukaemic cells adhere to feeders. To demonstrate this, 
an inversion test was implemented with this feeder assay (Figure 72). The principle is 
that co-cultured cells adhered to feeders, which were grown on a glass slide based 
chamber. If there is adhesion to the feeders these co-cultured cells stay connected even 
when the chamber is converted, while not bound and loosely bound cells are separated 
by gravity. A similar inversion test had already been described but had to be adapted for 
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these cells and the glass slide chambers used. SEM cells could not be used for this assay 
as they show adherence to surfaces. Consequently it could not been ruled out that 
adherence to M210B4 was unspecific adherence and not specific interaction. 
As a replacement the two AML cell lines Kasumi-1 and SKNO-1, which express 
AML/MTG8 fusion gene, were used. The test revealed that no substantial decrease in 
leukaemic cells on feeders was found after 2h of inversion and suspension cell removal. 
This finding could also be confirmed by hitting against the side of co-cultures wells. 
Cells in suspension moved, whilst cells on top of the M210B4 feeders did not. These 
results show that there is a physical interaction between these leukaemic cells and the 
M210B4 feeders. 
Next, the question was addressed if co-culture on feeders affect siRNA mediated 
knockdown and its consequences for cell growth was addressed. 
Several publications from the Heidenreich group have used electroporation mediated 
delivery of siRNA to knock down fusion genes. It was shown that this affects 
proliferation, clonogenicity and apoptosis (Thomas, Gessner et al. 2005). 
It was shown that the fusion gene depletion MLL/AF4 and AML/MTG8 can be detected 
in cells grown on feeders (Figure 79 and Figure 82), showing depletion to a similar 
extent. The accessibility for MLL/AF4 depletion has also been shown for SEMTeton 
(Figure 79). 
The qRT-PCR analysis of fusion gene expression levels of leukaemic cells grown on 
feeders was validated showing that M210B4 RNA did not influence housekeeping gene 
GAPDH expression used to normalise gene expression levels, because M210B4 genes 
have a mouse background and the genes tested are not recognised by human primers. 
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Secondly primers for MLL/AF4 in Kasumi-1 and primers for AML/MTG8 amplified 
product more than 10 cycles later than in the cells bearing those fusions, and the melting 
curves indicated primer-dimer peaks. Together this shows the high specificity of this 
qRT-PCR analysis. Another factor contributing to this was the excess of leukaemic cells 
used in co-culture in comparison to M210B4 numbers also reducing an effect of 
M210B4 RNA traces on the analyses.  
Normal SEM were treated for MLL/AF4 depletion and seeded in dilutions below 
normal culture concentrations on feeders. Determination of SEM numbers showed, that 
upon MLL/AF4 depletion cell numbers reduced 2 fold on average, while doubling times 
increased (Figure 76).  
To investigate the influence of feeder contact and leukaemic cell concentration on 
leukaemic cell numbers, a large scale experiment was performed using SEM and the 
AML fusion cell line Kasumi-1, as a leukaemic control.  
Cells depleted for MLL/AF4 (siMA6) together with controls (siAGF1) were seeded in a 
wide concentration rage from 1x103 to 1x106 cells / ml in wells with and without feeders 
(Figure 83). The most profound effect was that the lower the concentration the cells 
were seeded out at, the more these cells benefited from the interaction with the feeders. 
In the lowest concentrations SEM showed substantial increase of numbers while 
without feeders cells numbers diminished. Depletion of MLL/AF4 reduced cell numbers 
to a lesser extent in co-culture than in single culture.  The results in Kasumi-1 which 
were depleted for their fusion gene AML/MTG8 were quite comparable (Figure 84). 
This raises the question if this effect is dependent on these bone marrow feeders or if it 
is due to the proximity of other cells. With the knowledge of physical interactions 
already shown, a range of growth supporting factors secreted and later findings 
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regarding apoptosis it seems unlikely that these effects are just caused by the close 
proximity of other cells. The second question to be answered was if these differences 
from an increase of cell numbers on the feeder and a strong decrease without feeders 
were mainly caused by induced proliferation or also due to reduced apoptosis. This 
question was addressed and will be discussed later on. 
In addition to the determination of cell number changes in relation to fusion gene 
depletion, fusion gene depleted SEM and Kasumi-1 with their controls were seeded in 
several densities on feeders and the reduction of cell numbers due to fusion gene 
depletion could be shown in co-culture images (Figure 77 and Figure 78). Parallel to 
this, the reduction of cell numbers by fusion gene depletion had been confirmed by cell 
number determination.  
Following these pre-validations MLL/AF4 depletion sensitive niche / stemness 
associated gene expression was investigated comparing non feeder with feeder cultures.  
These genes had been validated in the previous chapter. The comparison of gene 
expression levels of MLL/AF4, TERT, MEF2C, FGFR1 and CDH2 (N-CADHERIN) 
showed no significant difference between non feeder and feeder interaction cultures 
(Figure 92). This result confirmed the feasibility of qRT-PCR analysis in co-cultured 
samples. It remains unknown if the feeder interaction had an influence on the genes as 
these cells had only been cultured for 96h after siRNA treatment.  
A simple experiment could address the role of MLL/AF4 in N-cadherin adhesion. This 
would be to knock down MLL/AF4 and to use the inversion assay already mentioned. If 
the number of cells attached to the M210B4 layers would decrease after inversion 
compared to a siRNA control, a direct influence of MLL/AF4 on N-cadherin adhesion 
would be indicated.   
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To address the question of the viability of the cells, an Annexin-V - PI assay to 
determine the viability of cells depending MLL/AF4 depletion and feeder contact was 
performed. To exclude basal levels of feeders from this analysis a pre CD19 gating, 
selecting for B-lymphocytes was performed. However, CD19 staining could to be 
stronger in dead cells due to the enrichment of antibody staining dead cells often show, 
but as M210B4 controls showed, they rarely spill into the CD19 gate .  
This analysis revealed that feeder interaction increases the proportion of viable cells 
especially by reducing late apoptosis but also by reducing necrosis and early apoptosis. 
Comparing MLL/AF4 knockdown and siRNA controls, feeder contact especially 
reduced the vast difference in viability found in non feeder cultured samples. In these 
samples MLL/AF4 depletion especially increases necrosis while in feeder co-cultured 
samples necrosis levels between MLL/AF4 depletion and control were the same. This 
analysis showed, that the effect of the feeder on leukaemic cells is not only growth 
enhancing, but also increasing viability and survival (Figure 90).  
Apart from cell cycle analysis and Annexin-V assays the apoptotic effect was shown 
also by a decrease in BCL-XL, an anti-apoptotic marker, while apoptotic markers such 
as cleaved Caspase 3 increased in expression. As a consequence of observed growth 
arrest, growth curves showed reduced proliferation when MLL/AF4 positive cells were 
depleted for MLL/AF4 (Thomas, Gessner et al. 2005).To answer the question if these 
effects are more correlated to apoptosis or decreased proliferation a CFSE assay was 
used. CFSE staining allowed tracking of cell populations for a certain period. Here 
MLL/AF4 depleted SEM and siRNA control SEM were tracked for 9 days (Figure 91). 
The analysis of daughter populations showed that the longer cells are incubated, the 
bigger the difference was between MLL/AF4 depleted cells and the siRNA control. 
While siRNA control cells were distributed in 3 main populations (furthest, 2nd and 3rd) 
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MLL/AF4 depleted cells were distributed in 7 main populations (furthest, to 7th furthest). 
The amount of dead cells was substantially increased for the MLL/AF4 depleted cells 
and these were gated out in this analysis. This means that from the cells surviving many 
cells grow slower, divide less often, but some very few proliferate as fast as the control 
cells. This heterogeneity is an interesting finding which offers some new insight when 
interpreting effects caused by apoptosis. For example, when determining cell numbers 
after MLL/AF4 depletion, the conclusion to levels of apoptosis, cell cycle arrest and 
proliferation should not depend on cell numbers alone.  
The influence of the feeders on MLL/AF4 depleted and HOXA7 depleted cells was 
further investigated by the determination of TERT and HOXA7 expression pattern 
changes of up to 144 hours (Figure 93). We have linked MLL/AF4 depletion with 
reduced HOXA7 and TERT expression levels and as well to reduced telomerase activity 
(Thomas et al. 2005).  
HOXA7 was found to be dramatically increased in human bone marrow derived 
mesenchymal stem cells and linked to angiogenesis of those bone marrow cells (Chung, 
Jee et al. 2009), which is known to be regulated by FGF2, VEGF and TGF-1. 
The role of TERT in the bone marrow context is poorly examined however, a study in a 
Chinese population connected TERT mutations to bone marrow failure syndrome (Liu, 
Han et al. 2009) which consisted of symptoms such as damaging of hematopoietic stem 
cells and their microenvironment. These TERT mutations probably reduce the 
proliferative potential of haematopoietic stem cells. 
Interestingly the expression level reductions of TERT and HOXA7 after 144h of 
MLL/AF4 depletion (Figure 93) seemed to be stronger in feeder free cell cultures 
compared to cells grown of feeders. Also the knockdown of HOXA7 by siHOXA7 is 
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more efficient in cells grown without feeders after 144h of culture than in those grown 
in co-culture. A possible explanation could be, that cells on feeders contain this 
generation of highly proliferating cells, previously mentioned in the CFSE analysis. 
This population probably has less depletion of MLL/AF4 or HOXA7 and can provide 
higher survival numbers, whilst the cells cultured without feeders probably contain 
more cells with less viability. However these results are based on a single experiment. 
In a previous, similar experiment (Figure 85 and Figure 86) the expression levels of 
TERT after MLL/AF4 depletion for 96h did not difer. Moreover HOXA7 mRNA levels 
had not been analysed.  It was shown previously that knockdown of HOXA7 harms the 
viability of treated cells (Gessner, Thomas et al. 2010).  
For this sustained knockdown of MLL/AF4 and HOXA7 for 144h three electroporations 
with siRNA had to be performed. This required that cells grown on feeders had to be 
trypsinized, differentially counted and electroporated with the feeders again and seeded 
onto new feeders repeatedly. Due to this extensive protocol, leukaemic cells had to be 
kept a higher concentration to provide enough cells for the next electroporation, 
considering the amount of apoptosis taking place, especially in MLL/AF4 depleted 
SEM cells. However the most substantial effects from this feeder culture on leukaemic 
MLL/AF4 depleted cells were seen in low concentrations. Such effects may could not 
be observed in these experiments because of higher concentrations used.  
The question if interaction with feeders influences the clonogenicity could be addressed 
with MLL/AF4 positive cells growth on feeders and then introduced to a clonogenetic 
assay, as feeder layer cells are growth arrested and can’t contribute to this. 
Finally the established feeder interaction system was tested in the maintenance of an 
MLL/AF4 infant patient sample. As previously described CD19 gating was used to pre 
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select B-lymphocytes from feeder cells. However CD19 signal seemed to be less 
strongly expressed, at least in this patient sample, than in ALL cell lines such as SEM. 
However CD19 signal could be shown to be proportional to the amount of SEM seeded 
on feeders. The viability analysis showed that the majority (77%) of patient cells were 
still viable after 3 weeks on feeders (Figure 97). This was not a surprising finding in 
context with the use of bone marrow feeders in the last 15 years. As already mentioned 
irradiation has an effect on the state of M210B4, when using irradiated M210B4 as a 
control in this viability assay, they were detected in the early apoptotic cell quadrant. 
This probably refers to the amount of damage in these cells by irradiation. The CD19 
signal for those M210B4 was mostly determined as negative by the gate set.  
Overall this chapter shows the importance of bone marrow interactions with leukaemic 
cells such as SEM, MV411 and Kasumi-1. Furthermore the established bone marrow 
feeder interaction assay can be used to investigate functions and interactions of 
leukaemic cells with those bone marrow feeders in the future. Furthermore this assay 
could be adapted for testing of therapeutic substances. Finally these data provide 
evidence for a role of MLL/AF4 in target gene regulated pathways and functions 
connected to haematopoietic niche interactions which could influence requirements of a 
leukaemic cell such as survival and growth.  
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5.1 Introduction and Theory 
 
In 1892 Dimitry Ivanovsky discovered viruses when he used a filter that removed 
bacteria to filtrate a solution made from infected tobacco plants. The filtrate could still 
infect new tobacco plants (Shultz, Schweitzer et al. 1995) and due to the absence of 
bacteria he assumed it could be due to a poison; in latin virus. Viruses are particles 
which can infect cells of organisms. There are different opinions if they are forms of life 
or not. Unlike living forms they cannot multiply themselves, they do not require 
nutrients or energy. Viruses are dependent on their host cells to be multiplied. But like 
living forms they do contain a genome meaning genetic information saved in DNA or 
RNA. 
Apart from genetic information viruses contain proteins, which encapsule the genome in 
a capsid, or other structural proteins, have enzymatic functions or signalling functions. 
Viruses are classified in 7 groups by the structure of their genome.  
The genome can either be single or double stranded and contain DNA, RNA or both. (+) 
sence RNA has to be transcribed into complementary (-)sence RNA before mRNA can 
be synthesized (see Figure 98). 
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The 7 classes are: 
I  dsDNA viruses containing double stranded DNA   e.g.  Herpesviruses  
II  ssDNA viruses containing single stranded (+) sence DNA  e.g.  Paroviruses  
III   dsRNA viruses containing double stranded RNA   e.g. Reoviruses 
IV  (+)ssRNA viruses containing (+) sence ss RNA  e.g. Picornaviruses 
V (-)ssRNA viruses containing (-) sence ssRNA    e.g. Rhabdoviruses 
VI ssRNA-RT viruses containing (+) sense RNA with an  
DNA intermediate in the life cycle using RT   e.g Retroviruses 
VII  dsDNA-RT viruses using Reverse transcriptase (RT)  e.g. Hepadnaviruses 
 
 
Figure 98 Baltimore Classification of Viruses Classes I-VII 
ds double stranded, ss single stranded, RT Reverse transcriptase free to publish 
 
As previously mentioned (see Figure 98) the best known example of number VI 
Baltimore classification system are Retroviridae. Amongst the seven retroviridae 
members the most common are Lentiviruses.  
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5.1.1 Lentiviruses 
 
As lenti means slow this naming stands for the long period it often takes from the 
infection to the onset of the disease, which can be more than ten years. The pandemic 
disease AIDS is caused by the lentivirus HIV. 
An HIV or lentivirus live cycle starts with the binding of gp120, a viral glycoprotein to 
the CD4 receptor on the cell surface of certain CD4 positive cells (Landau, Warton et al. 
1988). gp120 also binds to a secondary host cell receptor CCR5 forming a stronger 
complex (Dobrowsky, Zhou et al. 2008) and induces fusion of the virus covering 
membrane with the cellular membrane and subsequently the release of the virus content 
into the cell. gp41 complex formation provides the energy for the fusion (Melikyan, 
Markosyan et al. 2000). Campell et al. (Campbell, Nunez et al. 2004) proposed that nef 
(negative factor, viral) binding is responsible for the release of the virus core content 
into the host cell by actin rearrangement, however other reports rather expect virus 
cellular receptor interactions to be responsible for that (Pizzato, Popova et al. 2008). 
The viral genome is then reverse transcribed by the reverse transcriptase in a reverse 
transcription complex (RTC) inside the capsid (Arhel, Souquere-Besse et al. 2007). The 
resulting provirus DNA is then included in a preintegration complex (PIC) of 56nm 
(Miller, Farnet et al. 1997) which also contains viral proteins such as Integrase (IN), RT, 
nucleocapsid protein (NC), viral protein R (Vpr), matrix (MA) and cellular proteins 
(Bukrinsky, Sharova et al. 1992; Bukrinsky, Sharova et al. 1993). This PIC is then 
transported through the pore complexes into the nucleus consuming ATP (Bukrinsky, 
Sharova et al. 1992). Inside the nucleus the provirus DNA is integrated into the hosts 
genome by IN (this process will described further later on). The inserted sequence can 
be transcribed into proviral DNA by RNA polymerase II (RNAP II) which is supported 
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by viral tat protein. Transcriptional transactivator (TAT) binds to RNAPII generated 
stem-loop RNA (Feng and Holland 1988) and increases the processivity of RNAPII by 
interaction of several cofactors. Rev, another viral protein stabilises partially spliced and 
unspliced mRNA promoting transport to the cytosol (Schmid and Jensen 2008) and 
viral protein synthesis. New viral particles start to assemble using envelope (env), gag-
pol and gag proteins surrounding RNA. Gag binds to viral RNA and host cell membrane 
by its MA domain (Saad, Miller et al. 2006) and directs the gp120 and gp41 
glycoproteins to the cell membrane. By budding virus particles are released from the 
cell. The virus finally maturates by protease driven capsid formation (Pluta and 
Kacprzak 2009) (see Figure 99). 
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Figure 99  HIV Lifecycle 
An HIV virus binds to the membrane of a human cell (A).  The viral envelope membrane fuses with the 
cell membrane and the virus content is released into the cell (B).  In the cytosol the virus genome is 
reverse transcribed and an preintegration complex is formed (PIC) (C).  The PIC is imported into the 
nucleus (D).  Inside the nucleus viral DNA is integrated into the genome of the cell (E).  Genomic viral 
sequences can be transcribed into viral RNA and exported into the cytosol (F).  Coding viral RNA is 
translated into viral proteins (G).  Viral proteins and the viral ssRNA genome assemble at the cell 
membrane (H)  and viral contents are encapsuled into membrane by budding (I). A fully encapsuled virus 
is released from the cell (J)  and the cell undergoes lysis.    from (Pluta and Kacprzapk 2009) 
 
 
5.1.2 Reverse Transcription 
 
The discovery of Reverse Transcriptase (RT) in 1970 (Baltimore 1970) has overthrown 
the former dogma of a one way DNA –> RNA –> Protein mechanism.  
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Cytosol located capsid encapsules the reverse transcription complex (Arhel, Souquere-
Besse et al. 2007) where the RT reaction takes place, resulting in a dsDNA copy of the 
viral RNA. The (-) strand is the ssDNA strand which is complementary to viral RNA 
while the (+)strand corresponds to the viral RNA sequence. The process is highly 
complex (see Figure 100). 
 
Figure 100  Reverse transcription of lentiviral RNA 
A tRNA binds to the primer binding site close to the 5’ end of the viral RNA (2nd from top). A short 
complementary DNA is synthesized to the 3’ end of the minus strand DNA (3rd from top). This cDNA 
“jumps” to the 3’ end synthesis of the (–)DNA strand is started (4th from top). RNA upstream of PBS is 
digested by RT and DNA is synthesized until the new PBS end (5th  from top). A second jump takes place 
locating this short sequence to the end of the longer (–) DNA where the complementary PBS sites anneal 
(6th from top). This starts the (+) strand DNA synthesis and the fill in at the end of the minus strand 
resulting in an double stranded DNA with an 3’ and an 5’ LTR (7th from top).     LTR long terminal repeat  
PBS primer binding site  R repeat region   U 5/3 unique region 5’/3’   ppt polypurine tract     gag, pol,env 
viral genes encoding polymerase (pol), envelope proteins (env) and coat protein (gag)                       
from (Pedersen FS and Duch M  2001) 
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To start reverse transcription a producer cell tRNA is used as a primer (Figure 100). 
This tRNA binds to the primer binding site (PBS) close to the 5’ end of the viral RNA 
and a short complementary DNA is synthesized to the 3’ end of the minus strand DNA. 
This tRNA bound DNA serves as a primer at the 3’ end of viral RNA after “jumping” to 
that end and starting synthesis of the (–)DNA strand. For this RNA upstream of PBS 
including the R and the U5 region are digested by the RNase H function of the RT 
leading to an initial shortening of the 5’ end of viral RNA by the R and U5 region. The 
(–)strand DNA is then synthesized until the new PBS end while the remaining RNA is 
digested apart from the polypurinetract (PPt) sequence which is RNase H resistant and 
serves as a new primer. The “ppt” primer promotes the synthesis to the tRNA coupled 
end generating a short sequence complementary to U3 R U5 which is followed by an 
PBS complementary sequence corresponding to a part of the tRNA. Then the second 
jump takes place locating this short sequence to the other end where the complementary 
PBS sites anneal. This starts the (+) strand DNA synthesis and the fill in at the end of 
the minus strand resulting in an double stranded DNA with an 3’ and an 5’ LTR (long 
terminal repeat) (Pedersen and Duch 2001). 
 
5.1.3 Integration 
 
The Integrase (IN) recognizes att sequences in the provirus DNA and coils it into a 
circular shape. Then both provirus DNA 3’ ends are processed removing 2 nucleotides 
from both 3’ ends generating –OH groups there. Genomic DNA is cleaved creating 5’ 
overhangs of host DNA and joining these to the 3’-OH viral DNA groups in a trans-
esterification mechanism. The left gaps are filled and ligated by cellular enzymes. The 
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resulting genomic DNA bears an integrated provirus sequence. This sequence is stable 
and retained during cell division (Pedersen and Duch 2001) (see Figure 101).  
 
Figure 101  Lentiviral DNA integration 
Integrase (IN) recognizes att sequences in the provirus DNA and coils it into a circular shape (Top)  and 
processes both ends generating –OH groups. Genomic DNA is cleaved creating 5’ overhangs of host 
DNA and joining these to the 3’-OH viral DNA groups in a transesterification (2nd and 3rd from Top). Left 
gaps are filled and ligated by cellular enzymes (4th from top).                       
from (Pedersen and Duch 2001) 
 
LTRs contain vital signals for gene expression such as promoters, enhancers, 
transcription -initiating, -terminating and polyadenylation signals. LTR signals direct 
expression by host cell enzymes such as RNA polymerase II, poly A synthetase and 
guanyl transferase. The U3 region in the 5’ LTR encodes enhancer and other 
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transcription regulators. The promoter TATA box is located closely to the 5’LTR R 
sequence. The 5’LTR is a promoter for RNA polymerase II, the transcript starts at the 5’ 
R region and is terminated by the poly A tract after the 3’ R region (Nolan GP, LAB 
tutorials). 
 
5.1.4 Genomic structure 
  
An HIV virus contains two positive sense ssRNA molecules which provide its high 
genetic variability. Especially RT derived recombination is thought to contribute to this 
variability (Rhodes, Wargo et al. 2003). The HIV provirus DNA is 9.7kb long including 
nine open reading frames (ORF) which translate into nineteen proteins. As shown in 
Figure 102 A the majority of the provirus DNA is protein encoding while both edges, 
the 5’ and the 3’ LTRs (long terminal repeats) contain the 3’ unique element (U3), the 
repeat element (R) and the 5’ unique element (U5). While the trans elements are 
encoding proteins the LTRs contain cis elements functioning in integration, like the 
previously mentioned att repeats, enhancer/promoter sequences, transcativation 
response element (TAR) and a polyadenylation signal. Cis elements downstream the 5’ 
LTRs are primer binding site (PBS) and viral RNA packaging/dimerisation signals 
(and DIS), central cis elements are central polypurine tract (cPPT) and central 
termination sequence (CTS). Upstream of 3’ LTR are rev response element (RRE) 
responsible for the export of viral mRNA into the cytosol and purine rich region (PPT) 
important for +strand DNA synthesis (Pluta and Kacprzak 2009) (see Figure 102).  
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Figure 102  Genomic structure of HIV 
(A) Provirus DNA contains the 5’ and 3’LTRs (Long terminal repeats) which contain the U3, R and U5 
regions. Viral ORFs gag, gag-pol and env encode for proteins. Primer binding site (PBS) is located 
upstream of gag while the poly A sequence is contained in the R region of the 5’ LTR.                  (B)  
viral mRNA is alternatively spliced and by this the three open reading frames give rise to several different 
viral proteins    MA matrix, CA capsid, NC nucleocapsid, PR protease, SU gp120, TM gp41, tat 
transctivator protein, rev regulator of viral protein expression, nef negative factor, vif viral infectivity, vpr 
viral protein R and vpu viral protein U      from (Pluta and Kacprazk 2009) 
 
The 3 longest open reading frames (ORF) gag, gag-pol and env translate into structural 
proteins and enzymes while the smaller central and 3’ ORFs translate into regulatory 
proteins such as tat and rev genes and accessory proteins encoded by vif, vpr, vpu and 
nef (Figure 102). The high number of protein driven by one promoter is achieved by 
alternative splicing of proviral mRNA. By this the HIV virus can reduce the size of its 
genome. Gag polyprotein cleavage yields 6 structural proteins: matrix (MA) responsible 
for transport e.g. of PIC, capsid (CA), nucleocapsid (NC) involved virus processing, 
SP1and SP2 regulating cleavage rate and p6 a regulative factor. gag-pol polyprotein 
cleavage mainly produces enzymes like RT, protease (PR) and IN. env gives rise to the 
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two glycoproteins gp120 (SU) and gp41 (TM) responsible for virus uptake. Purely 
regulatory are the transctivator protein (tat) which initiates transcription from viral 
LTRs and regulator of expression of viral proteins (rev). The last group are accessory 
proteins including negative factor (nef) important in down regulation of CD4 receptor 
and other receptors, viral infectivity (vif) inactivating host immune response, viral 
protein R (vpr) connected to processes such as nuclear import of viral PIC and viral 
protein U (vpu) regulating CD4 receptor, viral particle release and apoptosis (Pluta and 
Kacprzak 2009). 
 
5.1.5 HIV derived Lentiviral vectors 
 
Lentiviruses are highly efficient gene delivery tools suitable for dividing as well as 
quiescent cells. Though these vectors are derived from viruses generating lethal diseases 
they have been refined over the last two decades to provide safe tools. The endeavour to 
make lentiviral vectors safer started in 1990 with replication defective HIV-1 vectors 
(Helseth, Kowalski et al. 1990). In the same year work using lentiviruses as a gene 
delivery tool was published (Page, Landau et al. 1990). Replication defective 
lentiviruses can transduce, integrate genetic material into the host cell, but do not 
produce new infectious particles. A well established system of lentiviral transduction is 
using three vectors a packaging vector, a transfer vector and an envelope vector. The 
principle is to separate trans elements encoding for structural, accessory and enzymatic 
proteins from cis elements required for reverse transcription, integration, RNA synthesis 
and packaging.  
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Genes encoding for structural proteins for formation of infectious particles as well as 
viral enzymes are encoded by the packaging vector. 
For this several elements were replaced, deleted or added. In the packaging vector the 5’ 
LTR is replaced by another promoter such as CMVie immediate early promoter (ie) 
from the cytomegalovirus (CMV) (see Figure 103). Additionally the sequence 
required for packaging was deleted. Poly A signals can be derived from other viruses 
e.g. simian virus 40 (SV40). Further modifications such as LTR and PBS abolished the 
full length viral mRNA to be included into viral particles (Naldini, Blomer et al. 1996). 
The functioning of mRNA processing was maintained by the RRE sequence. The 
development of the 2nd generation packaging vectors which we currently use in the 
Heidenreich group, was initiated by the removal of accessory proteins such as vif, vpr, 
vpu and nef reducing virulence and cytotoxicity while still allowing in vitro virus 
replication (Gibbs, Regier et al. 1994). The final 2nd generation packaging vectors were 
described by several authors 3 to 4 years later (Zufferey, Nagy et al. 1997; Mochizuki, 
Schwartz et al. 1998) and they contained only gagpol, tat and rev ORFs (Fig. 106 A).  
The transfer vector contains the sequence for gene(s) to be expressed and its own 
promoter, surrounded by elements such as PBS, gag, RRE, cPPT/CTS, PPT and LTRs 
(modified) (Naldini, Blomer et al. 1996) needed for reverse transcription, nuclear import, 
integration and packaging. RRE is used to enhance gene transfer efficiency in the 
presence of gag (Clever, Sassetti et al. 1995). A further step in safety was accomplished 
by the development of self inactivation (SIN) vectors by deletion of the U3 region in 
3’LTR (dull et all 1998) while the replacement of 5’LTR U3 by CMV promoter was 
shown to enable tat independent vector cassette expression (Kim, Mitrophanous et al. 
1998). SIN vectors express almost no transcripts and strongly reduce generation of new 
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virus particles in host cells (Bukovsky, Song et al. 1999). As retroviruses preferably 
integrate near promoter or regulatory proteins (Wu, Li et al. 2003) their LTRs 
potentially enhance transcription promoting insertional tumours. Hence the SIN vectors 
provide potentially less harmful viruses and this is supported by the finding that 
genotoxicity mainly depends on active LTRs (Montini, Cesana et al. 2009). Moreover 
they show a different integration behaviour (B Moreno-Carranza, M Gentsch, Gene 
Therapy 2009). 
The envelope vector provides glycoprotein missing on the two other vectors providing 
enhanced specificity towards target cells, reduced sequence homology to wt HIV and 
increasing particle stability enabling virus concentration and storage. The usage of 
heterologous glycoproteins such as gp160  in lentivirus production has been known 
since twenty years (Page, Landau et al. 1990). 
Alike the packaging vector the protein encoding sequence is followed by an pA signal 
and promoted by CMV replacing both LTRs (see Figure 103).  
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Figure 103  The development of lentiviral vectors 
(A) lentiviral packaging vectors. The 2nd generation packaging vectors only encode tat and rev proteins 
and lack the regulatory and accessory proteins from the 1st generation. 3rd generation packaging vectors 
additionally pack the rev sequence in another vector.    (B) Non-SIN vectors have intact 5’ LTR while 
SIN (self inactivating) vectors have a deletion in U3.     (C) Envelope vectors encode for glycoproteins.  
(D) SIN vector RNA of  2nd or 3rd generation systems has a deletion in U3  (E) After integration of (D) 
into host genome the mutated 5’LTR cannot initiate transcription.    CMV, cytomegalovirus immediate-
early promoter; EF1α, human elongation factor 1-α promoter; gag, 5' portion of gag gene containing 
dimerization /packaging signals; PBS, primer binding site; DIS, dimerization signal; SD,splice donor site; 
SA, splice acceptor site; ψ, packaging signal; cPPT, central polypurine tract; CTS, central termination 
sequence; RRE, Rev response element; PPT, polypurine tract; pA, polyadenylation signal; ΔU3, SIN 
deletion in U3 region of 3' LTR; P, internal promoter for transgene expression; WPRE, woodchuck 
hepatitis virus (WHV) post-transcriptional regulatory element      from (Pluta and Kacprzak 2009) 
 
5.1.6 IRES 
 
After viral infection cells often inhibit virus production by a strong reduction in protein 
synthesis (T. Pe’ery and Mathews 2000). To overcome this inhibition viruses have 
developed strategies including the use of an internal ribosome entry site (IRES) 
facilitating initiation of protein synthesis independent of the 5’ end. Nowadays IRES 
sequences a widely used in lentiviral vectors with more than 56 viral and 80 cellular 
IRES sequences characterised (Baird, Turcotte et al. 2006; Mokrejs, Vopalensky et al. 
2006). In SIV it was shown that ribosomes can be recruited to an internal sequence of 
mRNA by the 5’ UTR (Ohlmann, Lopez-Lastra et al. 2000). Experiments have shown 
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that if two ORFs are linked by an IRES the expression of the second ORF is driven by 
IRES enabling and enhancing downstream ORF translation. Even if the expression of 
the upstream ORF is inhibited by interference with an elongation factor (eIF4E) the 
second ORF is still productive (Balvay, Soto Rifo et al. 2009).  
If more than one gene product is to be co-expressed e.g. a marker gene like GFP the 
ORFs can be linked by an Internal ribosomal entry site (IRES).  IRES transcribes for an 
RNA sequence which form a complex 3 dimensional structure interacting with 
ribosome units, cellular initiation and elongation factors (Balvay, Soto Rifo et al. 2009). 
 
5.1.7 WPRE 
 
One of the regulative cis activating elements is WPRE. It consist of woodchuck 
hepatitis virus (WHE) post-transcriptional regulatory element  (PRE) (Zufferey et al., 
1999). The insertion of this element in the 3’ untranslated region of a transcript leads to 
a more than 6 fold increase in overall transgene expression (Oh et al., 2007). 
 
5.1.8 Tet-on 
 
The need for inducible lentiviral gene expression has lead researchers to develop several 
systems to inducibly regulate gene of interest expression with the tet-on system. Like 
tet-on all tet system are derived from prokaryontic components of tet (tetracycline 
resistance) operon. VP16 a viral transactivation element from herpes simplex virus 
(HSC) is fused to a mutated version of the bacterial tetrepressor (tetR) rtetR on which 
the tet system are based. VP16 can strongly activate viral gene transcription (see Figure 
104). 
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A reverse tet-controlled transactivator (rtTA) can bind the tet-responsive element (TRE) 
when complexed to doxycycline (dox), a synthetic tet-analoga. The binding of 
Doxycycline, a drug which can easily be distributed to all tissues e.g. by oral intake, 
induces a conformational change thus inducing gene expression (Gossen, Freundlieb et 
al. 1995) (see Figure 104). Teton systems have also been developed for HIV based 
Lentiviral systems however. One major problem were the high background expression 
levels (Reiser 2000) which would be achieved with the development of SIN 
Lentiviruses (Koponen, Kankkonen et al. 2003). Work has been done to enhance the 
rtTA transcativator furthermore by increasing the induction to background level. This 
was achieved by a different positioning of the tetracycline operator sequences (tetO) 
such as separating the tetOs by 36bp (Agha-Mohammadi, O'Malley et al. 2004). Such 
vectors represent now the 2nd generation of TREs.   
 
Figure 104  Tet-on system 
In the presence of Dox reverse Tet-controlled transactivator (rtTA, mutant version of tTA) binds TRE 
promoter and activates transcription.     P, promoter; TRE, Tet-responsive element; mP, minimal promoter   
from (Pluta and Kacprzak 2009) 
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5.1.9 Two vector system design 
 
Lentiviral vectors are efficient gene delivery tools which can also transduce non-
dividing cells. Since many leukaemic cell lines including the MLL/AF4 positive SEM 
used here are difficult to transfect, lentiviral gene delivery would be an ideal system for 
gene (over) expression in target cells. However anti-proliferative and pro-apoptotic 
genes could counter-select transduced cells before the experiment of interest can be 
performed. An inducible system would overcome these problems, but as many inducible 
systems allow basal gene expression before induction a tighter system was needed. 
The Heidenreich group is establishing a lentiviral two vector system in cooperation with 
Christian Berens (Microbiology University Erlangen-Nuernberg). Vector 1 of this 
system contains a second generation Tet-transactivator stTA2s-M2 linked to the reporter 
gene GFP via IRES. The constitutively active SFFV promoter drives expression of tet 
activator while marking transduced cells with GFP, which allows for the selection of 
positive cells (see Figure 105 A).  
The second vector contains the gene of interest (GOI). Upstream of GOI seven Tet-
operators (tetO) are located. They represent binding sites for the tet transactivator 
expressed by vector 1. Following rtTA binding sites (tetO7) a minimal CMV promoter 
is located. If two genes are to be co-expressed their ORF will be linked over an IRES 
sequence. The positive transduction with vector 2 can be reported by a mCherry 
sequence, coding for a red fluorescent protein which is constitutively expressed by an 
upstream PGK promoter. This PGK promoter should not interfere with the CMV 
promoter (see Figure 105 B). 
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Figure 105  Scheme of Lentiviral two vector system 
Vector 1 contains the SFFV promoter followed by the tet activator (rtTA) -, an IRES- and a GFP 
sequence     Vector 2 contains the tetO promoter followed by the gene of interest, a PKG promoter and a 
mcherry sequence  
 
The following schematic (Figure 106) shows how the 2 vector system would be used to 
provide cells with an inducible GOI expression. 
Target cells are transduced by an HIV based Lentivirus containing vector 1. Transduced 
cells express the rtTA protein constitutively as well as GFP. Positive cells are then 
selected by their GFP positivity either by clone selection in methylcellulose or by 
sorting. Cells transduced for rtTA expression are then transduced a second time with 
vector 2 and selected by the reporter gene, this time mcherry. Doubly transduced cells 
will be expanded and GOI expression is induced by administration of doxycycline 
(DOX) (see Figure 106). The administration of doxycyling derived regulation of gene 
expression can be performed in vitro and in vivo.  
The generation of double transduced highly inducible cells should enable us to 
investigate leukaemic stem cells (LSC) and apoptosis relevant genes without a selective 
pressure by these genes during selection. Moreover clonal artefacts can be excluded by 
further analysis and experimentation. 
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Figure 106  Schematic of the protocol for the lentiviral two vector system 
(Top left) A target cell is infected with vector 1.  (Below) Transduced cells express tet activator and GFP 
used for selection. Selected cells will be further transduced by vector 2 and selected by mCherry (Bottom 
left). By induction with doxycylin tet activator can bind to tet-operator and induce GOI expression (Right)    
GOI gene of interest; Tetact tet activator; tetO tet-operator 
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5.2 Aims 
 
As mentioned in the previous chapter gene functions can be investigated by knockdown 
of the transcript levels which should also affect the corresponding protein levels.  
An alternative approach is to over express the target genes and then assay their effect. 
The most convenient way to achieve this is to transfect cells with an expression vector 
or even to generate clones with a stable expression of a desired protein. Unfortunately, 
MLL/AF4 cells lines such as SEM are not accessible to conventional stable transfection.  
Instead viral expression of target genes is required. Considering that we are also 
interested in leukaemic stem cells, such an expression system must be able to transduce 
quiescent cells. Here, lentiviral systems provide the best option. Furthermore, some of 
the target genes we are interested in may be quite toxic if over-expressed and this would 
eliminate the selection of a target gene transduced clone. For this reason a novel 
lentiviral expression system had to be established which allows tight control of the 
expression of a target gene at a desired time point. Existing systems still allow basal 
expression levels of target genes. Following aims were to investigate the effect and 
functions of those target genes for example in the artificial niche assay described above. 
Furthermore this system is not restricted to analysis of MLL/AF4 target genes, but has 
potentially wide ranging applications in expression analysis.   
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Specific aims: 
 
0. To generate such a system, which allows tight control of target gene expression. 
 
1. To over express MLL/AF4 target genes using lentiviral transduction methods 
and a tetracycline-regulated expression system. 
 
2. To investigate the downstream effects of target gene over-expression on niche 
function and clonogenicity. 
  
Chapter 5 Lentiviral cloning, production and transduction 
232 
 
5.3 Results 
 
5.3.1 Generation of the TetOn Vector  
 
To produce the Teton vector the pUHrT62-1 vector was used as a source for the Tet 
activator sequence. A short sequence was removed upstream of the Tet activator 
element (rtTA2S-M2) and an oligo-linker inserted which provided a novel Asc1 
restriction site in the vector. In parallel, a short sequence between the last 10 bases of 
the SFFV promoter and the IRES element was removed from the lentiviral vector 
pSIEW. The Tet activator sequence was cut out of the pUHrT-oligo vector and inserted 
into SIEW (see Figure 107).    
 
 
Figure 107  Scheme of Lentivirus 1 (Teton vector) cloning 
CMV Cytomegalovirus (promoter), rtTA2S-M2 tet activator, SFFV Spleen focus forming virus 
(promoter), IRES Internal ribosome entry site, AscI  restriction site 
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5.3.2 Cloning of the TetOn vector 
 
 
 
Figure 108  Map of pUHrt62-1 
CMV Cytomegalovirus (promoter),   rtTA2S-M2 tet activator,   bla  Blasticidin resistance, ori-pMB1 ori 
(origin of replication) from pMB1 plasmid 
 
The 4198bp plasmid above (Figure 108) importantly contains an hCMV promoter 
upstream of the tet activator (rtTA2S-M2), followed by an PolyA tail.  
Oligo sequence 
5`-      ggaaggcgcgccagtcctccgag      -3`   
3`-  cgccttccgcgcggtcaggaggctcttaa  -5` 
      SacII   AscI     SFFV      EcoRI 
AscI  SFFV 
   ggcgcgccagtcctccga 
 
The oligo sequence consists of a 3’ protruding end, complementary to a 5’ end of a cut 
SacII sequence upstream of EcoRI (771). This is followed by an AscI restriction site, 
the last 10 base pairs of the SFFV element, which had to be replaced and the 5’ 
protruding end of an EcoRI restriction site. To be able to use the EcoRI restriction site 
in SIEW (see Figure 109) the last 10 bases of SFFV had to be replaced with the oligo so 
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that EcoRI and AscI could be used to cut out the Tet activator sequence and to open 
SIEW for this element. 
  
 
Figure 109  Map of pHR-SINcPPT-SIEW (SIEW) vector 
SFFV  Spleen focus forming virus (promoter), IRES Internal ribosome entry site ,AscI  restriction site, 
5’/3’ LTR Long terminal repeat,  cPPT central polypurine tract, EGFP enhanced Green fluorescent 
protein, RRE Rev-responsive element, WPRE Woodchuck posttranscriptional regulatory element. 
 
pHR-SINcPPT-SIEW
10209 bp
Amp.
EGFP
cPPT
WPRE
3´ -LTR
5´ -LTR
RRE
SP6
IRES
SFFV
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GaG SL4
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The pHR-SINcPPT-SIEW (SIEW) (see Figure 109) lentiviral vector contains an 
ampicillin resistance gene (Amp), an SFFV promoter, an IRES linker element, an EGFP 
reporter gene, and several viral elements like GaG, RRE, cPPT, WPRE and the 5’ and 3’ 
LTRs (Long terminal repeats, the cassette between 5’ and 3’ LTR is integrated into the 
genome of the transfected cell, termed transduction).  
The pUHrT62-1 (Figure 108) plasmid was digested with SacII and EcoRI. Oligo 1 was 
ligated into the open vector. The insertion was confirmed by a restriction digest with 
BamHI and SgsI. For clones with the oligo insertion, expected bands were 3500bp + 
750bp, while the vector without insert was expected at 4200bp of size (see Figure 110). 
 
Figure 110  Restriction analysis of pUHrT62-1 oligo ligation 
pUHrt Oligo ligation clones digested with BAMHI and SgsI 1% agarose gel with digests of 7 clones 
(Lane 1-7) and a 1kb DNA Ladder (Lane 8, Fermentas) 
 
This gel (Figure 110) showed that clones in lane 1, 2, 3 and 6 were positive for the 
oligo1 insert, while lane 4, 5 and 7 showed clones with no insert.  
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The tet activator sequence was excised from pUhrt-oligo1 (Figure 107) with BamHI and 
AscI. The SIEW lentiviral vector (Figure 107) was opened with BamHI and AscI and a 
short fragment removed. The Tet activator sequence was ligated into SIEW. 
To confirm the insertion of this element a control digest was performed using BamHI 
and AscI. Bands were expected at 750bp and 10000bp if the insertion had worked (see 
Figure 111). 
 
Figure 111  Restriction analysis of  Teton vector clone 
A Teton-vector clone was digested with BamHI and AscI. 1% agarose gel with digest of 1 clone (Lane 1) 
and a 1kb DNA Ladder (Lane 2, Fermentas) 
 
The successfully cloned Teton-vector was amplified and stored. 
 
5.3.2.1 Test of the TetOn Vector 
 
To test the functionality of the newly cloned Teton vector our collaborator Vasily 
Grinev has performed an assay using 293T cells. The Teton vector should express the 
Tet activator when transduced. If cells were transduced with pUHG16-3, a TetO driven 
beta-galactosidase expression vector in parallel and induced with doxycycline, cells 
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should have become blue (see Figure 112). The principle is that the induced Tet 
activator binds to TetO (Tet-operator element) and drives downstream expression of the 
reporter-gene β-Gal.  
   
 
Figure 112  Functionality test of vector 1 (Teton vector) 
Performed by Vasily Grinev. 293T cells were transfected with Teton vector (pHR-rtTA, blue columns), 
additionally transfected with pUHG16-6 reporter plasmid (beta-Gal vector + Teton vector, red columns) 
and additionally induced with doxycyline (beta-Gal vector + Teton vector + doxycyline) light green 
columns). Blue cells (β-galactosidase positive) were counted after 1 and after 3 hours of staining. Shown 
is one single experiment. 
 
The diagram (Figure 112) shows that 293T cells transduced with Teton-vector (pHR-
rTA) alone did not produce any blue cells. Cells additionally transduced with the β-Gal 
reporter plasmid (pUHG 16-3) produced 29.4% or 34.8 % stained cells after 1 or 3 
hours of X-Gal staining respectively. If cells were induced with doxycycline the number 
of blue cells rose to 64.6% or 70.4% stained cells after 1 or 3 hours of X-Gal staining 
respectively.  
Although this experiment proved that the Teton vector expresses the Tet activator it had 
some weaknesses. A control with cells only transduced with the β-Gal vector was 
missing to determine the background levels of β-Gal produced by this vector. Secondly 
this assay made it hard to judge when cells were positive or negative. Clearly cells were 
regarded as negative when colourless and positive when deeply blue, but some were 
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yellow to slightly faint blue. Interestingly, this percentage was higher in the cells with 
no doxycycline.  
In conclusion, it can be said that the doubling of stained cells induced by doxycycline  
reflects neither the linearity nor the proportionality of the Tet activator induction. 
Furthermore, doubling of stained cells is not informative with regard to the basal 
expression levels of Tet activator driven genes. 
 
5.3.2.2 Virus generation and transduction of TetOn 
 
SEM and MV4;11 were transduced with Teton virus, a lentivirus containing the Teton 
vector (see Chapter 4). 
 
5.3.2.2.1 Validation of Transduction 
 
The transduction of those cells was checked for the positivity and the intensity of the 
reporter gene GFP. The green shift compared to normal cells was determined by Flow 
cytometric analysis (see Figure 113). 
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Figure 113  Transduction rates of Vector 1 in SEM and MV4;11 
Flow cytometric analysis of SEM (Top row) and MV4;11 (Bottom row)   without (Left histograms) and 
after (Right histograms) Teton vector (vector 1) transduction. The reporter gene GFP was detected in the 
FITC channel and P3 comprised cells with signal strengh above control levels. The efficiencies of the 
primary inductions were 60% (MV411) to 80% (SEM) from a thawed virus. Sorting purities were 80% 
(transduced MV4;11) to 90% (transduced SEM). 
 
These new cell lines were further called SEMTeton or MV4;11Teton cells. 
 
 
5.3.2.2.2 Sorting of Transduced cell populations 
 
Surprisingly, after some weeks of culture, flow cytometry showed that less cells were 
identified as highly GFP positive or GFP positive in total.  
To obtain SEM and MV4;11 with a higher percentage of transduction, transduced cells 
were sorted for GFP expression. Several sorts per cell line were made. After cultivation 
for two weeks cells were analysed by flow cytometry for their GFP expression.  
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Sort were termed 73k or 100k for 73 - or 100 - thousand cells sorted and  k1,2 or 3 were 
fractions of those sorts (see Figure 114, Figure 115 and Table 14; Figure 116 and Table 
15). 
 
Figure 114  MV4;11 as negative control for transduction 
Flow cytometric analysis of normal MV4;11   (Left) SSC-FSC dot-plot with set p1 gate   (Right) count-
FITC histogram with p2 (GFP negative) and p3 gate. 
 
  A                                 B                                   C                              D 
 
  i. 
 
  ii. 
 
 iii. 
Figure 115  Sorts of Teton transduced MV4;11 
Flow cytometric analysis of Teton vector transduced MV4;11 sorted for GFP expression   (A and C) 
SSC-FSC dot-plot with set p1 gate   (B and D) count-FITC histogram with p2 (GFP negative) and p3 
(GFP positive) gate.    (Row i.)  sorts 73k1 (A + B) and 73k2 (C + D),   (Row ii.) sorts 73k3 (A + B) and 
100k1 (C + D) and    (Row iii.) sorts 100k2 (A + B) and 100k3 (C + D)   73k/100k 73/100 thousand cells 
sorted, k1/2/3 fraction of those sorts 
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Purity   %  sort 
0.2  MV4;11 control
89.2  73k1 
92.4  73k2 
89.8  73k3 
88.2  100k1 
86.8  100k2 
87.8  100k3 
Table 14  GFP positivity of different MV4;11 sorts 
GFP positivity (purity) of different sorts and control MV4;11 
 
The sorts of MV4;11Teton resulted in different patterns of GFP-intensity distribution 
but similar purities from 87% to 92 %.  Especially the sort 73k2 resulted in a high purity 
and a distribution with mostly high GFP expression.  
Figure 116  GFP positivity SEM and sorted SEMTeton 
(i and iii) SSC-FSC dot-plot with set p1 gate   (ii and iiii) count-FITC histogram with p2 (GFP negative) 
and p3 (GFP positive) gate.    (A) Flow cytometric analysis of normal SEM (i + ii) and Teton vector 
transduced SEMs sort 1a (iii + iiii)     (B) Flow cytometric analysis of Teton vector transduced SEM, the 
diagrams show sorts 1b (i + ii) and 1c (iii and iiii). 
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Purity   %  sort 
0.2  SEM control 
91.6  1a 
90.9  1b 
98.1  1c 
Table 15  GFP positivity of SEMTeton 
GFP positivity (purity) of different sorts and control SEM. 
 
The SEMTeton sorts resulted in high purities of nearly 100% (Table 15) but medium 
levels of GFP expression. Compared to the MV4;11Teton sorts (Figure 115) the 
SEMTeton sorts were more homogenous with less distribution in GFP expression.  
All sorts were expanded and stored in liquid nitrogen. 
 
5.3.2.2.3 Test for accessibility of MLL/AF4 Knockdown 
 
The Teton cells were of interest for experiments on feeders. To prove that the tet 
activator or the transduction itself had no influence on the transcript levels or the ability 
to knock down, native SEM and SEMTeton were treated with siMA6 and siAGF1 and 
the transcript levels were analysed 2 days after treatment.  
The transcript levels of MLL/AF4 were depleted comparably in the native SEM and the 
SEMTeton. The Ct values of the MLL/AF4 amplicons were in a comparable range for 
SEM (21 to 22.7) and SEMTeton (20.5 to 21.7). This data proved that the transduction 
did not influence the applicability for such experiments (see Chapter 4).  
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5.3.2.2.4 Test on bone marrow feeders 
 
As already shown in chapter 4 (chapter 4.3.3.2) SEMTeton were tested on M210B4. 
Also transcript-level analysis showed that SEMTeton behaved comparably to native 
SEM. 
 
5.3.2.2.5 Test of clonogenicity 
 
SEMTeton and MV4;11Teton were seeded in methylcellulose colony formation assays. 
Although they showed high proliferation no CFU could be determined due to technical 
problems, such as colony stability (the cells don’t stick together as a normal colony) and 
time restrictions.  
 
5.3.3 Cloning of expression vector 
 
The cloning of the 2nd vector of the bi-vector system relied on a more demanding 
strategy. It was planned to use the ptre-tight vector which contains the tetO element, 
insert the PGK promoter from the pWHE vector and downstream of this insert the 
cherry sequence from pcDNA3 cherry. This cassette would then be inserted into the 
lentiviral vector SIEW, which had been depleted for GFP beforehand (see Figure 117 
and Figure 118). The resulting vector could be used to clone in genes of interest.  
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Figure 117  Cloning of the Tet-PGK-cherry cassette 
PGK Phospho glycerine kinase (promoter), TetO7 Tet operator (promoter), SV40 Simian virus 40 (poly 
A), cherry  mCherry (red fluorescent protein) 
 
 
Figure 118  Scheme of  SIEW-Tre-PGK-cherry cloning 
SFFV  Spleen focus forming virus (promoter), IRES Internal ribosome entry site, AatII/AFlII  restriction 
sites, EGFP enhanced Green fluorescent protein, WPRE Woodchuck posttranscriptional regulatory 
element, PGK Phospho glycerine kinase (promoter), TetO7 Tet operator (promoter), SV40 Simian virus 
40 (poly A), cherry  mCherry (red fluorescent protein) 
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Figure 119  Map of pTRE-Tight vector 
tetO2 operator repeats, TRE tet responsive element, CMV Cytomegalovirus (promoter), min minimal, 
MCS Multiple cloning site, ColE1 C olicinogenic factor El 
 
 
Figure 120  Map of pWHE1105 vector 
PGK Phosphoglycerine kinase (promoter), bla Blasticidin resistance, ColE1 C olicinogenic factor El, 
tkneo tymidine kinse neomycin resistance gene 
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Figure 121  Map of pTre-PGK vector 
(In colour) restriction sites,  (Red)   one cutters, green two cutters,  (Blue) three cutters   tetO 1-389bp, 
PGK 388- 943bp 
 
 
Figure 122  Map of pcDNA3.1-mcherry vector 
SV40 Simian virus 40; pA (poly A) and ori (origin), cherry  mCherry (red fluorescent protein)  CMV 
Cytomegalovirus (promoter),  Amp Ampicillin resistance gene, BGH pA Bovine Growth Hormone and 
Polyadenylation signal, Zeocin   Zeocin (antibiotic) resistance gene  
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Figure 123  Map of pTre-PGK-cherry vector (PPC) 
(In colour) restriction sites,   (Blue) one cutters,   (Red)  two cutters, green three cutters    tetO 1-388bp, 
PGK 388- 943bp,  mCherry 988-1724bp 
 
 
To retrieve the PGK element it was cut out from the pWHE plasmid (Figure 120) using 
HindIII. In parallel, the pTre vector (Figure 119) was opened with HindIII. Next PGK 
fragment was ligated into the open pTre vector. To check the resultant clones, a control 
digest using PstI and PvuI was performed. For the correct product, bands were expected 
at 1600bp, as a double band, while vector without insert should have led to a 2600bp 
fragment (see Figure 121 and Figure 124). 
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Figure 124  Restriction digest of  pTre-PGK clones 
The pTre-PGK ligation clones were digested with PstI and PvuI separated and analyzed in an 1% agarose 
gel.   (Lane 1) undigested Plasmid,  (Lane 2) digested and  (Lane 3) 1-kb Marker Fermentas  
 
The gel (Figure 124) shows a clone with the pTre vector plus the PGK insertion, called 
pTre-PGK. 
Next the Cherry sequence was cut out of the pcDNA3.1-cherry plasmid (see Figure 122) 
using EcoRV and PmeI. The previously generated pTre-PGK plasmid was opened with 
EcoRV and the cherry fragment blunt end ligated into it. To confirm the insertion and 
the right orientation of the cherry sequence generated clones were digested with EcoRV 
and XbaI, leading to expected bands of 782bp and 3156bp at the right orientation (see 
Figure 123 and Figure 125). 
Chapter 5 Lentiviral cloning, production and transduction 
249 
 
 
Figure 125  Restriction digest of pTre-PGK cherry clones 
pTre-PGK cherry clones were digested with EcoRV and XbaI, run and analyzed  
in a 1% agarose gel.   (Lane 2-11)  pTre-PGK-cherry ligation clones and  (Lane 1) 
1-kb Marker Fermentas  
 
 
Positive clones were found in Lane 3,7 and 11 (Figure 125).  
The digest shown above proved that the pTre-PGK-cherry plasmid with the desired PPC 
cassette (tetO-PGK-cherry) was successfully cloned.  
Unfortunately, despite several strategies using different vector backbones such as 
p156RRLsinPPTCMV-GFP-PRE/NheI, it was not possible to clone the pTre-PGK-
cherry cassette into a lenti-viral vector. The 2 vector system could not be finished in this 
PhD project due to time restrictions. 
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5.4 Discussion lentiviral results 
 
The aim of this project was to develop and clone a novel tightly regulated lentiviral 
expression system able to transduce both proliferating and resting cells and allowing 
tight control led expression of MLL/AF4 target genes in order to investigate their 
functions. The design is based on a two vector system: a tet activator coding vector 
(Vector 1, Teton) and an inducible expression vector (Vector 2) (Figure 104).  
The cloning of Vector 1 (Teton) used the pSIEW vector backbone, a lentiviral SIN 
vector with an eGFP reporter following an IRES sequence (Figure 109), and the tet 
activator coding elements from the pUHrt vector (Figure 108). Before insertion of the 
tet activator coding sequence into the pSIEW backbone the required restriction sites 
were cloned into pUHRT via introduction of an oligo-nucleotide sequence. The cloning 
was confirmed by a control digest showing the insertion of the tet activator sequence 
(Figure 110 and Figure 111). 
The functionality of Vector 1(Teton) was tested in our group by Vasily Grinev. 293T 
cells were transfected with the teton vector alone or co-transfected with the reporter 
plasmid pUHG16-6 providing the tetO elements which on binding by the tet activator 
drive expression of beta-Galactosidase. Beta-Galactosidase is an enzyme which 
metabolizes the substrate X-Gal into a insoluble blue indigo dye. As expected cells only 
transduced with the Teton vector did not generate blue cells. Co-transfected cells 
induced with doxycycline showed approximately 30% of blue cells, increasing to over 
60% when doxycycline had been provided to the cells (Figure 112). The proportion of 
blue cells was slightly higher after 3 hours of staining compared to 1h while singly 
transfected cells showed no blue staining. Overall these results showed that the cloned 
Vector 1 is functional and inducible. However two findings were surprising: the high 
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level of background reporter-gene activity without doxycycline induction and the low 
fold change (>2fold) by induction. To understand this several parameters have to be 
considered: the test relied on counting of blue cells by eye, but there is no clear 
distinction into unstained or blue. Cells are stained from slightly yellow, light turquoise 
to blue. The experimentator had to decide which cells are counted as positive. So all the 
cells less than intense blue might have a weak expression of the tet activator, but are 
still positive for it. Also, from a certain intensity of blue there is no eye discrimination 
of more intense staining.  
In concordance to this, there were more deep blue cells in the group with doxycyline 
than in the group without. As such the whole range of tet activator driven reporter gene 
expression is compressed into a small level of response, so that the differences seen 
between with and without doxycycline induction do not correlate to a linear response. 
Concerning the high basal levels of X-Gal staining, this experiment lacks a reporter 
vector control to see the basal level of beta-galactosidase activity of the reporter vector 
without the presence of the tet activator. Finally, as doxycycline is known to be present 
in FCS from USA, it is possible that small amounts of doxycycline might result in the 
basal activity in the doxycycline negative group. In conclusion these results can only 
state that the vector is functional in tet activator expression and inducibility. 
A superior reporter system to quantify the inducibility of the Teton vector would be a 
tet-operator-driven luciferase system. Luciferase activity quantifiable read out of the 
signal strength, providing a linear range of doxycyline-mediated tet activator expression 
of the Teton vector. 
The t(4;11) positive cell lines SEM and MV4;11 were transduced with this Teton vector 
by spinocculation. Analysis by flow cytometry of the reporter gene eGFP showed 
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transduction rates of 60 to 80% (Figure 113), but as these dropped over several weeks 
transduced cells were sorted to retrieve cells with high percentage of transduction. The 
sorting related purities were ~ 90% for MV4;11Teton and up to 98% for SEMTeton 
(Table 14 and Table 15). However, cells still dropped slightly in eGFP expression over 
several weeks. To overcome this, aliquots of these highly pure, sorted cells were 
stocked in liquid nitrogen to provide highly positive Teton cells for experiments. As it 
seems very unlikely that previously integrated constructs disintegrate in these cells, the 
most likely cause for this must be a growth advantage of non–transduced cells to 
transduced ones. This would rise the question if high copy numbers of tet activator 
could be toxic or disadvantageous for the growth of cells. There were reports that high 
levels of tet activator can be toxic to mammalian cells (Gossen and Bujard 1992) and 
this effect was associated to reduced surfactant mRNA accumulation observed in rtTA 
induced mice and suggested to generate a “synthetic lethality” if  other genetic 
alterations are present (Morimoto and Kopan 2009). 
As previously shown (see chapter 4), Teton transduced SEM cells are still accessible to 
siRNA-mediated MLL/AF4 depletion to the same degree as non transduced SEM cells, 
making them suitable for any type of RNAi MLL/AF4 studying experiments. As 
previously shown they are suitable to test and develop the feeder interaction assay. 
There has been ongoing work on the functions of tet activators; especially challenging 
are approaches aiming to regulate several genes simultaneously including tet-repressor. 
Such a modification of the tet-activatior was to express it as a single chain molecule, 
reducing interference with other tet activation or repression molecules (Krueger, Berens 
et al. 2003; Zhou, Symons et al. 2007). 
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The cloning of the second vector of the two vector system, vector 2, consisted of several 
steps. First, it was required to generate an expression cassette for the cherry reporter 
gene, consisting of the cherry ORF under the control of a PGK promoter. Upstream of 
these elements the cassette should contain a MCS, providing an insertion site for ORF 
of target genes to be expressed. These elements had to be under the regulation of the tet-
O promoter (tet responsive promoter) (Figure 117 and Figure 118). 
The pTre tight vector was used as a backbone; it contained the tetO element with seven 
tet activator binding sites and a minimal CMV promoter. The PGK promoter is a 
relatively weak promoter which was used because it hardly influences the inducibility of 
the neighbouring tet responsive promotor. The sequence was retrieved from the pWHE-
vector and the cherry reporter gene from the pcDNA3-mcherry plasmid. Successful 
cloning was confirmed by restriction analysis. In order to test the functionality the ORF 
of the luciferase gene was cloned into the MCS of the generated cassette. However the 
introduction of this luciferase sequence brought new restriction sites into the cassette 
such as BsrGI, XhoI and HindIII which handicapped a sub sequential lentiviral vector 
insertion strategy.  
The second finalising part comprised the removal of the SFFV promoter - IRES - eGFP 
cassette from the SIEW vector and the insertion of the ptre-pgk-cherry (ppc) cassette. 
As the to be inserted cassette contained mCherry and as the sequential transduction of 
the two vectors relied on two different reporter genes, GFP in Vector 1 and mCherry in 
Vector 2, GFP had to be removed from the lentiviral host vector. But also the 
constitutive promoter SFFV and the IRES sequence, which can start translation 
independent of the SFFV promoter had to be removed. To provide the restriction sites 
corresponding to the ones flanking the ppc cassette, an oligo-nucleotide sequence was 
cloned and inserted into the SIEW vector after removal of the SFFV-IRES-eGFP 
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cassette. Unfortunately the restriction sequences originally planned were already present 
in the SIEW vector, although not stated as such in the vector map.  
Several alternative strategies using different oligo-nucleotides and different restriction 
enzymes for insertion; finally the use of two other lentiviral vectors as backbones did 
not succeed in inserting this ppc cassette. Due to time restrictions the final cloning step 
could not be finished.  
One of the possible explanations for this might be the size of the cassette and the final 
size of the lentiviral vector, which would be exceeding 12000bp. It is known that the 
cloning of large vectors is difficult. Such a vector could be less stable or produce 
physical tensions which handicap ligation into such a full size vector.  
A new method of cloning, the Gateway technology (Invitogen), does not require 
restriction enzymes, ligation, subcloning steps, or screening of colonies thereby 
accelerating cloning and increasing the likeliness of success. This system makes use of 
a reversible recombination reaction. It could be use for cloning of such large cassettes.  
The two vector lentiviral expression system will be used for the investigation of target 
genes in the future after being completed by my successors.  
The field of inducible gene expression is still progressing. Several tet activator variants 
were designed over the years, achieving reduced basal expression and increased 
sensitivity to doxycycline from 1000 ng /ml for the rtTA2S-S2 to only 10 ng /ml; such 
improved variants are rtTA-V14, -V15 and -V16 (Zhou, Vink et al. 2006). 
 
In conclusion, lentiviral inducible gene expression is a powerful tool in investigating 
target gene or protein function, but also in a more physiological context. Lentiviral Tet-
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On regulated expression was applied to bone marrow MSCs and HSCs. The 
implantation of those transduced cells into bone marrow was implicated for the 
treatment of diseases where certain protein over- expression is beneficial (Aguilar, 
Scotton et al. 2009) this could be used to either over express antagonist of MLL/AF4 
and target genes or deplete target genes by shRNA in blood cells. Lentiviral 
transduction can help to investigate the biology of MLL/AF4 or even be a therapeutic 
option. 
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Chapter 6 Mouse work 
 
6.1 Introduction: mouse models for leukaemia 
 
6.1.1 SCID 
 
In 1976 attempts to establish mouse models for leukaemia by s.c. injection of myeloid 
or lymphoid cell lines and primary material into nude mice produced myelosarcomas 
and solid tumours, but no leukaemia (Lozzio, Machado et al. 1976). In 1983 the SCID 
(severe combined immunodeficient) mouse model with deficient immunity was reported 
(Bosma and Carroll 1991). SCID mice cannot express rearranged antigen receptors 
(Lieber, Hesse et al. 1988; Malynn, Blackwell et al. 1988) due to an autosomal 
recessive mutation on chromosome 16 leading to a lack of functional B and T 
lymphocytes (Bosma and Carroll 1991). Genetically the recessive mutation on 
chromosome 16 is responsible for deficient activity of an enzyme involved in DNA 
repair. The humoral and cellular immune system cannot mature, because V(D)J 
recombination does not take place. Besides the impaired ability to make T or B 
lymphocytes they are also impaired in activating components of the complement system. 
This impaired immune system makes them especially vulnerable to infections but the 
main advantage is that they cannot reject tumors and transplants. The first successful 
engraftment of human stem cells in SCID mice was published in 1988 (McCune, 
Namikawa et al. 1988).  
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6.1.2 NOD SCID 
 
The NOD/SCID mouse strain was generated by crossing the SCID mouse with the NOD 
(non obese diabetic) mouse strain. NOD mice were originally used as a model for 
diabetes 1 which is generated in these mice by T-cell mediated destruction of the 
pancreas. This defect is generated by a spontaneous mutation. Additionally, NOD mice 
have defects in natural killer (NK) cells and in the complement system and therefore an 
impaired immune system (Shultz, Schweitzer et al. 1995). By combining these NOD 
and SCID backgrounds a mouse strain lacking B- and  T-cells and showing reduced NK 
function was generated and shown to be superior to the SCID strain in the modelling of 
lymphoid malignancy (Hudson, Li et al. 1998). However NOD mice are sometimes 
used for xenografts because of the low residual immunity, but to avoid rejection of 
transplant additional treatment is required such as anti-NK treatment (Taussig, Miraki-
Moud et al. 2008). In contrast to these advantages NOD/SCID mice have a high 
incidence of thymic lymphomas, which are produced by the reactivation of a murine 
provirus, shortening the lifespan of NOD/SCID mice to an average of 8.5 months. 
Therefore NOD/SCID mice are not the ideal host for xenografts (Chiu, Ivakine et al. 
2002) as the engraftment of leukaemic cells may require more time and events may be 
missed due to the short life-span of the mice. 
 
6.1.3 NSG 
 
The NOD/SCID mouse strain was further improved by knocking out IL2 receptor 
gamma chain. This depleted low immunity of NOD/SCID mice even more as NK cells 
were removed (Shultz, Lyons et al. 2005). The idea for this was based on the finding of 
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increased engraftment in NOD/SCID mice when treated with antibodies against NK 
cells (Shultz, Banuelos et al. 2003). So far these NOD/SCID/IL2R mice (NSG) are most 
widely used to engraft primary human cells with low levels of graft rejection. Moreover 
NSG mice also do not require irradiation before transplant because they lack 
lymphocytes (Vormoor, Lapidot et al. 1994). Irradiation of NOD/SCID mice was 
performed to get rid of mouse lymphoid cells which could compete with transplanted 
human lymphoid cells. 
Finally NSG mice also do not have a predisposition to developing thymic lymphomas, 
which the NOD/SCID strain does. Viral reactivation causing those lymphomas is 
prevented by the impaired interleukin signalling. NSG mice therefore have a lifespan of 
more than 15 months (Ishikawa, Yasukawa et al. 2005).  
 
6.1.4 Rag2 knockout mice 
 
Rag2 knockout mice mice bear a knock out for the Rag2 gene. Recombination active 
gene 2 (Rag 2) is a single exon gene (Oettinger, Schatz et al. 1990) that confers V(D)J 
rearrangement by recombination and was isolated in 1989 (Schatz, Oettinger et al. 
1989). In thymus and precursor B-cells a high Rag2 expression was found (Schatz, 
Oettinger et al. 1989). A mouse model was created with a germline mutation in the rag 
gene which aimed to block the production of the functional protein. No mature B or T 
cells were found in homozygous Rag2 knockout mice mice showing a SCID phenotype 
(Shinkai, Rathbun et al. 1992). Furthermore Shinkai et al could show that only 
lymphocyte development is affected by the deletion of the Rag2 gene product (Shinkai, 
Rathbun et al. 1992). 
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6.1.5 R2G 
 
Rag2 gamma c double knockout (R2G) mice have reduced peripheral B and T 
lymphocytes and no NK activity  due to gamma c gene (common cytokine receptor 
gamma chain) deletion (Goldman, Blundell et al. 1998). The development of an 
adaptive immune system by CD34+ cord blood cell injection into R2G mice could be 
shown for the first time by Traggiai et al. (Traggiai, Chicha et al. 2004). This was 
accomplished by intra hepatic (i.h.) injection of CD34+ cord blood cells, which are 
haematopoietic high repopulation active cells, into newborn R2G mice. As the liver 
facilitates perinatal haematopoiesis it is more suitable to provide an environment for 
stem and progenitor cells of haematopoiesis. This interaction possibly improves 
engraftment in the liver, expansion of the precursors and reconstitution of the immune 
system (Traggiai, Chicha et al. 2004).   
 
6.1.6 The use of mouse models for studying leukaemia 
 
The process of engraftment was thought to be dependent on accessory cells or cytokine 
treatment early after transplantation besides pluripotent stem cells. This was observed as 
injection of limited dilutions of special cord blood or AML cells required co-
transplantation of accessory cells or cytokine treatment, unlike in higher cell doses 
(Bonnet, Bhatia et al. 1999). 
The importance of CD133 expression in ALL blasts along with a primitive phenotype 
was found to be important in engrafted NOD/SCID mice as these cells showed long-
term in vivo proliferation (Cox, Diamanti et al. 2009). 
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Evidence that gender associated factors could influence self-renewal, proliferation and 
survival of engrafted cells was provided by injection of human HSCs into NSG mice 
which showed higher engraftment in female mice (Notta, Doulatov et al. 2010). 
Engraftment of flow sorted ALL patient cells to pick populations with certain surface 
expression profiles, proved to be difficult. To overcome this the Heidenreich group and 
collaborators have refined the protocol by engrafting directly after sorting, using a non 
irradiated NSG mice and implementation of intra-femoral injection (see Figure 126) 
which alone increases the stem cell assay sensitivity by tenfold compared to i.v. 
injection (Mazurier, Doedens et al. 2003). Mazurier et al. found so called rapid-SCID 
repopulating cells (R-SRC) in the CD34+CD38lowCD36- compartment of human bone 
marrow (Mazurier, Doedens et al. 2003). Intra femoral injection is often called an 
orthotopic technique because the cells to be engrafted are transplanted into their natural 
environment, the bone marrow, which was thought to improve engraftment.  
By using limiting dilutions of sorted blast populations of haematopoietic stemness and 
lymphoid lineage commitment markers the Vormoor / Heidenreich group and 
collaborators demonstrated that all sorted populations could produce leukaemia in NSG 
mice, also after secondary and tertiary transplant (le Viseur, Hotfilder et al. 2008).  
 
Figure 126  Intra-femoral injection (i.f.) into a mouse 
Xray  image of intra femoral injection position with a mouse leg shown.   personal communication from 
le Viseur, C 
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A similar finding was reported by Kong et al. who used NOD/SCID/IL2rcnull mice for 
the engraftment of B-cell ALL cells from 3 young patients of whom two had MLL 
rearrangements. They could establish leukaemia with populations of different maturity 
(CD38 +/- , CD34+,Cd19+) leading them to new conclusions about the LIC hierarchy in 
ALL (Kong, Yoshida et al. 2008).  
As t(4;11) leukaemic cells showed a hemangioblast phenotype expression profile 
(Armstrong SA, Staunton JE, 2002) and due to the ability of the hemangioblast to 
contribute to haematopoietic and endothelial lineages, a model suggesting t(4;11) 
leukaemias could supply cells for angiogenesis was proposed. To verify this model 
NOD/SCID mice were xeno-transplanted with t(4;11) cells. But tumour supplying 
vessels only contained murine cells. Together with angiogenesis involved expression 
profiles such as Tie1, the Ang1 receptor, they concluded that t(4;11) cells promote 
angiogenesis by cytokines and receptors (Hu, Li et al. 2009). 
The NOD/SCID model can also be used for gene expression profiling of ALL infiltrated 
tissues requiring high engraftment. The transcriptional profiles were species specific 
and reproducible making it a suitable model for xenotransplant expression profiling 
(Samuels, Peeva et al. 2010).  
Further injection types were described to engraft ALL cells in SCID mice. 
In 2009 a test model linking the aggressiveness of nodule growth to the clinical 
outcome of patients was published. Subcutaneous (s.c.) injections of patient ALL and 
AML blast cells were used and the growth of s.c. tumours compared to the clinical data, 
showing that the more aggressive the growth pattern of the s.c. SCID tumours, the 
poorer the outcome in patients (Yan, Wieman et al. 2009). 
Chapter 6 Mouse work 
263 
 
A successful engraftment of patient adult ALL using intrahepatic injection into 
unirradiated newborn NOD/SCID mice was reported in 2009. Cells from 5 of 13 ALL 
patients engrafted after 6-18 weeks. Interestingly the levels of bone marrow engraftment 
were linked to those in peripheral blood (Cheung, Fung et al. 2010). 
 
For more than 15 years the SCID mouse models were the standard model for studying 
leukaemia. Most importantly they proved to be of clinical relevance as for instance 
relapsed and high risk ALL showed better propagation in them (Kamel-Reid, Letarte et 
al. 1991). 
The R2G model has been used by our own group to investigate AML/MTG8 
translocation derived AML. An AML/MTG8 positive AML cell line (Kasumi-1) was 
injected into the liver of irradiated newborn R2G mice inducing human tumour 
formation in 53 to 55 days. Knockdown of the fusion gene prior to engraftment 
increased median survival from 50 (controls) to 73days (fusion gene knockdown) with 
all controls showing tumours while a part of the knockdown group did not develop 
tumours. Reducing the number of injected cells and usage of non irradiated newborn 
mice increased median survival from 64 (controls) to 90 days (fusion gene knockdown). 
This proved to be a suitable xenotransplantation model (Martinez Soria, Tussiwand et al. 
2009).   
Later the Vormoor/Heidenreich group compared different injections of ALL cells in 
R2G mice by i.f. injection resulting in bone marrow engraftment (unpublished work, 
Klaus Rehe). 
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By injection of SEM (ALL) intra-hepatically into R2G mice engraftment and tumour 
formation could be achieved within 2 months (unpublished work, Lars Buechler and 
Mike Batey). 
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6.1.7 Imaging 
 
Although already isolated in the 60s, GFP, a green fluorescent protein (see Figure 127), 
was first cloned and sequenced in 1992 by Douglash Prasher (Prasher, Eckenrode et al. 
1992). In 2008 the Nobel Prize was dedicated to 3 researchers for the discovery of GFP. 
Since then several improvements have been achieved such as optimising the spectrum 
until enhanced GFP (eGFP) was developed (see diagram below). 
  
Figure 127  GFP fluorescence 
from nobelprize.org/.../laureates/2008/illpres.html 
 
Several colour mutants such as EBFP (Blue fluorescent protein) and YFP (yellow 
fluorescent protein) have been generated since. Dsred another fluorescent protein, 
isolated from corals and emitting a much longer wavelength, was discovered 1999 
(Matz, Fradkov et al. 1999). Dsred fluorescence penetrates tissue effectively. Recently 
lentiviral induction of a dsred involved fluorescent protein was used to track pancreatic 
cancer cells in in-vivo imaging (Zhou, Yu et al. 2009).  
Nowadays fluorescent proteins in general are in wide use to label biological objects 
from a relatively small protein to tissues or even whole organisms. They serve as 
Chapter 6 Mouse work 
266 
 
marker or reporter genes for fluorescent microscopy, flow cytometry analysis, sorting, 
in vivo imaging and most recently live recording. 
Xie Y et al were tracing GFP labelled HSCs in NOD/SCID engrafted mice, which 
preferably localised in the trabecular regions of the inner bone, were the bone marrow 
niche is agreed to be localized. They observed that in well avasculated endosteum 
vessels tend to be found near N-cadherin positive osteoblasts (Xie, Yin et al. 2009). 
An ultimate implementation of in vivo imaging in SCID mice was performed by 
tracking fluorescent labelled pre-B ALL cells homing into the bone marrow niche and 
perivascular niches. The researchers presented real-time videos of LSCs moving into the 
cranial bone marrow. This work showed that stem cell factor (SCF) secreted by 
leukaemic cells is important in the manipulation of niches or creation of malignant 
niches (Colmone, Amorim et al. 2008).  
Overall, using mouse models and live imaging for investigating leukaemia will be an 
important tool to increase the understanding of the biology of this malignancy. 
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6.2 Aims 
 
In the previous chapters the functions of MLL/AF4 in the establishment and 
maintenance of acute lymphoblastic leukaemia were investigated. The majority of the 
work was performed using in vitro cell culture. To complement cell culture systems, 
interactions were investigated in an in vivo system including several mouse models. The 
ability to engraft and the time until the development of clinical disease provide 
important information about the disease and the relevance to model cell lines. Another 
aim was to establish a monitoring system for the behaviour of those leukaemic cells in 
the mouse, to see how those cells distribute in the organism and in which organs or 
tissues they first start to form tumours. 
 
Specific Aims: 
 
1. To investigate in vivo effects of MLL/AF4 in addition to cell line data 
 
2. To establish an in vivo monitoring system for engraftment of leukaemic cells 
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6.3 Results mouse work 
 
6.3.1 SCID mice i.f. injections with early SEM 
 
6.3.1.1 Flow cytometric analysis 
 
Early or primary SEM are peripheral blood lymphoblasts from a 5 year old female 
patient with ALL at relapse. These cells were used to establish the cell line SEM (Greil 
J et al. 1994). Primary SEM are an early passage of patient cells but unlike the cell line 
SEM, primary SEM are slowly proliferating and more dependent on growth factors. 
3 NSG mice and 3 R2G mice had been injected i.f. in 3 cell numbers with primary SEM 
cells. Two of the NSG mice with the highest doses died before a sample could be taken. 
1 NSG mouse (see Figure 131 and Figure 132) and 2 R2G mice (see Figure 128 and 
Figure 129) were sacrificed one month after injection. Blood was taken by cardiac 
puncture whilst bone marrow was isolated by dissecting out the femurs and flushing out 
the bone marrow. 
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Figure 128  Early SEM and engraftment in R2G mice 
Flow cytometry of early SEM   (A) Peripheral blood of a R2G mouse transplanted with early SEM, 0.0 % 
engraftment of early SEM in peripheral blood     (B) Bone marrow of a R2G mouse transplanted with 
early SEM, 0.2 % engraftment of early SEM in bone marrow of an R2G mouse   (C) Early SEM control, 
Early SEM from culture were used as a control for flow cytometry.  Shown are dotplots of CD19 
expression (y-axis) against CD34(Left)  and CD133(Right) expression (x-axis).  PB peripheral blood   
BM Bone marrow  
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This R2G mouse (Figure 128) showed low engraftment of early SEM in bone marrow 
and low numbers in peripheral blood. The peripheral blood analysis used many more 
cells than the bone marrow analysis, resulting in more cells in the dot plot. Despite this, 
engrafted leukaemic cellsmade up only a small proportion of all cells analysed. The 
strategy for distinguishing mouse lymphocytes from human was to gate out mouse cells 
using two murine specific antibodies. To ensure there was no overlap of mouse cells 
into the “human” gate, the thresholds for distinguishing these two populations were set 
quite rigidly. However this leads to a potential loss of human cells. As seen in Figure 
134 control early SEM are high in CD19 a B-lymphocyte marker and CD133 a stem cell 
marker. SEM are usually low in CD34 another stem cell marker. As the engraftment 
numbers of early SEM were so low, it could be they were harvested too early. 
The 2nd R2G mouse had an abdominal tumour. The spleen was slightly enlarged to 
1.6cm length, but still dark red with 120mg of weight.  
The blood and the bone marrow samples, and primary SEMs as a control, were labelled 
for CD19, CD34, CD133, and anti-mouse antibodies to gate mouse lymphocytes out 
(Figure 129). 
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Figure 129  Bone marrow of a 2nd transplanted R2G mouse 
An R2G mouse was transplanted with early SEM. The flow cytometric analysis showed 0.1% 
engraftment of early SEM in bone marrow of an R2G mouse. Shown are dotplots of CD19 expression (y-
axis) against CD34 (Left)   and CD133 (Right)  expression (x-axis). BM bone marrow  
 
Surprisingly the engrafted early SEM showed a second population high in CD34, which 
was not present in control early SEMs. 
 
 
Figure 130  Early SEM control 2 
Early SEM were used as a control for setting gates and to control expression patterns.  (Top) Histogram 
showing set of mouse gate (P2, gated out) and human gate (P1, gate in) with the mouse antibodies 
fluorescence in the PE-Cy7 channel.    (Below) Shown are dotplots of CD19 expression (y-axis, APC) 
against (x-axis)   (Left) CD34 (FITC channel) and   (Right) CD133 (PE channel) expression.  
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As seen before, the early SEM control (Figure 130) showed no second CD34 high 
population. 
The engraftment analysis of the 2nd R2G mouse (Figure 129) showed low engraftment 
again, although the SEM profile was clearly visible. A control using early SEM cells, 
labelled identically to the engrafted cells, showed that 82% of control early SEM were 
detected in the non-mouse gate (P1). It seems likely that the time allowed for 
engraftment in this experiment was too short.  
The NSG mouse spleen was substantially enlarged measuring approximately 5cm long 
and 1cm wide (see Figure 133). The mouse also had a large rubbery tumour at the back 
of the femur and an enlarged unfilled bladder. The spleen and tumour were removed. 
White blood cells were isolated from the blood and the bone marrow (Figure 131 and 
Figure 132). 
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Figure 131  Peripheral blood of a transplanted NSG mouse 
An NSG mouse transplanted with early SEM. The analysis showed that at least 36% of peripheral blood 
cells were early SEM.   (Top) Histogram showing set of mouse gate (P2, gated out) and human gate (P1, 
gate in) with the mouse antibodies fluorescence in the PE-Cy7 channel.  (Below) Dotplots of CD19 
expression (y-axis) against CD34 (Left)  and CD133(Right) expression (x-axis).  PB peripheral blood 
 
 
 
Figure 132  Bone marrow of a NSG mouse 
An NSG mouse (from Figure 131) transplanted with early SEM. The flow analysis showed 0.2% 
engraftment of early SEM in the bone marrow. Dotplots of CD19 expression (y-axis) against CD34 (Left) 
and CD133 (Right)  expression (x-axis).  
 
 
As Figure 131 shows, 36% of peripheral blood lymphocytes from transplanted NSG 
mice were early SEM. The histogram on top of Figure 131 shows clearly that the mouse 
and the human peaks overlap. A more refined gating by plotting using CD19 positivity 
against PE-Cy7 (mouse antibody signal) and defining the mouse and human populations, 
can increase that number to 78% early SEM in peripheral blood. However NSG mouse 
bone marrow showed low engraftment numbers (Figure 132) as did R2G mice before. 
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As the gating strategy employed is routinely used in other mouse engraftment 
experiments within the Heidenreich group, the question arises if these low engraftment 
numbers show that early SEM are not ideal for this protocol or that early SEM despite 
forming tumours, do not highly engraft in bone marrow.  
 
6.3.1.2 Histological examinations 
 
One portion of the enlarged spleen from the experiment described above was fixed in 
formaldehyde. Sections were produced onto glass-slides and HE stained (Kieran 
O`Toole). As a control, a normal spleen was prepared in the same way (see Figure 133).   
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20x 
Figure 133  Sections of NSG mouse spleens 
NSG mice spleens from a normal mouse and an NSG mouse engrafted with early SEM. The spleens were 
sectioned and HE stained.   (Left) Normal mouse tissue    (Right) leukaemic mouse spleen  imaged at 1x 
(Top), 5x (Middle) and 20fold (Bottom) magnification, arrows with + point to nodules (white pulp), 
arrows with # point to red pulp. Imaged with the Aperio system. 
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The images of the leukaemic NSG spleen and the normal spleen (Figure 133) showed 
how massively enlarged the leukaemic spleen was. This was due to leukaemic 
infiltration. The staining pattern of the control mouse spleen showed normal follicles 
stained lilac (+  arrows point to). These correspond to the white pulp which mostly 
comprises of lymphocytes. The reddish areas around the follicles represent the red pulp 
(#  arrow points to) which is mainly comprised of red blood cells and macrophages, 
but also accommodates murine haematopoiesis. In comparison to the normal spleen, this 
structure was completely wiped out by infiltration in the leukaemic spleen. The majority 
of cells are now leukaemic lymphocytes, demonstrating advanced disease. 
Tumours from all mice were disaggregated to produce a single cell suspension. The 
single cell suspension was cultured in pencillin and streptomycin containing medium to 
allow outgrowth of engrafted leukaemic cells. However, leukaemic cells recovered from 
the mouse did not survive in in vivo culture.  
 
 
6.3.2 Establishment of an SEM in vivo monitoring in 
mice 
 
6.3.2.1 SEM cami injections i.f., i.v. 
 
SEMcami are lentiviral expression vector transduced SEM, which express both GFP 
and Dsred making it easier to capture signal than with GFP alone. The corresponding 
vector and transduction was made by Vasily Grinev. 
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6.3.2.1.1 Hair removal 
 
One obstacle for in vivo monitoring of fluorescent leukaemic cells is that the fur reflects 
the excitation light and leads to a high background. Even if shaved (with a hair clipper) 
the hair follicles are enough to block signals.  To overcome this, the skin had been 
treated with the depilatory cream Veet, which also removes hair follicles. This was done 
on dead mice but can also be applied to living, anesthetized mice over a restricted area 
(see Figure 134).  
 
Figure 134  NSG mouse with fur and with Veet hair removal 
The fur of a NSG mouse was removed with veet cream.  (A) NSG-mouse with fur   (B) NSG mouse with 
Veet hair removal at the lower dorsal side. This mouse was also injected intrafemurally (i.f.). Imaged with 
an one colour filter. 
 
 
These images (Figure 134) showed that Veet removed hair-follicles in the lower back 
skin.  
NSG mice which had been injected intra-femorally with SEMcami 1.5 months ago were 
sacrificed and then images taken with excitation light and filters for fluorescence. Each 
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mouse was imaged successively with fur and then having been shaved, Veet treated, 
skinned and then after removal of muscle groups (see Figure 135, Figure 136 and Figure 
137). The brain was also dissected out and imaged separately to investigate the origin of 
signal coming from the head (see Figure 138). Frequently the signal was too weak to 
image through the skin. Sometimes a faint signal could be seen. Early experiments used 
an older imaging device (Lightbox) and sub-optimal filters, which only allow passage of 
either one of the fluorescent colours. 
 
Figure 135  NSG mouse i.f. transplated with SEMcami 
The back of a NSG mouse with i.f. transplanted SEMcami  (A) skin removed   (B) muscles above the 
right femur were removed    (C)  muscles above both femurs removed.   Imaged with an one colour filter. 
  
The images of the skinned mouse above (Figure 135) showed that SEMcami infiltrated 
both knees, the spine (lumbar to chest), the hips and several rip bones. The removal of 
muscles above the femurs revealed strong signals from both femurs, although the 
injection site was right. The SEMcami signal appears turquoise, while the green signal 
from the feet and the head results from reflection from the fur. The yellow signal from 
the intestines represents auto-fluorescence. At the right side of each picture a mirror is 
present, showing a right lateral view of the mouse. 
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Figure 136  NSG mouse injected i.f with SEMcami 
An NSG mouse injected i.f. with SEMcami.  (A) Dorsal side, hair removed with a hair clipper,  (B) 
Dorsal side, skin removed   (C) Ventral side, skin removed.   Imaged with an one colour filter. 
 
Having removed the skin of the mouse shown in Figure 136, a strong signal is revealed 
from the both knees, the right femur and the lumbar spine. Weak signals were present 
from the hips and some ribs. As mentioned before, green light represents reflection from 
the fur shown in Figure 134 A. In Figure 136 B, a mirror at the right side is shown. In 
Figure 136 C, mirrors are positioned on both sides of the mouse, seen from the ventral 
aspect. Here the strong intestinal auto-fluorescence in yellow can be seen. 
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Figure 137  Panel of a control mouse and an i.f. transplanted NSG mouse 
(A) control mouse, skinned, backside and not injected    (B-D) NSG mouse injected i.f. with SEMcami  
(A) hairs above right femur removed (hair clipper)   (B) mouse skinned and   (D) right femur muscles 
removed. Imaged with an one colour filter. 
 
In this panel (Figure 137) a skinned control mouse is shown alongside an injected 
mouse with a right leg tumour in showing progressive removal of fur, skin and muscle. 
This tumour delivered such a strong signal that it could be seen even through hair-
clipped fur. Skin and muscle removal showed that the tumour was surrounding the right 
knee region also involving muscle and other tissues. A weak signal from the spine was 
suggestive of vertebral infiltration.   
 
The following mice had been injected intravenously and were imaged using the filters 
and equipment mentioned above.  
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Figure 138  NSG mouse 1 transplanted i.v. with SEMcami 
NSG mouse injected i.v. with SEMcami.   (A) dorsal side of skinned mouse    (B)  muscles above 
cranium removed and   (C) isolated cranium, backside (Left); brain (Right). Imaged with an one colour 
filter. 
 
Here (Figure 138) the i.v. injection of SEMcami led to a signal from the right knee and 
the lower spine. Following removal of the skin from over the cranium, a signal can be 
recorded. The isolation of the cranium and the brain showed that the cranium (left) was 
infiltrated while the brain (right) showed no specific fluorescence. At the right side of A 
and B a mirror gives a lateral view. 
Next, another NSG mouse is shown which had been injected i.v. with SEMcami and 
monitored for signs of engraftment. 
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Figure 139  NSG mouse 2 with i.v. transplant of SEMcami 
Dorsal side of a skinned NSG mouse injected i.v.with SEMcami. Imaged with an one colour filter. 
 
 
In the image above (Figure 139), turquoise signal of SEMcami is present in the lower 
skeleton while intestines show yellow auto-fluorescence. 
This single image from one NSG mouse 2 confirmed again that predominantly the hips 
and lower spine were infiltrated by SEMcami. 
 
Next a third NSG mouse injected i.v. with SEMcami is shown (see Figure 140). 
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Figure 140  NSG mouse 3 injected i.v. with SEMcami 
(A) dorsal side with fur   (B) skinned, ventral side and   (C) skinned, left side (right: mirror image of 
back). Imaged with an one colour filter. 
 
 
In the panel (Figure 140) of this mouse, signals were captured from both knees and the 
spine. Picture A shows NSG mouse 3 with fur. In picture B the ventral side of this 
mouse is shown with specific signals from the knees while the feet show green 
reflections and the abdomen shows yellow auto-fluorescence. Picture C shows 
SEMcami signal in the left knee and the lower and middle spine, which can be seen in 
the mirror at the right side of the picture. Here single engrafted vertebrae are shown. 
 
 
The following images were captured from mice injected i.v., i.f and s.c. with SEMcami. 
In contrast to the previous images, these were captured using a dual filter which allowed 
recording of the green signal from GFP as well as the red signal from Dsred resulting in 
higher signal strength and a lower background. These two signals (red and green) 
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generate a composite signal which, depending on the filter used, generate a rather 
turquoise specific signal, as seen in previous images, or a light blue signal, seen in the 
following images.  
 
Figure 141  NSG mouse injected i.v. with SEMcami 
(A) hair removed with Veet   (B) skinned, dorsal side   (C) muscles above femurs removed and  (D) inter-
costal tumor cut and turned over. Imaged with a dual filter (GFP + Dsred). 
 
These images (Figure 141) of i.v. injected mice showed a weak signal through the skin 
in the tail region (injection site), the left hip and the right dorsal thorax/rib region. 
Skinning also revealed infiltration in the right hip, the knees, the cranium and an 
intercostal tumour. Under the muscles there was also signal from the femurs. Cutting 
out and flipping of the inter-costal tumour revealed that the majority of the infiltrated 
cells had localized above the ribs. 
The skull vault and the brain were removed from this mouse also. Imaging confirmed 
leukaemic infiltration of the cranium and not the brain (Figure 142). 
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Figure 142  Cranium and brain of NSG mouse 
Mouse from Figure 141   (Top) isolated cranium   (Bottom) brain.  Imaged with a dual filter (GFP + 
Dsred) 
 
 
 
The following mice were injected subcutaneously with SEMcami using a medium with 
high viscosity which retains the cells were they were injected. This was done to 
investigate how well signal can be detected through the skin. 
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Figure 143  NSG mouse injected s.c. with SEMcami 
(A) right side, hair cut  (B) right side, hair removed by Veet   (C) hair removed, dorsal side.  Imaged with 
a dual filter (GFP + Dsred). 
 
 
Figure 144  NSG mouse injected s.c. 2nd panel from Figure 143 
(A) skinned   (B) muscles above femurs removed   (C) isolated cranium (Top), brain (Middle) and back of 
s.c tumor (Bottom). Imaged with a dual filter (GFP + Dsred). 
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The first panel of this mouse (Figure 143) proved that strong signal can be detected 
even throughout the fur. A comparably big right s.c. tumour was present. This mouse 
also showed that if the signal is strong enough, the imaging parameters can be set 
optimally leading to low background. 
The second panel (Figure 144) of this mouse shows spine, femur and strong cranial 
infiltration from SEMcami which had disseminated from the s.c. injection site. As 
before the brain showed no infiltration.  
Concluding, these results show that primary SEM can engraft in R2G and NSG mice 
and form tumours, however bone marrow did not seem to be preferred for engraftment. 
The imaging work with cell line SEM shows the value of hair removal, the double 
fluorescent cell line SEMcami and double filters. Most importantly SEMcami show 
good engraftment especially in large bones and especially in this context the imaging in 
the whole mouse proved to be very useful.  
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6.4 Discussion mouse results 
 
The aim of this chapter was to investigate MLL/AF4 in vivo to expand the data gained 
in vitro into a more physiological context. For that, a mouse imaging model had to be 
established to track engrafted MLL/AF4 positive or leukaemic cells in general, how 
they distribute and where they form tumours first, in mice.  
Intra femoral injection of early SEM, MLL/AF4 positive patient cells, into NSG and 
R2G mice affected health and survival in those mice. Unfortunately two NSG mice died 
before a sample could be taken. Most likely the injected early SEM restricted survival. 
Because other mice were injected with the same batch of cells, it is unlikely that the 
injection, which took place in a sterile environment, caused the death of the animals by 
an infection. However two rag mice were sacrificed one month after injection and 
analysed for engraftment in bone marrow and blood. The first R2dKmouse showed low 
numbers of cells defined as non-mouse cells (Figure 128). By comparing these 
transplantation derived cells to the whole number counted, low engraftment was found. 
Although human cells were present in the blood, the proportion was lower than 0.01%, 
although the few cells were classified as human. For the bone marrow analysis fewer 
cells were analysed, therefore even low numbers of cells classified as human generated 
a proportion of 0.2%. Flow cytometric analysis of control early SEM showed high 
CD19 expression levels, a B-cell marker, and high CD133 levels, a stem cell marker. 
The second R2G mouse had an abdominal tumour with a slightly enlarged spleen. A 
very clear early SEM signature from a distinct population was found (Figure 129). 
However in comparison to the majority of cells these did only comprise for 0.1%. The 
blood contained no human cells at all. Recently the involvement of natural killer cells in 
rejection of engraftment of human hepatocytes in R2G and NOD/SCID mice was shown 
Chapter 6 Mouse work 
289 
 
(Kawahara, Douglas et al. 2010), however both mouse strains used should have very 
low levels of natural killer cells. Referring to this, a possible explanation for low 
engraftment could be a remaining low activity of natural killer cells. Earlier work 
indicated that unconditioned, e.g. not irradiated, mouse strains have fewer niche space 
available to engraftment for HSCs (Bhattacharya, Rossi et al. 2006).  
The one surviving NSG mouse was sacrificed and harvested. The section showed an 
enormously enlarged spleen of approximately 5cm length and 1cm thickness. 
Additionally a huge rubber like tumour at the back of the right femur (injection site) 
was found, as well as an enlarged unfilled bladder. Bone morrow and blood was  
analysed as before. The blood showed 36% human cells with clear early SEM signature, 
a high expression of CD19 and CD133 (Figure 131). However the bone marrow 
analysis showed only few cells which only comprised 0.2% of all cells (Figure 132).  It 
was reported that enlarged spleens can also be caused by extramedullary haematopoiesis 
to replace supplanted haematopoiesis (van der Loo, Hanenberg et al. 1998). However, 
the low bone marrow engraftment makes a displacement of murine HSCs unlikely. 
More likely these cells are reduced in their ability to migrate and could therefore favour 
the spleen as an easy accessible niche. 
Cells from several organs were isolated and put into culture. Due to the large number of 
mouse cells present after organ-extraction, which die in culture, a huge amount of debris 
is crowding the cells intended to culture. The large, almost “white” spleen, compared 
with the dark red spleen from a normal mouse, was sectioned, PE stained and analysed 
using a half automated imaging system (Aperio). The histological structure of that 
spleen was compared to a normal mouse spleen (Figure 133). Several magnifications 
showed that the normal histological structure was wiped out. The spleen was highly 
engrafted; normally a sign of advanced leukaemia. In contrast the low engraftment in 
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the bone marrow does not support this. As a similar finding was made in a R2G mouse 
with tumour, but no substantial engraftment in the bone marrow, it is unclear if these 
early SEM preferably engraft non bone marrow murine tissues or if the time given to 
engraft was enough to form tumours or spleen enlargement, but not for bone marrow 
engraftment. Additionally the properties of SEM such as the tendency in forming 
tumours may just out compete tumour growth to bone marrow engraftment. In contrast, 
bone marrow samples of siRNA treated SEM (cell line) injected into mice, contained 
substantial numbers of CD45 positive cells (Thomas, Gessner et al. 2005) indicating 
that human cells (SEM) had engrafted. The established cell line SEM shows high 
proliferation and less dependence on growth factors compared to primary SEM. 
Another possibility is the gating method which gates out cells by mouse antibody 
staining. The fact that pure early SEM are determined as 82% non-mouse cells shows 
that there is loss of cells in this analysis. For example if gated by CD19 versus PE-Cy7 
mouse specific antibody TER119, the number of human cells in the NSG blood rises 
from 36 to 78%. However, this different gating approach did not change the ratios in the 
bone marrow samples. Both methods of gating were established and used successfully 
for detecting engraftment with many different patient cells (le Viseur, Hotfilder et al. 
2008). Maybe the early SEM cells are less accessible to this method or are not 
preferably engrafting in the bone marrow, at least in these two mouse models. 
Most interestingly early SEM cells produced 2 second high CD34+ population after 
engraftment compared to control early SEM (Figure 130). There were early reports 
stating that a human CD43+CD38- stem cell fraction has the ability to engraft in 
NOD/SCID mice and re-establish leukaemia (Lapidot, Sirard et al. 1994).  
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Additionally, the CD19 signature seemed to drop, sometimes more than 2 decades. In 
this context, observations in co-cultured patient MLL/AF4 cells showed lower CD19 
levels than in cell line SEM. Hotfilder et al. and Castor et al. have  found immature 
CD34+CD19- cells in two types of high-risk ALL, these were infant ALL with a 
translocation t(4;11) and Philadelphia chromosome-positive ALL (Castor, Nilsson et al. 
2005; Hotfilder, Rottgers et al. 2005). The increase in CD34 expression could indicate 
that the cells reactivate stem cell programs and also indicate a role in the niche. 
The second part of my mouse work dealt with the imaging of fluorescent MLL/AF4 
positive cells engrafted in NSG mice.  For this, fluorescent SEMcami, which had been 
generated by Vasily Grinev by transduction of SEM with a lentiviral expression vector, 
were used. SEMcami express GFP and DsRed, allowing for fluorescent detection. As 
preliminary experiments show, fur of mice can strongly block a fluorescent signal and 
reflect excitation light, used to induce fluorescence, which produces a strong 
background. To be able to detect weak fluorescent signals from small numbers of cells, 
we worked on hair removal strategies (technical assistance from Mike Batey). Hair 
clipper cut fur still blocks fluorescent signal strongly, therefore hair follicles were 
removed using Veet cream (Figure 134). This treatment can be performed on 
anesthetised live animals, apart from the head and other sensitive areas. In the following 
data, sacrificed mice had been used, showing an endpoint analysis. 
3 NSG mice transplanted i.f. with SEMcami showed engraftment in femurs knee joints, 
vertebrae, rip bones, hips and soft tissue (tumours). Some signals from bones could be 
enhanced or even unveiled by removal of covering muscles. Overall, i.f. injections of 
SEMcami showed engraftment of SEMcami, tumour formation and preferential 
localisation to large bones (Figure 135, Figure 136 and Figure 137). 
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Intravenous injections of SEMcami into 4 NSG mice showed engraftment in femurs, 
rips, hips, vertebrae, soft tissue (tumours) and cranium. The brains of those mice with 
cranium infiltration showed no signal. These data showed that also i.v. injected 
SEMcami engraft preferably in bone tissue, especially the detection in the cranium is 
interesting. SEMcami behave like SEM, they are more aggressive and engraft easily in 
several tissues compared to primary SEM (Figure 138, Figure 139, Figure 140, Figure 
141 and Figure 142). 
As many of the bone engraftment signals were only retrieved after skin and muscle 
removal this method was not sensitive enough to monitor living mice, at least not in that 
stage of the disease. The use of a dual filter, which allows green and red light to pass, 
increased the signal strength and quality.  
The through skin and tissue signal imaging was further tested by injecting SEMcami in 
the viscous matrigel medium. This medium has a high viscosity and keeps the cells 
together, enabling the generation of subcutaneous tumours. The accumulation of high 
numbers of fluorescent cells was thought to produce strong signals for imaging. As 
expected tumour signals could be detected through the skin and even through clipped 
fur. Interestingly this s.c. injected mouse also showed engraftment in femur, vertebrae 
and cranium. No signal was found in the brain as before (Figure 143 and Figure 144). 
The Heidenreich group has shown before that SEM with normal levels of MLL/AF4 
transcript engrafted in liver, spleen and bone marrow of intraperitoneal injected NSG. 
SEM depleted for MLL/AF4 showed reduced engraftment, especially the spleen was 
much smaller than the spleens from mice with non depleted MLL/AF4 expression 
(Thomas, Gessner et al. 2005). As mentioned before engraftment in the spleen produced 
an enlarged organ. 
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All injection methods used in this thesis such as i.f., i.v. and s.c., showed engraftment of 
SEMcami. In the i.f. injected mice we could detect cranium infiltration. Moreover mice 
injected i.f. in the right femur also showed engraftment in the left femur. This shows 
that cells must have left the bone, circulated in the blood stream and settled in the femur 
and other large bones. Additionally a gradient of signal strength from lumbar to cervical 
vertebrae was observed in several mice. This gradient cannot have been generated by an 
intraspinal migration. An explanation would be that circulating cells leave the blood 
stream and migrate into vertebrae preferably in the lumbar spine because here the 
cavities are bigger and probably more blood vessels penetrate it.  
Large bones contain the spongiosa structure, a trabecular structure with many cavities 
and blood vessels. The bone marrow niche for haematopoietic and also leukaemic stem 
cells is thought to be located here. By the high vascularisation blood cells or even 
tumour cells can access the bones and subsequently the bone marrow. The environment 
there, formed by stromal cells such as endothelial cells, osteoblasts at the bone site and 
fibroblasts, is called the endosteeal niche. It provides secreted factors such as 
interleukins 6 and 8, which possibly attract migration though the vessels. This 
enviromnemt also provides adhesion factors which allow the cell to settle. Interactions 
like this also regulate the “homing” cells in growth and differentiation. Shiozawa 
proposed that cancer cells could act as “parasites of the niche” (Shiozawa, Havens et al. 
2008). 
The engraftment of MLL/AF4 positive SEMcami in cranial bone is a very interesting 
finding, because the first real time imaging of HSC cell - bone marrow niche migration 
was made in the cranial region of mice (Xie, Yin et al. 2009).  
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The problem of lacking signal strength for the detection of leukaemic cells was 
addressed very recently by the purchase of a state of the art mouse imager. Additionally 
generation of SEM with luciferase expression was used in the Heidenreich group, 
allowing repeated detection of fewer cells in living mice even through fur. The model 
established in this thesis provided the rational for this further improvement of an 
imaging system. 
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Chapter 7 General Discussion 
 
 
7.1 Summary of thesis 
 
MLL/AF4 leukaemia is the most common infant leukaemia. It is a high risk acute 
lymphoblastic leukemia and associated with a poor treatment outcome. The fusion gene 
causing this disease, MLL/AF4, is generated by the reciprocal translocation between 
chromosome 4 and chromosome 11. Extensive research and numerous publications over 
the last 20 years have increased the understanding of how the fusion gene is generated 
and how it functions. Despite the many advances in understanding, the most recent 
treatment protocol failed to achieve cure, defined by the 5 year event free survival, in 
two thirds of cases. Therefore the understanding of MLL/AF4 biology has to be 
improved. 
This thesis investigated several topics. Firstly this work validated gene expression array 
data of MLL/AF4 depleted t(4;11) ALL cells, identified and investigated several 
potential target genes of MLL/AF4. Secondly this study aimed to analyse identified 
target genes of MLL/AF4 in the haematopoietic stem cell niche context. For this an 
interaction system had to be established to analyse bone marrow feeder - leukaemic cell 
interactions.  Thirdly this work aimed to develop a lentiviral gene expression system to 
investigate MLL/AF4 target genes by over expression. Finally the biology of MLL/AF4 
cells was investigated in an in vivo context using immuno deficient mice. An imaging 
model was developed to track engrafting and migrating MLL/AF4 leukaemic cells  
The expression array analysis was carried out in MLL/AF4 positive SEM cells, which 
had been treated with MLL/AF4 and control siRNA. Gene pattern changes 
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corresponding to the comparison of MLL/AF4 control cells and MLL/AF4 depleted 
cells were analysed for their significance and bio-informatically linked to functions, 
pathways and diseases by the Ingenuity Pathway Analysis 8.5. Additionally, interesting 
candidates were validated by qRT-PCR. Ingenuity Pathway analysis showed three main 
groups of functions, pathways and diseases: cancer / leukaemia, haematopoiesis / niche 
and inflammation. 
MLL/AF4 is clearly related to leukaemia as several publications have indicated its 
oncogenic potential (Chen, Li et al. 2006; Metzler, Forster et al. 2006)  and its 
restriction to mostly lymphocytic leukaemia (Pui and Campana 2007; Lazic, Tosic et al. 
2010; Zuo, Zhang et al. 2010), rarely myelocytic leukaemia (Shih, Liang et al. 2006) but 
not to cancer of other tissues.  
MLL/AF4 was functionally implicated in the haematopoietic niche as mesenchymal 
stem cells of t(4;11) positive patients expressed the fusion gene MLL/AF4 and thus the 
authors assumed the bone marrow environment played a role in the disease (Menendez, 
Catalina et al. 2009). TIE-2, which is known to be involved in the regulation of the 
vascular niche was reported to be expressed in some t(4;11) cells (Hu, Li et al. 2009). 
Marschalek speculated that leukaemic cells interact with the niche to support survival 
and reduce stress caused by oncogenic MLL fusions (Marschalek 2010).  
The last main group of function, pathways and diseases associated to MLL/AF4 was 
inflammation. This was the most surprising finding. However MLL/AF4 was linked to 
interferon (IFN) response recently. Although many ALLs are known to be IFN resistant, 
the two tested MLL/AF4 cell lines SEM and RS411 were not and NF-kB was found to 
be an important transcription factor in interferon response (Tracey, Streck et al. 2010). 
The Heidenreich group found no increase in interferon response due to MLL/AF4 
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depletion (Thomas, Gessner et al. 2005), however the depletion of MLL/AF4 may 
increase inflammation pathways i.e. Interferon independent. A possible explanation is 
that the time interval after siRNA mediated MLL/AF4 depletion was not sufficient. 
Alternatively, inflammation signalling could be a consequence of the leukaemic biology 
of the cells rather than a response to siRNA treatment. In a study of children with ALL 
increased inflammation markers (TNF-alpha and IL-6) were found at diagnosis. After 
induction of chemotherapy inflammatory chemokines were significantly reduced 
(Giordano, Molinari et al. 2010). This could suggest that inflammation signalling may 
help cancer cells to allow proliferation in combination with a differentiation block 
resulting in the propagation of a leukaemic population. MLL/AF4 could help the cells to 
survive inflammation related apoptosis due to their apoptotic resistance. 
Gene array analysis is a powerful tool in examining MLL/AF4 related gene expression 
patterns which can provide insights into the biological functions. Other  groups 
experienced in MLL/AF4 research have investigated MLL/AF4 related gene expression 
by array analysis as well (Gaussmann, Wenger et al. 2007; Guenther, Lawton et al. 
2008; Stumpel, Schneider et al. 2009).  The effect of MLL/AF4 on epigenetic regulation, 
which is known to be important in malignant processes, can be addressed by 
methylation array analysis. Recent work from Ronald Stams group analysed 
methylation patterns of MLL rearranged leukaemias and showed MLL fusion specific 
promoter methylation, particularly MLL/AF4 related hypermethylation. Additionally 
methylation patterns corresponded to clinical outcomes of patients (Stumpel, Schneider 
et al. 2009).  
MLL/AF4 targets DOT1L a H3K79 (histone 3 lysine 79) methylase. The fusion gene 
can recruit DOT1L to new methylation sites upregulating genes important for 
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haematopoietic stem cell function, chromatin regulation such as histone demethylases, 
cell signalling and cycle progression (Barry, Corry et al. 2010).  
 
The use of MLL/AF4 cell-lines for gene expression arrays has some restrictions, as cell-
lines often acquire several mutations which makes it unclear if observed expression 
patterns are only related to MLL/AF4 depletion or are a consequence of mutations. 
However, patient material is difficult to manipulate, so far. For the future, the use of 
more primary material such as early SEM could be beneficial, as knockdown of 
MLL/AF4 in the latter proved to be feasible (unpublished work). 
From the validated genes especially HOXA7, FGFR1, MEF2C, DUSP6 and N-cadherin 
were significantly down-regulated upon MLL/AF4 depletion. 
HOXA7 is known to be involved in the regulation of haematopoiesis. Additionally, 
involvement in leukaemia was reported as research has shown HOXA7 was 
dysregulated in AML and mixed lineage leukaemias (Eklund 2007). FGFR1 is known 
to be involved in chromosome 8 translocation related fusion genes. As patients with an 
FGFR1 fusion gene mostly suffer from myoproliferative neoplasms (Patnaik, Gangat et 
al. 2010) it could show the influence of FGFR1 on proliferation and transformation. 
MEF2C was reported to regulate homing and invasiveness in MLL fusion, MLL/ENL 
positive, AML patients (Schwieger, Schuler et al. 2009). In a very recent study N-
cadherin amongst other adhesion molecules was found to be upregulated in AML 
leukaemic stem cells (LSC) by chemotherapeutic treatment. The authors stated that 
interaction of LSCs and the niche environment by adhesion molecules played a role in 
chemoresistance (Zhi, Wang et al. 2010).  Very recent findings strengthen the role of N-
cadherin in the endosteal niche. One of such was the work of Nakamura et al., who 
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showed that the osteoblast fraction of the endosteal niche which most strongly 
supported long term reconstitution activity of HSCs, were high in cadherin expression 
and expressed cytokines such as angiopoietin 1 (Nakamura, Arai et al. 2010).  The 
initial finding that N-cadherin expression was altered in our array and in related 
analyses had focused our attention towards the niche, although the importance of N-
cadherin in the HSC niche regulation was doubted by some authors who saw a lack of 
evidence for the requirement of N-cadherin for HSC (Kiel, Radice et al. 2007). N-
cadherin is playing an important role in the haematopoietic niche regulation (Hosokawa, 
Arai et al. 2010), however due to the complexity of regulation by secreted factors, 
adherence molecules and numerous involved pathways it is not justified to regard it as 
an irreplaceable actor in the niche (Li and Zon 2010).  
Furthermore MLL/AF4 related functions such as “Haematopoiesis” and validated 
genes such as N-cadherin and FGFR1 strongly pointed to the HSC niche and this aspect 
was investigated in more detail.  To test such interactions an assay involving bone 
marrow fibroblasts had to be established. Co-culture of haematopoietic cells with bone 
marrow feeders such as HS-5 have been used for many years to increase survival of 
primary patient material (Seiffert, Stilgenbauer et al. 2007; Lwin, Crespo et al. 2009).   
Several obstacles had to be overcome to establish the feeder assay and analyse co-
cultured leukaemic cells. The separation of leukaemic cells from feeders had to be done 
in the data analyses of experiments as the harvest of cells by trypsination also caused 
feeders to be removed. If specific inhibitors of main feeder – leukaemic cells adhesion 
molecules were identified they could be used for such a separation and the latter would 
be even more interesting as a therapeutic option.  Several such adhesion molecules 
inhibitors are known. For example matrix adhesion induced by N-CAM could be 
blocked by inhibitors of FGFR signalling and anti-1-integrin antibodies (Cavallaro, 
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Niedermeyer et al. 2001). N-cadherin adhesion could be targeted by a HAV domain 
mimetic peptide or a N-cadherin specific blocking antibody; both of which were 
described in the investigation of N-cadherin mediated adhesion (El Sayegh, Arora et al. 
2004). Finally small-molecule inhibitors of 4-integrins were indicated to interfere with 
lymphocyte adhesion (Martin, de Moraes et al. 2005) and could be used to reduce 
leukaemic cell adhesion to feeder cells.  
While establishing the feeder assay it could be shown that leukaemic cells adhere to the 
feeder cells, are easily distinguishable from feeders and can be harvested and analysed 
for gene expression, apoptosis and proliferation. Feeder co-culture of SEM cells and 
SEM depleted for MLL/AF4 increased proliferation particularly at low cell 
concentrations. The M210B4 feeders used in this assay were reported to secrete growth 
factors and to induce cell expansion of haematopoietic progenitors (Koschmieder, Bug 
et al. 2001).  Additionally SEM cells, SEM depleted for MLL/AF4 and t(4;11) positive 
patient cells showed increased viability when grown on feeders.  In concordance with 
this M210B4 co-culturing was reported to increase survival of CLL patient cells 
(Edelmann, Klein-Hitpass et al. 2008).   
In a rather recent work a Japanese group presented a “biomimetic osteoblast niche”. 
They created a “3 D” niche by using bone which was seeded with mesenchymal stem 
cells (MSC) of CML patients and subsequently the MSCs were induced to differentiate 
into osteoblasts. This system was used to culture CML patient cells and to analyse the 
latter by flow cytometry, colony formation assays and long term culture initiating cell 
LTC-IC assays (Hou, Liu et al. 2009). 
In order to examine the influence of feeders on gene expression of MLL/AF4 target 
genes such as FGFR1, N-cadherin, HOXA7 and TERT, SEM cells depleted for 
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MLL/AF4 were grown with and without feeders and concomitant expression profiles 
compared. In the future such a system would be useful for detecting gene responses i.e. 
due to a chemotherapeutic treatment in a bone marrow context.  
To investigate target genes of MLL/AF4, such as N-cadherin, in more detail in the 
leukaemic context, a lentiviral highly regulated expression system was designed. In this 
system target genes of MLL/AF4 are analysed by over-expression in leukaemic cells 
and their effect  on features of leukaemic cells including proliferation, clonogenicity and 
viability is measured. The design of this system was based on a two vector system; 
vector 1 coding for the tet activator and vector 2 coding for the gene to be expressed 
under the control of an inducible tet-O promoter. The tet activator expression plasmid 
(vector 1) was cloned and lentivirally transduced in t(4;11) SEM and MV4;11 cells. 
Although this vector was shown to be functional, transduced cells showed decreased 
expression of the reporter gene eGFP, which is under the constitutive control of an 
IRES element. In the literature reports show that high levels of tet activator can be toxic 
to mammalian cells (Gossen and Bujard 1992).  However stable expression of tet 
activator was successfully performed before in Jurkat cells transduced with a retroviral 
tTA vector (Jurkat-tTA cell clone 4D9#32) (Chu, Pardo et al. 2003).  Very recently a tet 
on transgenic rat, expressing tet activator, was reported. When transduced with a 
TetO7/CMV-EGFP lentivirus, fibroblasts from this tTA rat showed doxycycline 
inducible and dose dependent eGFP reporter gene expression (Sheng, Lin et al. 2010).  
The cloning of vector 2 could not be finished in time and stopped at the stage of the ppc 
(ptre-PGK-mcherry) cassette which only has to be inserted into a suitable lentiviral 
vector.  
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Lentiviral (over)expression has already been used to investigate target gene functions. 
For example, CAV1 function which is known to mediate radioresistance, was tested by 
over-expression with a lentiviral SIN vector in the lymphoblastic TK6 cell line (Barzan, 
Maier et al. 2010).  More advanced regulated over-expression of target genes was 
reported using the tet-off system and regulating expression with doxycycline (Kim and 
Lee 2009). More recently a double transduced teton tet-O system, induced by 
doxycycline, was used to investigate FGF10 by over-expression (Gupte, Ramasamy et 
al. 2009). However, the tight (low basal expression) and highly regulated gene 
expression to investigate functions of genes of interest still remains an important goal. 
The latter is of interest because genotoxic proteins are difficult to analyse with common 
expression systems. 
In addition to the investigation of MLL/AF4 target genes by lentiviral over expression 
the biology of MLL/AF4 was also addressed in a more appropriate physiological 
context. For this xenotransplantation mouse models were used which study human 
leukaemic cells following engraftment.  
Early SEM cells which are an early passage of SEM, derived from patient material, 
were transplanted intrafemorally into R2G and NSG immuno deficient mice. Early 
SEM cells are unlike the established cell line SEM, as they grow slowly and are 
sensitive in culture. Although these t(4;11) cells were able to form tumours in R2G mice 
and possibly impacted survival if sufficient time was given before sacrificing them, cell 
numbers of primary SEM were quite low in peripheral blood and bone marrow. 
However R2G mice are not a common model for xenotransplantation in leukaemia; the 
majority of ALL xeno-transplantaion models published use NOD/SCID mice (Yu, Yang 
et al. 2008).  
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From the three NSG mice transplanted two died before analysis could be performed, 
possibly due to leukaemic cells restricting survival. The one surviving NSG mouse 
showed large tumours and a massively enlarged spleen, which was shown to be 
infiltrated by leukaemic cells by histological analysis. The blood was crowded with 
leukaemic cells which made up for more than 60%, however only a small number of 
leukaemic cells were present in bone marrow. No work was published stating bone 
marrow engraftment of primary SEM cells. The Heidenreich group has shown bone 
marrow engraftment of cell line SEM cells previously (Thomas, Gessner et al. 2005). 
A possible explanation could be that primary SEM are not as aggressive as cells which 
received additional events to transform into a cell line. Cell line SEM cells were 
injected intra hepatically into Rag newborn mice which restricted survival and produced 
tumours (data not shown). However cell line SEM are so aggressive that they formed 
tumours in i.p. injection directly at the site of injections (data not shown). Additionally 
the Heidenreich group has shown that beside forming tumours, i.p. injected SEM still 
produced a leukaemic phenotype in NSG mice (Thomas, Gessner et al. 2005). To 
retrieve more aggressive primary SEM - organs such as spleen, liver, kidneys and 
tumour tissues were isolated and cultured from mice with tumours. However even from 
the highly infiltrated NSG spleen tissue no leukaemic cells could be maintained in 
culture or amplified (data not shown) 
Reducing injected cell numbers and increasing the time until such immune deficient 
mice are sacrificed could help to develop a more leukaemic phenotype.  It was shown 
that in the mouse model used in this thesis, even 1000 cells could engraft and give rise 
to bone marrow infiltration (le Viseur, Hotfilder et al. 2008). 
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As these type of experiments relied on the right time point to sacrifice animals to be 
able to see engraftment, tumours and a leukaemic phenotype - the development of the 
disease is difficult to track, apart from taking bone marrow punctures and blood samples 
at various time points. To be able to monitor location and progression after engraftment, 
a mouse system using fluorescent SEM cells was developed. For the development and 
testing, mice were injected i.f., i.v. and s.c. and sacrificed after a timepoint estimated to 
be sufficient. 
Fluorescent, stably GFP expressing ALL cells were used before to track cells in vivo; in 
such a work Nalm-6 cells were investigated for their homing into bone marrow niches, 
however for the imaging the skin of the back of the skull had to be opened under 
anaesthesia to allow microscopic imaging (Colmone, Amorim et al. 2008) which is 
invasive and makes repeated imaging ethically and technically questionable.  
As the fur proved to be an effective barrier for fluorescent signal, a method was 
established to remove areas of fur which would also be suitable with anesthetized living 
animals. Apart from establishing this system, engraftment in large bones such as spine, 
cranium and femurs could be shown. The model will be further improved as the Faculty 
has purchased a state of the art, (IVIS, In Vivo Imaging System) sensitive live imager. 
Additionally the development of a luciferase SEM cell in the Heidenreich group has 
succeeded and will increase signal strength and reduce background in mouse imaging. 
Recently such as system was reported for murine xenograft models using cell lines such 
as THP1 (acute leukaemia) with an improved red shifted luciferase signal (Mezzanotte, 
Fazzina et al. 2009).   
In the future the Heidenreich group will be able to track small amounts of leukaemic 
cells in living animals at various time points, further improving the understanding of the 
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pathology of t(4;11) positive cells. The imaging system developed in this thesis could 
also be used to investigate therapeutic compound functions in a physiological context. 
 
7.2 Overall summary 
 
In summary this work validated target genes of MLL/AF4 and provided evidence for 
associated biological functions. The feeder assay established during this project showed 
the influence of bone marrow feeders on MLL/AF4 positive SEM and patient cells, 
enhancing proliferation and survival. A lentiviral expression system was designed and 
should allow the functional analysis of MLL/AF4 target genes by over-expression. The 
more physiological investigation of MLL/AF4 biology in mouse engraftment models 
and the development of an in vivo imaging system in mice can offer more detailed 
understanding of MLL/AF4 and has already provided evidence for the preferential 
engraftment of t(4;11) positive SEM into large bones of transplanted mice. Finally this 
work provided the basis for subsequent live imaging of leukaemic cells in NSG mice. 
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Appendix 
 
cDNA array data 
 
97 most significantly altered genes from the cDNA array fold change >2 
genes >2 are genes upregulated more than 2 fold 
genes < 0.5 are genes downregulated more than 2 fold  
 
 
 
Gene Fold change Gene Fold change Gene Fold change
ACSL3 0.49 GABPB2 0.47 SEMA3B 0.48
ALDOC 0.33 GLG1 0.36 SERPINE2 0.20
ANTXR2 0.46 GNA15 0.49 SERPINE2 0.21
APP 0.37 INSIG1 0.39 SLC12A7 0.46
ATP2B3 0.45 IRX3 0.39 SLC20A1 0.27
B3GNT1 0.32 ISLR 0.44 SLC2A3 0.49
BMI1 0.29 KIAA0828 0.43 SLC2A5 0.36
BMP4 0.50 LAPTM5 0.34 STS-1 0.38
BNIP3 0.33 LRIG1 0.51 TERF2 0.49
BNIP3L 0.48 MEF2C 0.23 TMP21 0.37
BUB3 0.48 MT1F 0.48 TRA2A 0.49
C17orf27 0.50 MT1X 0.50 UBE1DC1 0.47
C6orf33 0.41 MYO6 0.41 UBL3 0.45
C7orf36 0.37 MYST2 0.41 VAV3 0.39
C9orf91 0.50 NAP1L4 0.36 VPS39 0.50
CAMK2D 0.41 NDUFB6 0.51 AMICA1 1.97
CAT 0.47 NR3C1 0.41 ATAD3B 3.59
CD38 0.31 NR3C1 0.50 CACNA1B 2.80
CD69 0.27 P2RY5 0.47 DAAM1 2.09
CDH2 0.43 PDE7A 0.36 FBL 1.97
CHI3L2 0.47 PELI1 0.42 FLJ13639 2.66
DHRS3 0.22 PLAT 0.46 LMCD1 2.07
DTL 0.36 PLXNC1 0.31 LZTS2 2.29
DUSP6 0.20 PSAP 0.21 MAGED1 2.54
ECE1 0.40 PSMB2 0.43 NME1 1.96
EGLN1 0.46 PTPRC 0.34 PRCP 2.47
EMR3 0.35 PTPRG 0.42 RAB9P40 2.04
ENO2 0.42 RAB3IL1 0.32 REEP3 2.65
ETV5 0.29 RAB6A 0.31 RPS6KA3 2.33
EZH2 0.50 RBP5 0.48 SYT4 2.37
FBXL11 0.51 RGS16 0.50 VEZATIN 2.14
FGFR1 0.43 SCD 0.43
FGFR1 0.49 SDCBP 0.49
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oligo array data  
genes analysed by MAS with a fold change >4 
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(Hamburg), June 2007  
 
      Presentation: Identification and Characterisation of MLL-AF4 target Genes 
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Manuscript accepted in Leukaemia, June 2009 
Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukaemic self-renewal by 
controlling expression of the telomerase subunit TERT 
*Andreas Gessner1, *Maria Thomas2,5, Patricia Garrido Gastro1, Lars Büchler1, Tim 
Brümmendorf4,6, Natalia Martinez Soria2,7, Josef Vormoor1, Johann Greil3 and Olaf 
Heidenreich1 
 
Abstract 
Leukemia relapse and persistence of leukemic cells are greatly dependent on the self-
renewal capacity of leukemic cells. Telomerase plays an important role in self-renewal 
in both malignant and non-malignant cells. However, the underlying molecular 
mechanisms and genes involved in malignant self-renewal remain incompletely 
understood. MLL/AF4 and AML/MTG8 represent two leukemic fusion genes, which are 
most frequently found in infant acute lymphoblastic leukemia (ALL) and acute myeloid 
leukemia (AML), respectively. By using RNA interference, we examined more 
precisely the influence of MLL/AF4 and AML1/MTG8 fusion genes on the expression of 
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TERT coding for the telomerase protein subunit, and subsequently telomerase activity in 
t(4;11)-positive ALL and t(8;21)-positive cell lines, respectively. MLL/AF4 suppression 
diminished telomerase activity and expression of TERT. Blocking pro-apoptotic caspase 
activation in conjunction with MLL/AF4 knockdown enhanced the inhibition of TERT 
gene expression, which suggests that MLL/AF4 depletion does not reduce TERT 
expression levels by inducing apoptosis. Knockdown of HOXA7, a direct transcriptional 
target of MLL/AF4 fusion gene, caused a reduction of telomerase and TERT to an extent 
similar to that observed with MLL/AF4 suppression. Chromatin immunoprecipitation of 
SEM cells, using ectopically expressed FLAG-tagged Hoxa7, indicate HOXA7 binding 
site in the TERT promoter region. Furthermore, suppression of the AML1/MTG8 fusion 
gene was associated with severely reduced clonogenicity, induction of replicative 
senescence, impaired TERT expression and accelerated telomere shortening. We thus 
present findings that demonstrate a mechanistic link between leukemic fusion proteins, 
essential for development and maintenance of leukemia, and telomerase, a key element 
of both normal and malignant self-renewal.  
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